Document:

ANDA OWNERSHIP TRANSFER
                          AND PRODUCT LICENSE AGREEMENT

         This license agreement (the "Agreement")  dated as of May 17, 2006 (the
"Effective Date") is entered into by and between Nostrum  Pharmaceuticals,  Inc.
("Nostrum"), a Delaware corporation, and Synovics Laboratories,  Inc. ("Synovics
Labs"), a Nevada corporation.

WHEREAS,

         A. Nostrum has  developed,  and is in the process of  developing,  time
release and other technology for pharmaceutical products.

         B. Synovics Labs is researching, developing,  manufacturing,  marketing
and selling pharmaceutical products.

         C. Synovics Labs desires to license from Nostrum the exclusive right to
develop,  manufacture,  market and sell the Product (as hereinafter  defined) in
the United  States of  America,  and  Nostrum  desires to grant such  license to
Synovics Labs, all on the terms and conditions hereinafter set forth.

         NOW,  THEREFORE,  in  consideration  of the  premises,  and the  mutual
agreements hereinafter set forth, the parties hereby agree as follows:

                             ARTICLE 1 - DEFINITIONS

         The  capitalized  terms set forth  below  (whether  in the  singular or
plural) shall have the meanings indicated for the purposes of this Agreement.

                  "Affiliate" means any Person which controls,  is controlled by
         or is under common  control with Synovics Labs or Nostrum,  as the case
         may be. The term "control" means the ownership, directly or indirectly,
         of more than fifty percent (50%) of the voting stock or equity interest
         of the subject Person, or the right to receive over fifty percent (50%)
         of the profits or earnings of such Person.  Such other  relationship as
         in fact gives a Person the power or ability to control the  management,
         business  and  affairs of the  subject  Person  shall also be deemed to
         constitute control.

                  "Biobatch"  means a  batch  suitable  for  use in the  Pivotal
         Study.

                  "cGMP" means  current  good  manufacturing  practices  for the
         methods to be used in, and the  facilities and controls to be used for,
         the manufacture,  storage and handling of the Product, all as set forth
         from  time-to-time  by the FDA pursuant to the federal  Food,  Drug and
         Cosmetic  Act and the  rules  and  regulations

                                       1
<PAGE>

         promulgated thereunder (including  specifically,  Title 21, part 211 of
         the Code of Federal Regulations of the United States).

                  "FDA" means the United States Food and Drug  Administration or
         any successor agency of the United States government.

                  "Future  Strength"  shall mean a to be  determined  additional
         strength of extended release  metformin  formulation  using the Nostrum
         Technology  that  may be  developed  and  filed as a  separate  ANDA in
         Synovics' discretion.

                  "TRANSFERED  FILING" shall mean  Nostrum's ANDA No. 76-756 for
         the  Product  and  supplements   thereto,   including  all  pending  or
         in-process   registrations  issued  by  United  States  Food  and  Drug
         Administration related to the Products.

                  "Litigation  Expenses"  shall  mean  out-of-pocket  costs  and
         expenses  incurred by Synovics Labs (i) connection  with the defense of
         any claim,  suit or other legal action  alleging that the Product being
         marketed  and  sold  by  Synovics  Labs  hereunder  infringes  upon  or
         misappropriates  a third party  patent or other  intellectual  property
         right or (ii) in connection with the resolution of any such claim, suit
         or other legal action, including any judgment or award against Synovics
         Labs or any of its Affiliates or subcontractors and any amounts paid in
         settlement (including license fees and royalties).

                  "Nostrum  Technology"  means  all  of  Nostrum's   proprietary
         information,  know-how, materials and technology related to the Product
         (including  without  limitation,  manufacturing  information)  and  any
         related patent  applications  or patents owned or controlled by Nostrum
         or its  Affiliates  to the  extent  they cover the  Product  and Future
         Strength or any such information,  know-how, materials or technology as
         applied  to  the  Product  and  Future  Strength,  including  patent  #
         6,416,786.

                  "Net Sales" means, with respect to the Product for any period,
         the amounts  actually  received by Synovics Labs or its Affiliates from
         unaffiliated  third  parties  (whether an end-user,  a  distributor  or
         otherwise) for the sale of Products in the Territory,  and exclusive of
         intercompany transfers or sales between and among Synovics Labs and its
         Affiliates,  less the following  reasonable  and  customary  deductions
         (without duplication) from such gross amounts:

                  (i)      normal  and  customary   trade,   cash  and  quantity
                           discounts, allowances and credits;

                  (ii)     credits or  allowances  actually  granted for damaged
                           goods,   returns  or   rejections   of  Product   and
                           retroactive price reductions;

                                       2
<PAGE>

                  (iii)    sales or  similar  taxes  (including  duties or other
                           governmental charges levied on, absorbed or otherwise
                           imposed  on the sale of  Product  including,  without
                           limitation,  value added taxes or other  governmental
                           charges  otherwise  measured by the  billing  amount,
                           when included in billing); and

                  (iv)     all  charge  back  payments,  discounts  and  rebates
                           (whether  mandated or  otherwise)  granted to managed
                           health care  organizations  or to federal,  state and
                           local governments, their agencies, and purchasers and
                           reimbursers or to trade customers,  including but not
                           limited to, wholesalers and chain and pharmacy buying
                           groups  and  charge  back  payments,   discounts  and
                           rebates  (whether  mandated or otherwise)  charged by
                           national or local government; and

                  (v)      commissions  paid to third  parties and sales  agents
                           other than  Synovics  Labs sales  personnel  and sale
                           representatives.

                  (vi)     freight,  postage,   shipping,   customs  duties  and
                           insurance charges, when included in billing.

                  "Person" means any natural person, corporation, unincorporated
         organization,  partnership,  association,  joint stock  company,  joint
         venture, limited liability company, trust or government,  or any agency
         or political subdivision of any government, or any other entity.

                  "Pivotal    Study"    means   the   pivotal    pharmacokinetic
         biostudy(ies)  conducted by a fully licensed biostudy facility mutually
         satisfactory to Synovics Labs and Nostrum which is reasonably  expected
         to demonstrate,  to the  satisfaction of the FDA, the intended AB rated
         bioequivalence of the Product with the Reference Product  sufficient to
         enable Synovics Labs to submit to the FDA an acceptable Abbreviated New
         Drug  Application  ("ANDA") for the  manufacture and commercial sale of
         the Product.

                  "Prestudy" means a pharmacokinetic  biostudy which is intended
         to indicate  likelihood of demonstrating  bioequivalence of the Product
         with the Reference  Product,  typically carried out in a smaller number
         of volunteers than those required by FDA for pivotal biostudies.

                  "Product"  means  the  AB  rated,   generic  500mg  equivalent
         (Metformin ER Tablet) of the branded product Glucophage-XR,.

                  "ANDA"  shall  mean  an  abbreviated   new  drug   application
         submitted to the FDA covering the Product.

                  "Territory"  means  the  United  States  of  America  and  its
         territories, possessions and commonwealths (including Puerto Rico).

                                       3
<PAGE>

                          ARTICLE 2 - GRANT OF LICENSE

         2.1      LICENSE  GRANT.  Nostrum  hereby grants to Synovics  Labs, and
Synovics  Labs  accepts,  ownership  of the  Transfered  Filing and an exclusive
license under the Nostrum  Technology to develop,  make, have made, use, import,
offer  for  sale,  market  and sell the  Product  and a  Future  Product  in the
Territory.

         2.2      RETAINED  RIGHTS.  Subject to the licenses granted to Synovics
Labs  hereunder,  Nostrum shall remain the sole owner of any Nostrum  Technology
which  Nostrum  shall have  furnished to Synovics  Labs in  connection  with the
performance of Nostrum's  obligations pursuant to this Agreement.  Nostrum shall
retain all right, title and interest to use or license the Nostrum Technology in
connection with any product, formulation or process except the Product.

                          ARTICLE 3 - RESEARCH PROGRAM

         3.1      NOSTRUM'S OBLIGATIONS.

                  (a)      (i) As of the  Effective  Date,  With  respect to the
Future Strength, Nostrum has completed work necessary to develop a bioequivalent
Product (as  compared to the  Reference  Product)  suitable for use in the Pilot
Study,  and to develop a reliable and efficient  manufacturing  process suitable
for producing  commercial scale quantities of the Product meeting the applicable
specifications,  necessary  for filing an ANDA for the  Product.  Nostrum  shall
provide  to  Synovics  Labs  access  to  all of the  results  of the  Prestudies
completed by Nostrum  with  respect to the Product.  Such access shall be during
normal  business  hours and shall include the right to make copies,  at Synovics
Labs' expense, of all relevant records,  data and results of the Prestudies.  In
the event  that any  modifications  or  adjustments  to the  formulation  of the
Product are necessary to achieve  bioequivalence  for the Product as compared to
the  Reference  Product,  or to  develop  a  commercially  viable  manufacturing
process,  Nostrum  shall use  diligent  efforts  to  complete  such work and all
analysis and testing in connection therewith.

                           (ii)     As of the  Effective  date,  with respect to
the 500 mg strength, Nostrum has filed an ANDA - the Transfered Filing.

                  (b)      Nostrum  shall provide to Synovics Labs access to all
information and copies of all records relating to the Product, including without
limitation  information relating to formulation  development,  manufacturing and
scale-up  (including  procedures  and batch  records),  Product  specifications,
stability  testing,  analytical  procedures  and methods,  dissolution  testing,
preclinical  and clinical  testing  (including food effect studies) and all data
generated  by Nostrum  relating  thereto.  Such  access  shall be during  normal
business  hours and shall  include the right to make copies,  at Synovics  Labs'
expense, of all such records.

                                       4
<PAGE>

                  (c)      Nostrum  will  cooperate  with  Synovics  Labs in all
phases  of the  work to be  performed  under  Section  3.2,  including,  without
limitation,  the scale up, any Pivotal Study,  process validation,  any ANDA and
stability testing relating to the Product performed  pursuant to this Agreement,
at any time. Until such time as Synovics Labs has received ANDA approval for the
Product in the Territory, Nostrum shall also make available to Synovics Labs the
Nostrum personnel  directly involved with the Product to advise and consult with
regard to the development and manufacture of the Product.  In addition,  Nostrum
agrees that Nostrum's President,  Dr. Nirmal Mulye, will be personally available
to consult and advise during all aspects of the  development of the ANDA for the
Product.  Synovics Labs shall reimburse Nostrum for its reasonable out-of-pocket
expenses  incurred in performance of the  obligations  set forth in this Section
3.1(c).

                  (d)      Nostrum shall use diligent efforts in the performance
of its obligations  under this Section 3.1, as well as any other  obligations to
be performed  by Nostrum on Synovics  Labs' behalf under this Article 3. Nostrum
shall  use  diligent  efforts  to comply  with all  applicable  laws,  rules and
regulations in the performance of such activities,  including without limitation
good  laboratory  practices,  good clinical  practices and cGMPs,  to the extent
applicable.

         3.2      SYNOVICS LABS' OBLIGATIONS.

                  (a)      With   respect  to  the  Future   Strength   and  any
modifications  of the  formulation  for both the strengths,  Synovics Labs shall
promptly commence and diligently  conduct all work preparatory to, and necessary
for, the performance of a Pivotal Study for the Product. Synovics Labs shall use
diligent  efforts to complete  such  Pivotal  Study as promptly as  practicable.
Synovics  Labs shall have the right,  in its sole  discretion,  to contract with
Nostrum or use third party  contractors  to conduct the Pivotal Study under this
Section 3.2(a).  Synovics Labs' obligation to conduct the Pivotal Study shall be
contingent upon successful  manufacture and release of finished  product for use
in the Pivotal Study.

                  (b)      With   respect  to  the  Future   Strength   and  any
modifications  of the formulation for both the strengths,  in the event that the
Pivotal Study demonstrates bioequivalence for the Product in accordance with FDA
regulations,  Synovics Labs in cooperation with Nostrum shall promptly  prepare,
submit and  diligently  prosecute an ANDA for such  Product.  Synovics Labs will
keep Nostrum fully informed with respect to such  activities,  and Nostrum shall
have the right to be present at all meetings with FDA regarding the Product,  at
its own expense.

                  The ownership of Transfered Filing shall be transferred to and
in the name of Synovics Labs.  Synovics Labs shall be  responsible,  at Synovics
Labs' expense,  for conducting the  post-clinical  and stability  testing of the
Product necessary for the approval thereof and for obtaining of all governmental
approvals  for  the  manufacture  and  commercial  sale  of the  Product  in the
Territory.  Synovics  Labs shall use  diligent  efforts to cause such ANDA to be
approved. Synovics Labs will have full and complete ownership thereof.

                                       5
<PAGE>

                  (c)      Synovics Labs shall be responsible  for all costs and
expenses  incurred by it in connection  with the  performance of its obligations
under this Section 3.2.

         3.3      DILIGENCE.  Following  Synovics  Labs' receipt of FDA approval
with  respect  to the  manufacture  and  commercial  sale of the  Product in the
Territory,  Synovics  Labs shall use diligent  efforts to  manufacture,  market,
distribute and sell the Product in the Territory. Such diligent efforts shall be
commensurate with the efforts expended by Synovics Labs in the commercialization
of its other  products of similar  value,  stage of  development  and commercial
potential.

         3.4      EXCUSED   PERFORMANCE.   All  of  Synovics   Labs'   diligence
obligations with respect to the development and commercialization of the Product
under this Agreement are expressly  conditioned  upon the continuing  absence of
any  adverse  condition  or event  relating  to the  safety or  efficacy  of the
Product,   or  lack  of  regulatory   approval,   which   warrants  a  delay  in
commercialization of the Product.

         3.5      OWNERSHIP  OF RESULTS.  Subject to the  provisions  of Section
9.5,  all data and  results  obtained  or  generated  by or on  behalf of either
Nostrum or Synovics Labs in  performance  of the Prestudy,  the Pivotal Study or
other development  activities related to the Product to be performed pursuant to
this  Agreement  (the  "Results")  shall be the sole and  exclusive  property of
Synovics Labs and shall be treated as Synovics  Labs'  Confidential  Information
pursuant  to Article 5 hereof.  Nostrum  undertakes  to execute,  without  undue
delay,  any and all  documents  deemed  necessary to perfect  this right,  on an
as-needed, as-requested basis.

         3.6      MANUFACTURE/SUPPLY.  Synovics  Labs  shall  have the  right to
contract directly with a suitable third party to manufacture and supply Synovics
Labs'  requirements  for  commercial  supplies  of the  Product.  Alternatively,
Synovics Labs may elect to have the Product  manufactured and supplied by itself
or  one  of its  Affiliates;  provided  that  the  cost  of  goods  for  Product
manufactured by Synovics Labs or such Affiliate is competitive  with the cost of
goods for the Product as manufactured  by a qualified third party  manufacturer.
Upon request,  Nostrum shall  cooperate with Synovics Labs in  transferring  and
implementing the Nostrum  Technology  related to manufacture of the Product from
one site of  manufacture  for the  Product  to another  in  accordance  with FDA
guidelines  applicable to the proposed  transfer.  Synovics Labs shall reimburse
Nostrum  within  thirty  (30)  days  of  Synovics  Labs'  receipt  of  Nostrum's
invoice(s) for all reasonable  out-of-pocket expenses which Nostrum may incur in
connection with the performance of its obligations pursuant to this Section 3.6.

                                       6
<PAGE>

                              ARTICLE 4 - PAYMENTS

         4.1      INITIAL PAYMENT. In partial consideration for the transfer of
ownership  of the  Transfered  Filing  and  license  granted  to  Synovics  Labs
hereunder,  Synovics  Labs shall pay  Nostrum  One  hundred  and fifty  thousand
dollars ($150,000) USD within fifteen (15) days of the Effective Date.

         4.2      MILESTONE PAYMENTS.  In further  consideration for the license
granted to  Synovics  Labs  hereunder,  Synovics  Labs  hereby  agrees to pay to
Nostrum One hundred and fifty thousand  dollars  ($150,000) USD upon the receipt
of  approval  for  Transfered  Filing  by the FDA  within  thirty  (30)  days of
achieving the indicated milestone

         4.3      ROYALTIES. Synovics Labs agrees to pay to Nostrum royalties on
Net Sales of Product in the Territory equal to Twenty Percent (20%) of Net sales
up to a maximum of One million five hundred thousand ($1,500,000).

         4.4      MANNER OF  PAYMENT.  Within  thirty  (30) days after the first
commercial sale of the Product in the Territory by Synovics Labs,  Synovics Labs
shall provide Nostrum with written notice to that effect.  Thereafter,  Synovics
Labs shall furnish to Nostrum within sixty (60) days following the close of each
calendar  quarter,  a written  report for the calendar  quarter  showing the Net
Sales and Gross  Profits from the sale of the Product sold by Synovics  Labs and
its Affiliates in the Territory  during such calendar  quarter and the royalties
payable under this Agreement for such calendar quarter.  Simultaneously with the
submission of such written report,  Synovics Labs shall pay to Nostrum,  for the
account of Synovics Labs or the applicable Affiliate,  as the case may be, a sum
equal to the  aggregate  royalty due for such  calendar  quarter  calculated  in
accordance  with this Agreement  (reconciled  for any previous  overpayments  or
underpayments). All payments to Nostrum hereunder shall be made by wire transfer
of immediately available funds to the account designated in writing by Nostrum.

         4.5      RECORDKEEPING/AUDITS.

                  (a)      Synovics  Labs,  and to  the  extent  applicable  its
Affiliates,  shall keep complete and accurate  records in  sufficient  detail to
enable the  royalties  payable  hereunder  to be  determined.  Upon the  written
request of Nostrum and not more than twice in each calendar year, Synovics Labs,
and to the extent responsible for the manufacture of the Product its Affiliates,
shall permit an  independent  certified  public  accounting  firm of  nationally
recognized standing,  which is bound by a confidentiality  agreement in favor of
Synovics Labs to have access, at Nostrum's expense, during normal business hours
to such  records  of  Synovics  Labs and such  Affiliates  as may be  reasonably
necessary to verify the accuracy of the royalty reports hereunder for any twelve
(12) month  period(s).  Nostrum  shall  provide such notice at least thirty (30)
days prior to the intended audit.  Nostrum shall have no right to audit any such
records  with  respect to any twelve  (12) month  period  which  ended more than
ninety-six  (96) months prior to the date of such request.  The accounting  firm
shall only disclose to Nostrum the relevant Net Sales, Gross Profits and cost of
goods sold  information and whether the royalty reports are correct or incorrect
and the specific  details  concerning any  discrepancies.  No other  information
shall be shared by the  accounting  firm with

                                       7
<PAGE>

Nostrum.  Nostrum's  audit  rights  under this  Section  4.5 shall  survive  the
expiration or termination of this Agreement for a period of one (1) year.

                  (b)      The cost of each audit  conducted  under this Section
4.5 shall be borne by  Nostrum  unless  such  audit  correctly  determines  that
Synovics Labs underpaid the royalties due to Nostrum hereunder by more than five
percent (5% ) in any five month period in which case, Synovics Labs shall pay to
Nostrum the  deficiency  (as Synovics  Labs is required to do  regardless of the
amount  thereof or the  results,  requirement  or pendency of any audit)  within
fifteen  (15) days of the date that a final  audit  report is issued,  and shall
also bear the cost of such audit.  In the event that such audit  determines that
Synovics Labs  overpaid the  royalties  due to Nostrum,  Nostrum shall refund to
Synovics  Labs the amount of such  overpayment  within  fifteen (15) days of the
date that a final audit report is issued.

                  (c)      Nostrum shall treat all financial information subject
to review under this Agreement in accordance with the confidentiality provisions
of this  Agreement,  and  shall  cause  its  accounting  firm to  enter  into an
acceptable  confidentiality agreement with Synovics Labs obligating it to retain
all such financial  information in confidence  pursuant to such  confidentiality
agreement.

         Section 4.6    WITHHOLDING. If at any time, any jurisdiction within the
Territory  requires the  withholding of income taxes or other taxes imposed upon
payments set forth in this Article 4, Synovics Labs shall make such  withholding
payments as required and subtract  such  withholding  payments from the payments
set forth in this Article 4 or if  applicable,  Nostrum will promptly  reimburse
Synovics Labs or its  designee(s) of the amount of such payments.  Synovics Labs
shall provide Nostrum with  documentation of such  withholding and payment.  Any
withholdings  paid when due  hereunder  shall be for the  account of Nostrum and
shall not be  included  in the  calculation  of Net Sales or Gross  Profits,  as
applicable.  In addition, if any deficiency in the amount or failure to make any
such withholding  payment is caused,  in whole or in part, by any intentional or
negligent action or inaction on the part of Nostrum, Nostrum shall be liable for
any fine, assessment or penalty imposed by any taxing authority in the Territory
for such  deficiency  in the amount of any such  withholding  or such failure to
make such  withholding  payment.  If  Synovics  Labs is required to pay any such
deficiency, or any fine, assessment or penalty for any such deficiency,  Nostrum
shall promptly  reimburse  Synovics Labs for any such payments for which Nostrum
is liable in accordance with this Section 4.6, which  reimbursement shall not be
included in the calculation of Net Sales or Gross Profits.

                           ARTICLE 5. CONFIDENTIALITY.

         5.1      CONFIDENTIALITY.  During the term of this  Agreement and for a
period of ten (10) years after its expiration or  termination,  each party shall
maintain as confidential the Nostrum  Technology,  any know-how  relating to the
Product,   the  Results  and  any  other  proprietary,   technical  or  business
information   received  from  the  other  party   pursuant  to  this   Agreement
("Confidential Information") and shall only use such Confidential

                                       8
<PAGE>

Information  in  furtherance  of this  Agreement.  Both  parties  agree that any
employees provided or given access to the other party's Confidential Information
shall be bound by confidentiality  obligations essentially the same as those set
forth herein. The foregoing  obligations of confidentiality and use restrictions
shall not apply, however, to the extent that such Confidential Information:

         (i)      was known to the receiving  party, as evidenced by its written
                  records, prior to receipt from the other party;

         (ii)     is in the public  domain at time of  receipt  or  subsequently
                  enters the public domain  through no breach of this  Agreement
                  by the receiving party;

         (iii)    after  the date of  receipt  from  the  disclosing  party,  is
                  received without secrecy obligations from a third party with a
                  bona fide right to disclose it without  violating any right of
                  the disclosing party;

         (iv)     is independently  developed by the receiving party without the
                  aid,  application  or use of  any  of the  disclosing  party's
                  Confidential Information (and such independent development can
                  be properly documented by the receiving party);

         (v)      is disclosed to governmental or other  regulatory  agencies in
                  order  to  obtain  patents  or to  gain  approval  to  conduct
                  clinical  trials or to market  the  Product  pursuant  to this
                  Agreement,  but  such  disclosure  may be only  to the  extent
                  reasonably necessary to obtain such patents or authorizations;

         (vi)     is  necessary   to  be   disclosed  to  agents,   consultants,
                  Affiliates  and/or  other third  parties  for the  developing,
                  making,  using,  selling or  importing of Product (or for such
                  third parties to determine  their interest in performing  such
                  activities) in accordance with this Agreement on the condition
                  that such third parties  agree to be bound by  confidentiality
                  obligations  and use  restrictions  at least as restrictive as
                  those contained in this Agreement; or

         (vii)    is required to be disclosed  by law or court  order,  provided
                  that notice is promptly  delivered to the disclosing  party in
                  order to provide the disclosing party  sufficient  opportunity
                  to seek a protective order or other similar order with respect
                  to  such  Confidential  Information  and the  receiving  party
                  thereafter  discloses only the minimum information required to
                  be disclosed  in order to comply with the request,  whether or
                  not a protective  order or other  similar order is obtained by
                  the disclosing party.

         5.2      NO PUBLICITY; DISCLOSURE OF AGREEMENT TERMS. Neither party may
use  the  name  of the  other  party  or its  Affiliates  in  any  publicity  or
advertising without the prior written permission of such party.  Notwithstanding
the  provisions  of Section 5.1 and this Section 5.2,  either party may disclose
the terms

                                       9
<PAGE>

of this Agreement to the extent necessary to (a) actual or potential  lenders or
investors;  (b) the party's agents,  consultants,  Affiliates and/or other third
parties  necessary to facilitate  such a loan or investment;  or (c) the party's
accountants,  consultants and attorneys,  for other corporate  transactions  and
business, on a need to know basis.

                               ARTICLE 6 - PATENTS

         6.1      INFRINGEMENT AND THIRD PARTY LICENSES.

                  (a)      In the event that Synovics  Labs', or its Affiliates'
making,  having made, using, offering for sale, selling or importing the Product
infringes or misappropriates, will infringe or misappropriate or is alleged by a
third party to  infringe  or  misappropriate  a third  party's  patents or other
intellectual  property  rights,  the party hereto  becoming  aware of same shall
promptly notify the other. The parties shall thereafter  attempt to agree upon a
course of action with respect thereto.

                  (b)      Synovics Labs shall be responsible, at Synovics Labs'
expense, for the defense of any claims, demands,  actions or proceedings arising
from allegations that  development,  making,  having made,  using,  offering for
sale,  selling or importing  the Product  infringes or  misappropriates  or will
infringe  or  misappropriate  a third  party's  patents  or  other  intellectual
property  rights.  Upon  Synovics  Labs'  request  and  expense,  Nostrum  shall
cooperate with Synovics Labs in such defense;  provided that Synovics Labs shall
promptly  reimburse  Nostrum for  reasonable  out-of-pocket  costs and  expenses
incurred by Nostrum in providing such cooperation.

         6.2      INFRINGEMENT  OF NOSTRUM'S  INTELLECTUAL  PROPERTY RIGHTS BY A
THIRD PARTY.  Synovics Labs and Nostrum shall promptly  notify each other of any
infringement of the patent rights included in the Nostrum  Technology as applied
to the Product,  and/or any  misappropriation  or unauthorized use of any of the
Nostrum Technology as applied to the Product, in the Territory which may come to
their attention.  The parties shall thereafter attempt to agree upon a course of
action  with  respect  thereto.  If  Nostrum  declines  to  participate  in  the
prosecution of legal proceedings to prevent such infringement,  misappropriation
or misuse of the Nostrum Technology,  Synovics Labs may do so at its own expense
using counsel of its choice.

                   ARTICLE 7 - REPRESENTATIONS AND WARRANTIES

         7.1      REPRESENTATIONS  AND  WARRANTIES  BY  BOTH  PARTIES.  Each  of
Synovics  Labs and Nostrum  hereby  represents  and  warrants to the other party
that:

         (i)      it is a corporation  duly organized and validly existing under
                  the laws of the state or other  jurisdiction of  incorporation
                  or formation;

                                       10
<PAGE>

         (ii)     the execution,  delivery and  performance of this Agreement by
                  such party has been duly authorized by all requisite corporate
                  action;

         (iii)    it has all  requisite  power  and  authority  to  execute  and
                  deliver  this   Agreement  and  to  perform  its   obligations
                  hereunder;

         (iv)     the execution,  delivery and performance by such party of this
                  Agreement  and its  compliance  with the terms and  provisions
                  hereof  does not and will not  conflict  with or  result  in a
                  breach of any of the terms and  provisions  of or constitute a
                  default  under  (i)  a  loan  agreement,  guaranty,  financing
                  agreement, agreement affecting a product or other agreement or
                  instrument  binding or affecting it or its property;  (ii) the
                  provisions  of its charter  documents or bylaws;  or (iii) any
                  order, writ, injunction or decree of any court or governmental
                  authority  entered  against it or by which any of its property
                  is bound;

         (v)      except for the governmental and regulatory  approvals required
                  to  market  the  Product  in  the  Territory,  the  execution,
                  delivery and  performance of this Agreement by such party does
                  not require the  consent,  approval  or  authorization  of, or
                  notice,   declaration,   filing  or  registration   with,  any
                  governmental  or  regulatory   authority  and  the  execution,
                  delivery or performance of this Agreement will not violate any
                  law, rule or regulation applicable to such party;

         (vi)     this  Agreement  constitutes  such  party's  legal,  valid and
                  binding obligation  enforceable  against it in accordance with
                  its  terms  subject,   as  to   enforcement,   to  bankruptcy,
                  insolvency,   reorganization   and  other   laws  of   general
                  applicability  relating to or affecting  creditors' rights and
                  to the  availability  of  particular  remedies  under  general
                  equity principles; and

         (vii)    it shall comply with all applicable  material laws,  rules and
                  regulations  relating to the  performance  of its  obligations
                  relating to the Product under this Agreement.

         7.2      REPRESENTATIONS  AND  WARRANTIES  BY NOSTRUM.  Nostrum  hereby
represents and warrants to Synovics Labs that:

         (i)      it owns all right,  title and  interest  in and to the Nostrum
                  Technology  as applied to the  Product,  free and clear of all
                  liens,   charges,   encumbrances   and  to  Nostrum's   actual
                  knowledge, other adverse claims;

         (ii)     to Nostrum's  actual  knowledge as of the Effective  Date, (1)
                  the  Nostrum  Technology  as applied to the Product and Future
                  Product does not, and (2) the use of the Nostrum Technology as
                  applied to the Product and Future Product,  will not, infringe
                  on or  misappropriation  the  existing  intellectual  property
                  rights of any other party;

                                       11
<PAGE>

         (iii)    there are no adverse actions,  suits or claims pending against
                  Nostrum  or any of its  Affiliates  in or before  any court or
                  governmental  or  regulatory  authority  with  respect  to the
                  Product  and/or  the  Nostrum  Technology  as  applied  to the
                  Product,  and no such  actions,  suits  or  claims  have  been
                  threatened against Nostrum or any of its Affiliates;

         (iv)     to  the  best  of  Nostrum's  knowledge,  all  data  summaries
                  provided  in writing to Synovics  Labs by Nostrum  relating to
                  the Pre-study  accurately  represent  the raw data  underlying
                  such summaries;

         (v)      as of the Effective Date, to the best of Nostrum's  knowledge,
                  there is no reason  (e.g.,  debarment  under the Federal Food,
                  Drug, and Cosmetic Act) that would prevent  Synovics Labs from
                  using data and  information  supplied by  Nostrum,  as part of
                  Synovics Labs' regulatory submissions for the Product.

         7.3      CONTINUING REPRESENTATIONS. The representations and warranties
of each party  contained in Sections 7.1 and 7.2 shall  survive the execution of
this Agreement.

         7.4      NO INCONSISTENT AGREEMENTS.  As of the Effective Date, neither
Party has entered  into,  and during the term of this  Agreement,  neither party
shall enter into,  any oral or written  agreement or  arrangement  that would be
inconsistent with its obligations under this Agreement.

         7.5      NO WARRANTY AS TO REGULATORY APPROVAL. Nothing herein shall be
construed as a  representation  or warranty by either party that the  applicable
health regulatory  authorities within the Territory will consider the Product to
be safe and effective,  or will grant regulatory approval to market and sell the
Product in the Territory even if any  additional  studies are conducted by or on
behalf of Synovics Labs or its Affiliates.

                           ARTICLE 8 - INDEMNIFICATION

         8.1      INDEMNIFICATION  BY NOSTRUM.  Nostrum shall,  at its sole cost
and  expense,  defend,  indemnify  and  hold  harmless  Synovics  Labs  and  its
Affiliate(s),  and their respective  officers,  directors,  agents and employees
from and against all claims, liens, demands, damages, liability, actions, causes
of action,  losses,  judgments,  amounts paid in settlement,  costs and expenses
(including,  without  limitation,   reasonable  attorneys'  fees)  (collectively
"Claim(s)") to the extent such Claims arise out of or in connection with, result
from,  or are caused by:  (i) any  breach by Nostrum of its  representations  or
warranties contained in Sections 7.1 or 7.2 of this Agreement; or (ii) the gross
negligence  or  willful   misconduct  of  Nostrum  in  the  performance  of  its
obligations under this Agreement;  PROVIDED, HOWEVER, that Nostrum shall have no
liability or indemnification  obligations hereunder to the extent any such Claim
is caused by the gross  negligence or

                                       12
<PAGE>

willful  misconduct  of  Synovics  Labs,  its  Affiliates  or  their  respective
officers, directors, agents and employees.

         8.2      INDEMNIFICATION BY SYNOVICS LABS.  Synovics Labs shall, at its
sole cost and  expense,  defend,  indemnify  and hold  harmless  Nostrum and its
Affiliate(s),  and their respective  officers,  directors,  agents and employees
from and  against  all  Claims  to the  extent  such  Claims  arise out of or in
connection with,  result from, or are caused by: (i) any breach by Synovics Labs
of its representations or warranties contained in Section 7.1 of this Agreement;
(ii)  the  gross  negligence  or  willful  misconduct  of  Synovics  Labs or its
Affiliates in the performance of its or their  obligations under this Agreement;
(iii) the marketing, manufacture, use or sale of the Product in the Territory by
or on behalf of Synovics Labs or its Affiliates;  or (iv)  allegations  that the
manufacture,  use or sale of the  Product  in the  Territory  by or on behalf of
Synovics Labs or its Affiliates infringes third party patents or misappropriates
the other intellectual  property rights of any third party;  PROVIDED,  HOWEVER,
that  Synovics  Labs  shall have no  liability  or  indemnification  obligations
hereunder  to the  extent any such  Claim is caused by the gross  negligence  or
willful  misconduct of Nostrum,  its  Affiliates or their  respective  officers,
directors, agents and employees.

         8.3      CONDITIONS  TO   INDEMNIFICATION.   The   obligations  of  the
indemnifying  party under Articles 8.1 and 8.2 are conditioned upon the delivery
of written  notice to the  indemnifying  party of any potential  Claim  promptly
after the indemnified party becomes aware of such potential Claim. The foregoing
notwithstanding,   the  parties  acknowledge  and  agree  that  failure  of  the
indemnified party to promptly notify the indemnifying party of a potential Claim
shall not  constitute a waiver of, or result in the loss of, such party's  right
to  indemnification  under  Articles 8.1 or 8.2, as  appropriate,  except to the
extent  that the  indemnifying  party's  rights,  and/or  its  ability to defend
against such liability are materially  prejudiced by such failure to notify. The
indemnifying  party is hereby  authorized to carry out the sole  management  and
defense of such potential  Claim, and shall have the right to assume the defense
of any suit or claim related to the Claim if it has assumed  responsibility  for
the Claim in writing.  However, if in the reasonable judgment of the indemnified
party,  such Claim  involves an issue or matter  which  could have a  materially
adverse effect on the business  operations or assets of the  indemnified  party,
the indemnified party may waive its rights to indemnity under this Agreement and
control the defense or settlement thereof. If the indemnifying party defends the
suit or claim,  the  indemnified  party may participate in (but not control) the
defense thereof at its sole cost and expense.

         8.4      SETTLEMENTS.  Neither  party  may  settle  a claim  or  action
related to a Claim  without the consent of the other party,  if such  settlement
would  impose any  monetary  obligation  on the other party or require the other
party to submit to an  injunction or otherwise  limit the other  party's  rights
under this  Agreement.  Any payment  made by a party to settle any such claim or
action shall be at its own cost and expense.

         8.5      LIMITATION  OF  LIABILITY.  With  respect  to any claim by one
party against the other arising out of the performance or failure of performance
of the other party under

                                       13
<PAGE>

this Agreement,  the parties expressly agree that the liability of such party to
the other  party for such  breach  shall be  limited  under  this  Agreement  or
otherwise at law or equity to compensatory  damages only and in no event shall a
party be liable for punitive or exemplary damages. The foregoing limitation will
not prevent a party entitled to indemnification  pursuant to this Agreement from
recovering  all  components  of any judgment or award against such a party by an
unaffiliated party.

         8.6      INSURANCE.  During the term of this  Agreement  Synovics  Labs
shall maintain adequate insurance and/or a self-insurance  program for liability
insurance, including products liability insurance,  adequately covering Synovics
Labs' obligations under this Agreement. Synovics Labs shall provide Nostrum with
evidence of such insurance and/or self-insurance upon request.

                        ARTICLE 9 - TERM AND TERMINATION

         9.1      TERM AND  EXPIRATION.  This Agreement shall be effective as of
the  Effective  Date and unless  terminated  earlier  pursuant to this Article 9
shall  continue  in effect for the longer of a period of ten (10) years from the
first  commercial  sale of the Product by or on behalf of  Synovics  Labs in the
Territory,  or until such time as the  commercial  sale of the  Product by or on
behalf of Synovics Labs in the Territory is discontinued.

         9.2      RIGHTS OF SYNOVICS LABS TO TERMINATE.

     a)  With respect to the Future Product, in the event that (i) Synovics Labs
         determines  that the  results of the  Pivotal  Study do not  adequately
         demonstrate  bioequivalence  of the Future  Strength with the Reference
         Product,  or (ii)  Synovics Labs fails to obtain FDA approval to market
         and sell the Product in the  Territory,  then  Synovics Labs shall have
         the right to terminate this  Agreement by notifying  Nostrum in writing
         to that effect.

     b)  With  respect to the  Product,  Synovics  Labs shall have the option to
         terminate  this  Agreement in the event that Synovics Labs  determines,
         based on the actual results of manufacturing,  distribution and sale of
         the Product,  that the profitability or market size of the Product does
         not equal or exceed the profitability or market size, as applicable, of
         other Synovics Labs products of similar market size and cost structure.

         9.3      TERMINATION  FOR CAUSE.  Either  party shall have the right to
terminate  this  Agreement  upon sixty (60) days written notice in the event the
other party is in breach of one or more of its material  obligations  under this
Agreement;  provided that the breaching party shall have the opportunity to cure
any  alleged  breach  during  such sixty  (60) day  period.  To assist  with the
interpretation  of this Agreement,  the parties agree that: a breach by Synovics
Labs of the provisions of any of Sections 3.1(c),  3.2(a),  3.2(b), 3.2(c),

                                       14
<PAGE>

3.3, 4.1, 4.2, 4.3 and 4.5 shall be a material  breach;  and a breach by Nostrum
of the provisions of any of Sections 3.1(a),  3.1(b), 3.1(c) and 3.1(d) shall be
a material breach. For avoidance of doubt, the provisions listed in this Section
9.3 do not constitute an exhaustive list of those provisions the breach of which
may be material.

         9.4      BANKRUPTCY  OR  INSOLVENCY.  Either party shall be entitled to
immediately   terminate  this  Agreement  upon  the  filing  or  institution  of
bankruptcy,  reorganization (in connection with any insolvency),  liquidation or
receivership proceedings,  or upon an assignment of a substantial portion of the
assets  for the  benefit  of  creditors  by the other  party,  or in the event a
receiver or custodian  is appointed  for such other  party's  business,  or if a
substantial  portion of such other party's  business is subject to attachment or
similar  process;  PROVIDED,  HOWEVER,  that  in the  case  of  any  involuntary
bankruptcy  proceeding or the  attachment of a substantial  portion of a party's
assets such right to terminate shall only become  effective if the proceeding or
attachment is not dismissed within sixty (60) days after the filing thereof.

         9.5      EFFECT OF  TERMINATION.  In the event that this  Agreement  is
terminated,  the  license  granted  to  Synovics  Labs under  Section  2.1 shall
terminate,  Synovics  Labs shall  transfer to Nostrum  all of the  formulations,
processes and other technology,  approvals,  applications and records related to
the  development  and  commercialization  of  the  Product,  and  Nostrum  shall
thereafter have the right to develop,  manufacture  and otherwise  commercialize
the  Product  in the  Territory,  together  with all other  countries  and their
territories, possessions and commonwealths.

         9.6      SURVIVING  TERMS.  The  provisions  of  Section  9.5,  and  of
Articles 5, 8 and 11,  Nostrum's  audit rights under Section 4.5, and such other
provisions of this Agreement  which by their expressed terms are to be performed
or complied with  subsequent to the termination or expiration of this Agreement,
shall survive such  termination  or expiration  and shall continue in full force
and effect in accordance with their respective terms.

                            ARTICLE 10. FORCE MAJEURE

                  (a)      No  failure  or   omission  by  the  parties  in  the
performance  of any  obligation  according to this  Agreement  shall be deemed a
breach of this  Agreement  or create any  liability if the same shall arise from
any cause or causes beyond the control of the party, including,  but not limited
to, strikes, riots, war, acts of God, invasion,  fire, explosion,  floods, delay
of carrier,  energy shortages and acts of government or governmental agencies or
instrumentalities.

                  (b)      In the event that due to force  majeure  either party
hereto shall be delayed or hindered in or prevented from the  performance of its
duties or doing acts required under the terms of this Agreement, the performance
of such act,  except for the obligation to pay amounts due under this Agreement,
shall be excused for the period of delay.  Notwithstanding  the  aforementioned,
the party subject to force majeure shall promptly take all  reasonable  steps to
resolve the condition(s) forming the basis of force

                                       15
<PAGE>

majeure;  provided,  however,  that nothing  contained  herein shall require any
party to settle on terms  unsatisfactory  to such party any strike,  lock-out or
other labor difficulty, any investigation or proceeding by any public authority,
or any litigation by any third party. If a condition  constituting force majeure
as defined herein exists for more than ninety (90) consecutive days, the parties
shall meet to negotiate a mutually  satisfactory  resolution to the problem,  if
practicable.

                           ARTICLE 11 - MISCELLANEOUS

         11.1     ASSIGNMENT.  (a) Neither this  Agreement nor any or all of the
rights and obligations of a party hereunder shall be assigned,  delegated, sold,
transferred,  sublicensed  (except as  otherwise  provided  herein) or otherwise
disposed of, by operation of law or  otherwise,  to any third party  without the
prior written consent of the other party. Any attempted assignment,  delegation,
sale,  transfer,  sublicense  or  other  disposition,  by  operation  of  law or
otherwise,  of this Agreement or of any rights or obligations hereunder contrary
to this  Article  11.1  shall be a  material  breach  of this  Agreement  by the
attempting party, and shall be void and without force or effect. Notwithstanding
the foregoing,  either party may, without the consent of the other party, assign
the Agreement and its rights and obligations hereunder (i) to an Affiliate; (ii)
in  connection  with the  transfer  or sale of all or  substantially  all of its
assets related to the subject division or the subject business;  or (iii) in the
event of its merger or consolidation.

                  (b)      Any  assignment,  sublicense  or  other  transfer  by
either  party  permitted  by this Section 11.1 shall not operate to release such
party from its responsibilities under this Agreement.

         11.2     NO  WAIVER.  No  failure  by a party to  exercise  any  rights
hereunder in the event of a breach or violation  hereof by the other party shall
constitute a waiver of any such rights.  No waiver by any party of any breach or
violation hereof by the other party,  shall constitute a waiver of any rights in
respect of any other or subsequent breach or violation.

         11.3     NOTICES. All notices required to be given under this Agreement
shall be in writing  and given by  personal  delivery,  facsimile  transmission,
nationally  recognized  overnight  courier  (prepaid) or registered or certified
mail, postage prepaid with return receipt requested. Notices shall be addressed:

                  if to Nostrum, at

                           10 Erin Ct.
                           Kendall Park, New Jersey   08824
                           Attn: Nirmal Mulye, Ph.D.
                           Fax: (732) 422-0416

                                       16
<PAGE>

                  if to Synovics Labs, at

                           Synovics Laboratories, Inc.
                           505 Thornhall Street, Suite 304
                           Edison, New Jersey 08837
                           Attention:  Theodore Miro
                           Fax:  (732) 635-0042

A party may change its address by written notice in accordance with this Section
11.3

         11.4     GOVERNING  LAW/DISPUTES.  This Agreement  shall be governed by
and  construed  in  accordance  with the laws of the  State of New York  without
regard to the conflict of laws provisions  thereof.  In the event of any dispute
hereunder or otherwise arising out of or relating to this Agreement, the parties
hereto  agree  that  such  dispute  will  be  resolved  only by  arbitration  in
accordance with the terms set forth in Article 12, attached hereto.

         11.5     INDEPENDENT  CONTRACTOR.   The  parties  shall  be  considered
independent  contractors,  and  neither  the  making of this  Agreement  nor the
performance  of any of the  provisions  hereof shall be construed to make either
party an agent,  employee or legal  representative  of the other, nor shall this
Agreement be deemed to establish a joint venture or partnership.

         11.6     SEVERABILITY.  Should any section, or portion thereof, of this
Agreement be held invalid by reason of any law,  statute or regulation  existing
now or in the future in any jurisdiction by any court of competent  authority or
by a legally  enforceable  directive of any governmental body, then such section
or portion thereof shall be validly  reformed so as to approximate the intent of
the  parties  as  nearly  as  possible  and,  if  unreformable,  shall be deemed
divisible and deleted with respect to such jurisdiction and this Agreement shall
not otherwise be affected.

         11.7     EFFECT OF ASSIGNMENT.  This  Agreement  shall be binding upon,
and inure to the  benefit  of,  each  party  and its  permitted  successors  and
permitted assigns.  Each party shall be responsible for the compliance by any of
its permitted assignees with the terms and conditions of this Agreement.

         11.8     RECORDING.  Each party shall have the right,  at any time,  to
record, register, or otherwise notify this Agreement in appropriate governmental
or regulatory  offices anywhere in the Territory,  and Nostrum or Synovics Labs,
as the  case  may be,  shall  provide  reasonable  assistance  to the  other  in
effecting such recording, registering or notifying.

                                       17
<PAGE>

         11.9     FURTHER ACTIONS. Each party agrees to execute, acknowledge and
deliver  such  further  instruments  and to do all such  other  acts,  as may be
necessary or  appropriate  in order to carry out the purposes and intent of this
Agreement.

         11.10    COUNTERPARTS. This Agreement shall become binding when any one
or more  counterparts  hereof,  individually or taken  together,  shall bear the
signatures of each of the parties  hereto and is delivered to the other party in
accordance  with Section 11.3.  This  Agreement may be executed in any number of
counterparts,  each of which shall be an original as against  either party whose
signature appears thereon,  but all of which taken together shall constitute but
one and the same instrument.

         11.11    ENTIRE AGREEMENT.  This Agreement,  together with the attached
schedule,  represents the entire  agreement  between the parties with respect to
the subject matter hereof and  supersedes and replaces all prior  agreements and
understandings,  whether  written  or  oral.  No  terms  or  provisions  of this
Agreement shall be varied or modified and no subsequent  alteration,  amendment,
change or addition to this  Agreement  shall be binding upon the parties  unless
reduced to writing and signed by an authorized officer of each party.

                                   ARTICLE 12
                          DISPUTE RESOLUTION PROCEDURES

         12.1     Except as otherwise set forth in the  Agreement,  any dispute,
controversy  or claim arising out of or relating to the validity,  construction,
enforceability or performance of this Agreement,  including disputes relating to
an alleged breach or termination of this Agreement,  shall be settled by binding
arbitration in the manner set forth below in this Article 12; provided, however,
that the neutral  referred to below shall give effect to the  provisions of this
Agreement and shall not adjust,  modify or change the effects of  termination as
set forth in Article 9 of this Agreement  Notwithstanding the foregoing,  in the
event of a claim,  action,  suit or  proceeding  against or involving  any party
entitled to indemnification  pursuant to this Agreement brought or asserted by a
third party that is not affiliated with either party to this Agreement, then the
entitled to the indemnification will have the option to include the indemnifying
party to such claim, action suit or proceeding notwithstanding the provisions of
this Article 12.

         12.2     If a party  intends  to  begin an  arbitration  to  resolve  a
dispute, such party shall provide written notice (the "Request") by certified or
registered  mail or properly  documented  overnight  delivery to the other party
informing such other party of such intention and the issues to be resolved.  The
notice  shall  explain  the nature of the  complaint  and refer to any  relevant
Articles of the  Agreement  upon which the complaint is based.  The  complaining
party  shall also set forth a proposed  solution  to the  problem,  including  a
suggested time frame within which the parties must act.

         12.3     The  non-complaining  party must  respond  in  writing  within
thirty (30) calendar  days of receiving  notice with an  explanation,  including
references  to the relevant

                                       18
<PAGE>

provisions  of the  Agreement  and a  response  to  the  proposed  solution  and
suggested time frame for action.  The  non-complaining  party may add additional
issues to be resolved.

         12.4     Within ten (10)  business days of receipt of the response from
the  non-complaining  party,  the  parties  shall meet and  discuss  options for
resolving the dispute. Each party shall make available all appropriate personnel
to meet and confer with the other party within the ten (10)  business day period
following the complaining party's receipt of the response by the non-complaining
party.

         12.5     Any and all  disputes  that  cannot be  resolved  pursuant  to
Paragraphs  (b), (c) and (d) above shall be submitted to an arbitrator  selected
by mutual  agreement of the parties.  If the parties are unable to agree upon an
arbitrator,  then  the  arbitrator  shall be  selected  in  accordance  with the
procedures of the American Arbitration  Association.  The arbitrator shall be an
individual who shall preside over and resolve any disputes  between the parties.
The arbitrator  selected shall be a former judge of a state or federal court and
shall not be an employee,  director or  shareholder  of, or  otherwise  have any
current  or  previous   relationship   with,  either  party  or  its  respective
Affiliates. The arbitration shall be conducted in accordance with the commercial
arbitration  rules  of the  American  Arbitration  Association  then in  effect,
subject  to the time  periods  and other  provisions  of this  Article  12 or as
otherwise set forth in the Agreement.

         12.6     Consistent  with the time  schedule  established  pursuant  to
Paragraphs  (g) and (h) below,  the  arbitrator  shall hold a hearing to resolve
each of the issues  identified  by the  parties  and shall  render a decision as
expeditiously  as possible but in no event more than thirty (30)  calendar  days
after the close of hearings. In rendering the decision the arbitrator shall rule
on each disputed  issue and shall adopt in whole or in part the proposed  ruling
of one of the parties on each disputed issue.

         12.7     During the meeting  referred to in  Paragraph  (d) above,  the
parties  shall  negotiate  in good faith the scope and  schedule  of  discovery,
relating to depositions, document production and other discovery devices, taking
into account the nature of the dispute submitted for resolution.  If the parties
are unable to reach  agreement  as to the scope and schedule of  discovery,  the
arbitrator may order such discovery as the arbitrator  deems  necessary.  To the
extent  practicable  taking into account the nature of the dispute submitted for
resolution,  such discovery  shall be completed  within sixty (60) calendar days
from the date of the selection of the  arbitrator.  At the hearing,  which shall
commence within twenty (20) business days after  completion of discovery  unless
the arbitrator  otherwise orders, the parties may present testimony (either live
witness or deposition), subject to cross-examination,  and documentary evidence.
To the  extent  practicable  taking  into  account  the  nature  of the  dispute
submitted for resolution and the  availability  of the  arbitrator,  the hearing
shall be conducted over a period not to exceed thirty (30) consecutive  business
days, with each party entitled to approximately half of the allotted time unless
otherwise ordered by the arbitrator.  The hearing shall be held in New York, New
York at such place as may be agreed upon by the parties.  The  arbitrator  shall
have sole  discretion with regard to the  admissibility  of any evidence and all
other matters relating to the conduct of the hearing.  The arbitrator  shall, in
rendering  its

                                       19
<PAGE>

decision, apply the substantive laws of the State of New York (regardless of its
or any other  jurisdiction's  choice of law  principles).  The  decision  of the
arbitrator shall be final and not appealable, except in the case of fraud or bad
faith on the part of the arbitrator or any party to the  arbitration  proceeding
in connection with the conduct of such  proceedings;  manifest  disregard of the
law by the  arbitrator  concerning a material issue in rendering the decision or
upon any other  ground for vacating or  modifying  the decision  pursuant to the
Federal Arbitration Act, as amended..

         12.8     At least ten (10)  business days prior to the date set for the
hearing,  each party shall submit to each other party and the  arbitrator a list
of all  documents  on which  such  party  intends to rely in any oral or written
presentation  to the arbitrator and a list of all witnesses,  if any, such party
intends to call at such hearing and a brief summary of each witness'  testimony.
At least five (5) business days prior to the hearing,  each party must submit to
the  arbitrator  and serve on each other  party a proposed  findings of fact and
conclusions  of law on  each  issue  to be  resolved.  Following  the  close  of
hearings,  the  parties  shall  each  submit  such  post-hearing  briefs  to the
arbitrator  addressing the evidence and issues to be resolved as may be required
or permitted by the arbitrator.

         12.9     Except as otherwise set forth  herein,  the  arbitrator  shall
determine  the  proportion  in which the parties shall pay the costs and fees of
the  arbitration,  and each party  shall pay its own costs  (including,  without
limitation,  reasonable  attorneys'  fees) and expenses in connection  with such
arbitration;  provided,  however,  that if the  arbitrator  determines  that the
action of any party was arbitrary, frivolous or in bad faith, the arbitrator may
award such costs and expenses to the prevailing party.

         12.10    The arbitration  proceeding shall be confidential  and, except
as required by law,  neither  party shall make (or  instruct the  arbitrator  to
make) any public announcement with respect to the proceedings or decision of the
arbitrator  without the prior written consent of the other party.  The existence
of any dispute submitted for arbitration, and the award of the arbitrator, shall
be kept in confidence by the parties and the  arbitrator,  except as required in
connection  with the  enforcement  of such  award or as  otherwise  required  by
applicable law.

         12.11    Judgment  upon any award  rendered  by the  Arbitrator  may be
entered in any court having jurisdiction thereof.

         12.12    Nothing  contained  herein  shall be  construed  to permit the
arbitrator or any court or any other forum to award  punitive,  exemplary or any
similar  damages.  By entering  into this  Agreement to  arbitrate,  the parties
expressly waive any claim for punitive,  exemplary or any similar  damages.  The
only damages  recoverable  under this Agreement are  compensatory  damages.  The
foregoing  limitation  will not  prevent  a party  entitled  to  indemnification
pursuant to this  Agreement  from  recovering  all components or any judgment or
award against such party by an unaffiliated third party.

                                       20
<PAGE>

         12.13    The procedures  specified in this Article 12 shall be the sole
and exclusive  procedures  for the  resolution  of disputes  between the parties
which are expressly  identified for  resolution in accordance  with this Article
12.

         IN WITNESS WHEREOF,  the parties have executed this Agreement as of the
date set forth above.

NOSTRUM PHARMACEUTICALS, INC.                 SYNOVICS LABORATORIES, INC.

By:                                           By:
    ------------------------------                ------------------------------

Name:  Nirmal Mulye, Ph.D.                    Name: Ronald Howard Lane. Ph.D.
Title: President                              Title: President

                                       21EXHIBIT 4.1

                   FORM OF STANDARD TERMS FOR TRUST AGREEMENTS

                                     between

                         MERRILL LYNCH DEPOSITOR, INC.,

                                  as Depositor,

                                       and

                              THE BANK OF NEW YORK,

                    as Trustee and as Securities Intermediary

                               TRUST CERTIFICATES

                              Dated as of [ ], 200X

<PAGE>

     Reconciliation and tie between the Standard Terms, dated as of [ ], 2006,
and the Trust Indenture Act of 1939, as amended. This reconciliation and tie
does not constitute part of the Standard Terms.

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
                Trust Indenture Act                     Standard
                  of 1939 Section                     Terms Section
--------------------------------------------------------------------------------
                  310(a)(1)                                          7.07
--------------------------------------------------------------------------------
                      (a)(2)                                         7.07
--------------------------------------------------------------------------------
                      (a)(5)                                         7.07
--------------------------------------------------------------------------------
                  312(a)                                             7.14
--------------------------------------------------------------------------------
                  313(a)                                             7.16
--------------------------------------------------------------------------------
                  314(a)                                             3.10
--------------------------------------------------------------------------------
                      (c)(1)                                         1.03
--------------------------------------------------------------------------------
                      (c)(2)                                         1.03
--------------------------------------------------------------------------------
                      (e)                                            1.03
--------------------------------------------------------------------------------
                  315(a)(1)                                          7.01
--------------------------------------------------------------------------------
                  315(a)(2)                                          7.03
--------------------------------------------------------------------------------
                  315(b)                                             7.01(d)
--------------------------------------------------------------------------------
                  315(d)                                             7.01(c)
--------------------------------------------------------------------------------
                  316(a)(1)(A)                                       5.19
--------------------------------------------------------------------------------
                      (a)(1)(B)                                      5.20
--------------------------------------------------------------------------------
                      (b)                                            5.21
--------------------------------------------------------------------------------
                      (c)                                            1.03(b)
--------------------------------------------------------------------------------
                  317(a)(1)                                          5.18
--------------------------------------------------------------------------------
                      (b)                                            5.13
--------------------------------------------------------------------------------
                  318(a)                                            11.11
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

<PAGE>

                                TABLE OF CONTENTS

Article I DEFINITIONS AND ASSUMPTIONS.........................................1

   Section 1.01.  Definitions.................................................1
   Section 1.02.  Rules of Construction. Unless the context otherwise
                    requires:.................................................13
   Section 1.03.  Compliance Certificates and Opinions; Record Date...........14

Article II DECLARATION OF TRUSTS; ISSUANCE OF CERTIFICATES; PURPOSE
             AND CLASSIFICATION OF TRUSTS.....................................14

   Section 2.01.  Creation and Declaration of Trusts; Assignment of
                    Deposited Assets..........................................14
   Section 2.02.  Acceptance by Trustee.......................................16
   Section 2.03.  Representations and Warranties of the Depositor.............16
   Section 2.04.  Breach of Representation, Warranty or Covenant..............17
   Section 2.05.  Agreement to Execute, Authenticate and Deliver
                    Certificates..............................................17
   Section 2.06.  Custody and Holding of Deposited Assets.....................17

Article III ADMINISTRATION OF EACH TRUST......................................19

   Section 3.01.  Administration of Each Trust................................19
   Section 3.02.  Collection of Certain Underlying Security Payments..........19
   Section 3.04.  Distribution or Sale of the Underlying Securities...........20
   Section 3.05.  Investment of Funds in the Accounts.........................21
   Section 3.06.  Maintenance of Credit Support...............................21
   Section 3.07.  Realization upon Defaulted Underlying Securities............21
   Section 3.08.  Retained Interest...........................................22
   Section 3.09.  Access to Certain Documentation.............................22
   Section 3.10.  Reports by the Depositor....................................22
   Section 3.11.  Charges and Expenses........................................23

Article IV DISTRIBUTIONS AND REPORTS TO CERTIFICATEHOLDERS....................23

   Section 4.01.  Distributions...............................................23
   Section 4.02.  Distributions on Certificates...............................23
   Section 4.03.  Reports to Certificateholders...............................24
   Section 4.04.  Advances....................................................25
   Section 4.05.  Allocation of Realized Losses and Trust Expenses............25
   Section 4.06.  Compliance with Withholding Requirements....................25
   Section 4.07.  Optional Exchange...........................................26
   Section 4.08.  Call Right..................................................27

Article V THE CERTIFICATES....................................................29

   Section 5.01.  The Certificates............................................29
   Section 5.02.  Execution, Authentication and Delivery......................29
   Section 5.03.  Temporary Certificates......................................29
   Section 5.04.  Registration; Registration of Transfer and Exchange.........30
   Section 5.05.  Mutilated, Destroyed, Lost and Stolen Certificates..........31
   Section 5.06.  Persons Deemed Owners.......................................31
   Section 5.07.  Cancellation................................................31

                                       i

<PAGE>

   Section 5.08.  Global Securities...........................................32
   Section 5.09.  Notices to Depository.......................................33
   Section 5.10.  Definitive Certificates.....................................33
   Section 5.11.  Currency of Distributions...................................34
   Section 5.12.  Conditions of Execution, Authentication and Delivery of
                    New Series................................................34
   Section 5.13.  Appointment of Paying Agent.................................36
   Section 5.14.  Authenticating Agent........................................36
   Section 5.15.  Voting Rights with Respect to Underlying Securities.........37
   Section 5.16.  Actions by Certificateholders...............................37
   Section 5.17.  Events of Default...........................................38
   Section 5.18.  Judicial Proceedings Instituted by Trustee; Trustee May
                    Bring Suit................................................38
   Section 5.19.  Control by Certificateholders...............................38
   Section 5.20.  Waiver of Past Defaults.....................................38
   Section 5.21.  Right of Certificateholders to Receive Payments Not to Be
                    Impaired..................................................39
   Section 5.22.  Remedies Cumulative.........................................39

Article VI THE DEPOSITOR......................................................39

   Section 6.01.  Liability of the Depositor..................................39
   Section 6.02.  Limitation on Liability of the Depositor....................39
   Section 6.04.  Merger or Consolidation of the Depositor....................40
   Section 6.05.  No Liability of the Depositor with Respect to the
                    Underlying Securities; Certificateholders to Proceed
                    Directly Against the Underlying Securities Issuer(s)......40

Article VII THE TRUSTEE.......................................................40

   Section 7.01.  Duties of Trustee...........................................40
   Section 7.02.  Agreements Between Trustee and Administrative Agents........43
   Section 7.03.  Certain Matters Affecting the Trustee.......................44
   Section 7.04.  Trustee Not Liable for Recitals in Certificates or
                    Underlying Securities.....................................45
   Section 7.05.  Trustee May Own Certificates................................45
   Section 7.06.  Trustee's Fees and Expenses.................................45
   Section 7.07.  Eligibility Requirements for Trustee........................45
   Section 7.08.  Resignation or Removal of the Trustee; Appointment of
                    Successor Trustee.........................................46
   Section 7.09.  Appointment of Office or Agency.............................48
   Section 7.10.  Representations and Warranties of Trustee...................48
   Section 7.11.  Indemnification of Trustee by the Depositor;
                    Contribution..............................................48
   Section 7.12.  No Liability of the Trustee with Respect to the
                    Underlying Securities; Certificateholders to Proceed
                    Directly Against the Underlying Securities Issuer(s)......49
   Section 7.13.  The Depositor to Furnish Trustee with Names and Addresses
                    of Certificateholders.....................................49
   Section 7.14.  Preservation of Information.................................50
   Section 7.15.  Reports by Trustee..........................................50
   Section 7.16.  Trustee's Application for Instructions from the Depositor...50
   Section 7.17.  Assessment of Compliance by Trustee; Annual Independent
                    Certified Public Accountants Report; etc..................50
   Section 7.18.  Information to be Provided by the Trustee...................51

                                       ii

<PAGE>

Article VIII MARKET AGENT.....................................................52

   Section 8.01.  Market Agent................................................52

Article IX SECURITIES INTERMEDIARY............................................52

   Section 9.01.  Resignation or Removal of the Securities Intermediary;
                     Appointment of Successor Securities Intermediary.........52

Article X TERMINATION.........................................................54

   Section 10.01.  Termination upon Liquidation of All Underlying
                     Securities...............................................54

Article XI MISCELLANEOUS PROVISIONS...........................................54

   Section 11.01.  Amendment..................................................54
   Section 11.02.  Limitation on Rights of Certificateholders.................55
   Section 11.03.  Governing Law..............................................56
   Section 11.04.  Notices....................................................56
   Section 11.05.  Notice to Rating Agencies..................................57
   Section 11.06.  Severability of Provisions.................................57
   Section 11.07.  Nonpetition Covenant.......................................58
   Section 11.08.  No Recourse................................................58
   Section 11.09.  Article and Section References.............................58
   Section 11.10.  Counterparts...............................................58
   Section 11.11.  Trust Indenture Act........................................58

                                       iii

<PAGE>

         STANDARD TERMS FOR TRUST AGREEMENTS dated as of [ ], 2006 between
MERRILL LYNCH DEPOSITOR, INC., a Delaware corporation, as Depositor (the
"Depositor"), and THE BANK OF NEW YORK, a New York corporation, as Trustee (in
such capacity, the "Trustee") and as securities intermediary (in such capacity,
the "Securities Intermediary").

                              PRELIMINARY STATEMENT

         The Depositor, the Trustee and the Securities Intermediary have duly
authorized the execution and delivery of these Standard Terms for Trust
Agreements (the "Standard Terms") to provide for one or more Series (and one or
more Classes within each such Series) of Certificates, issuable from time to
time as provided in these Standard Terms.

         Each such Series (inclusive of any Classes specified within such
Series) will be issued under a separate Supplement to these Standard Terms, duly
executed and delivered by the Depositor, the Trustee and the Securities
Intermediary. With respect to each Series, these Standard Terms and all
amendments hereof and, unless the context otherwise requires, the related
Supplement and all amendments thereto shall be known as the "Trust Agreement".

         All representations, covenants and agreements made herein by each of
the Depositor, the Trustee and the Securities Intermediary are for the benefit
and security of the Holders and, to the extent provided in the applicable
Supplement, for the benefit and security of any Credit Support Provider or any
other party as specified therein.

         The Depositor and the Securities Intermediary are entering into these
Standard Terms, and the Trustee is accepting the trust created hereby, for good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged.

                                   ARTICLE I
                           DEFINITIONS AND ASSUMPTIONS

         Section 1.01. Definitions. Except as otherwise specified herein or in
the applicable Supplement or as the context may otherwise require, the following
terms have the respective meanings set forth below for all purposes of this
Trust Agreement.

         "Account": As defined in Section 3.05.

         "Accounting Date": With respect to any Series, if applicable, as
defined in the related Supplement.

         "Administration Account": As defined in Section 7.02.

         "Administrative Agent": Any Person with which the Trustee has entered
into an Administration Agreement and that meets the qualifications of an
Administrative Agent, pursuant to Section 7.02.

         "Administration Agreement": The written contract, if any, between the
Trustee and an Administrative Agent and any successor Trustee or Administrative
Agent providing that the Trustee can delegate certain of its administrative
obligations with respect to any Series hereunder.

         "Administrative Agent Termination Event": With respect to any given
Series, any of the following: (i) any failure by an Administrative Agent to
remit to the Trustee any funds in respect of collections on the Underlying
Securities and Credit Support, if any, as required under this Trust Agreement,
that continues unremedied for five days after the giving of written notice of
such failure to the Administrative Agent by the Trustee or the Depositor, or to
the Administrative Agent, the Depositor and the Trustee by the Holders of not
less than 25% of the Voting Rights; (ii) any failure by an Administrative Agent
duly to observe or perform in any material respect any of its other covenants or
obligations under the Administration Agreement with respect to such Series that
continues unremedied for thirty days after the giving of written notice of such
failure to the Administrative Agent by the Trustee or the Depositor, or to the
Administrative Agent, the Depositor and the Trustee by the Holders of not less
than 25% of the Voting Rights; and (iii) events of insolvency, readjustment of
debt, marshalling of assets and liabilities or similar proceedings and certain
actions by or on behalf of an Administrative Agent indicating its insolvency or
inability to pay its obligations. Any additional

<PAGE>

Administrative Agent Termination Event with respect to any given Series may be
set forth in the applicable Supplement.

         "Advance": As defined in Section 4.04.

         "Affiliate": With respect to any specified Person, any other Person
directly or indirectly controlling or controlled by or under direct or indirect
common control with such specified Person. For the purposes of this definition,
"control", when used with respect to any specified Person, means the power to
direct the management and policies of such Person, directly or indirectly,
whether through the ownership of voting securities, by contract or otherwise;
and the terms "controlling" and "controlled" have meanings correlative to the
foregoing.

         "Allocation Ratio": With respect to any Series, as defined in the
related Supplement.

         "Authenticating Agent": As defined in Section 5.14.

         "Authorized Denomination": The minimum denomination in which a
Certificate may be issued, or any multiple thereof, as specified in the related
Supplement.

         "Available Funds": Unless otherwise specified in the applicable
Supplement, for any Distribution Date in respect of a given Series or Class, the
sum of (i) all amounts actually received on or with respect to the Underlying
Securities (including Liquidation Proceeds and investment income earned on
Account funds invested pursuant to Section 3.05) with respect to such Series
during the related Collection Period, (ii) all amounts received pursuant to any
Credit Support Instruments with respect to such Series for such Distribution
Date and (iii) all other amounts, if any, specified by the applicable Supplement
less any amount held for the benefit of the Retained Interest.

         "Beneficial Owner": With respect to Certificates held through a
Depository, the beneficial owner of a Certificate. For purposes only of Section
5.16, the Trustee shall be obligated to treat a Person who claims to be a
beneficial owner of a Certificate as a "Beneficial Owner" within the meaning of
the Supplement only if such Person has first delivered to the Trustee, (i) a
certificate or other writing executed by such Person stating the full name and
address of such Person, the principal distribution amount of the Certificate
with respect to which such Person claims to be the Beneficial Owner, and the
participant in the Depository ("such Person's Participant") through which such
Person holds its beneficial ownership interest in the Certificates and (ii) a
certificate or other writing executed by such Person's Participant confirming
that such Person's Participant holds on its own books and records Certificates
for the account of such Beneficial Owner and identifying the principal
distribution amount held for such Beneficial Owner.

         "Book-Entry Securities": Securities maintained in the form of entries
(including, without limitation, the Security Entitlements in such Securities) in
the commercial book-entry system of the Fed and held for the Trustee, directly
or indirectly, by any Trustee's Fed Member. Book-Entry Securities shall not
include, in any event, any Certificated Security (or any Security Entitlement in
any Certificated Security) held, directly or indirectly, through a Clearing
Corporation.

         "Business Day": With respect to any Series, as defined in the related
Supplement.

         "Calculation Agent": If applicable with respect to any Series, as
specified in the applicable Supplement.

         "Call Date": The date on which the Call Right may be exercised, as
specified in the applicable Supplement.

         "Call Price": If applicable with respect to any Series, as specified in
the applicable Supplement.

         "Callable Series": A Series or Class within such Series subject to a
Call Right, as specified in the applicable Supplement.

                                       2

<PAGE>

         "Call Right": The right of the holder thereof (or any successor), as
named in the applicable Supplement, to purchase Certificates from the Holders
thereof or to purchase Underlying Securities from the Trust.

         "Call Terms": The terms pursuant to which a Call Right may be
exercised, as set forth in the applicable Supplement.

         "Certificate" and "Certificates": Any trust certificate or trust
certificates authorized by, executed pursuant to and authenticated and delivered
under, this Trust Agreement, and unless the context requires otherwise,
"Certificate" and "Certificates" shall also be deemed to refer to the Retained
Interest.

         "Certificate Account": As defined in Section 3.03.

         "Certificate Principal Balance": With respect to an Outstanding
Certificate, as determined at any time, the maximum amount that the Holder
thereof is entitled to receive as distributions allocable to principal payments
on the Underlying Securities. The Certificate Principal Balance, if any, of any
Class within a given Series (other than those Classes, if any, specified in the
related Supplement), as of any date of determination, shall be equal to the
aggregate initial Certificate Principal Balance thereof less the sum of (i) all
amounts allocable to prior distributions made to such Class in respect to
principal of the Underlying Securities, (ii) any reductions attributable to
Certificates surrendered in exchange for Underlying Securities, as and to the
extent provided in the applicable Supplement, and (iii) any reductions in the
Certificate Principal Balance thereof deemed to have occurred in connection with
allocations of (A) Realized Losses in respect of principal of the Underlying
Securities and (B) expenses of the Trust if any only to the extent specified in
the applicable Supplement, each as allocated to such Class pursuant to the
applicable Supplement.

         "Certificate Register" and "Certificate Registrar": As defined in
Section 5.04.

         "Certificated Security": As defined in Section 8-102(a)(4) of the UCC.

         "Certificateholder": Any holder of a Certificate or a Retained
Interest.

         "Class": With respect to any Series, any one of the classes of
Certificates of such Series, each class consisting of Certificates having
identical terms.

         "Clearing Agency": An organization that (i) is registered as a
"clearing agency" pursuant to Section 17A of the Exchange Act and (ii) is a
Clearing Corporation.

         "Clearing Agency Participant": At any time, in respect of any Clearing
Agency, a securities intermediary that maintains Securities Accounts with such
Clearing Agency at such time.

         "Clearing Corporation": The meaning specified in Section 8-102(a)(5) of
the UCC.

         "Closing Date": With respect to any Series, the day on which
Certificates of such Series are first executed, authenticated and delivered, as
specified in the related Supplement.

         "Code": The Internal Revenue Code of 1986, as amended, and Treasury
Regulations promulgated thereunder.

         "Collection Period": With respect to any Distribution Date for a Series
(or Class within such Series), the period specified in the related Supplement.

         "Commission": The Securities and Exchange Commission, as from time to
time constituted, created under the Exchange Act or, if at any time after the
execution and delivery of this Trust Agreement such Commission is not existing
and performing the duties now assigned to it, then the body then performing such
duties.

         "Concentrated Underlying Securities": Any Underlying Security that is
issued by a Significant Obligor.

                                       3

<PAGE>

         "Corporate Trust Office": The principal corporate trust office of the
Trustee located at the address set forth in the related Supplement or such other
address as the Trustee may designate from time to time by notice to the Holders
and the Depositor, or the principal corporate trust office of any successor
Trustee (or such other addresses as a successor Trustee may designate from time
to time by notice to the Holders and the Depositor).

         "Credit Support": As specified in the related Supplement, a Letter of
Credit, Limited Guaranty, Surety Bond, Swap Agreement, Swap Guarantee, or other
asset intended to support or ensure the timely or ultimate distributions of
amounts due in respect of a Series (or Class within such Series).

         "Credit Support Instrument": The instrument or document pursuant to
which the Credit Support for a given Series (or Class within such Series) is
provided, as specified in the applicable Supplement.

         "Credit Support Provider": With respect to any Series (or Class within
such Series), the Person, if any, that will provide any Credit Support with
respect to all or a portion of a Series or Class, as specified in the applicable
Supplement.

         "Cut-off Date": With respect to any Series, the date specified as such
in the related Supplement. For purposes of this Trust Agreement, any Underlying
Security acquired by the Depositor after the applicable Cut-off Date but prior
to the applicable Closing Date and included in the related Trust as of such
Closing Date shall be deemed to have been Outstanding as of such Cut-off Date
and references to the principal balance of such Underlying Security as of such
Cut-off Date shall be deemed to be to the principal balance of such Underlying
Security as of the date on which it was acquired by the Depositor.

         "Definitive Certificates": As defined in Section 5.10.

         "Deposited Assets": With respect to any Series, the following assets,
properties and items (together with the accounts and book-entry accounts
containing or reflecting, directly or indirectly, such assets, properties and
items), in each case, wherever located, however held and whether now existing or
hereafter acquired:

         (i)  all Underlying Securities and Related Assets;

        (ii)  all payments receivable or received in respect of the Underlying
     Securities including the immediate and continuing right to claim for,
     collect, receive and give receipt for principal, premium, if any, and
     interest payments in respect of the Underlying Securities and all other
     monies payable thereunder;

       (iii)  all Financial Assets, Security Entitlements and Investment
     Property in, constituting, evidenced by, resulting from or otherwise
     related to, any of the Deposited Assets;

        (iv)  all other rights and remedies (but none of the obligations)
     comprising, arising or resulting from or related to the Grant of the
     Deposited Assets including, without limitation, the right to give and
     receive notices and other communications, to make waivers or other
     agreements, to exercise all rights and options of the Depositor, to bring
     Proceedings in the name of the Depositor or otherwise, and generally to
     exercise all of the rights and remedies of the Depositor and to do and
     receive anything that the Depositor is or may be entitled to do or receive
     thereunder or with respect thereto; and

         (v)  any other assets identified as Deposited Assets in the related
     Supplement, which assets may include cash, cash equivalents, guarantees,
     letters of credit, financial insurance, interest rate, currency, equity,
     commodity and credit-linked swaps, caps, floors, collars and options,
     forward contracts, structured securities and other instruments and
     transactions that credit enhance, hedge or otherwise support the Underlying
     Securities designed to assure the servicing or timely distribution of
     payments to Holders.

         "Depositor": Merrill Lynch Depositor, Inc., a Delaware corporation,
and, if a successor Person shall have become the Depositor pursuant to any
applicable provisions of this Trust Agreement, "Depositor" shall mean such
successor Person. With respect to any

                                       4

<PAGE>

provisions of this Trust Agreement that relate to the provisions of the TIA,
"Depositor" shall include any obligor on the Certificates as the term obligor is
defined in the TIA.

         "Depositor Order": A written order or request, respectively, signed in
the name of the Depositor by any one of its Executive Officers.

         "Depository": With respect to the Certificates of any Series (or Class
within such Series) issuable in whole or in part in the form of one or more
Global Securities, the Person so designated in the applicable Supplement, and,
if at any time there is more than one such Person, "Depository" as used with
respect to the Certificates of any such Series or Class shall mean the
Depository with respect to the Certificates of that Series or Class.

         "Disqualified Credit Support" Any Credit Support in relation to which
(i) the Credit Support Provider, together with any other affiliated entities
providing any Credit Support in relation to any Series (or Class within such
Series) is liable or contingently liable to provide payments representing 10% or
more of the cash flow supporting any such Series (or Class within such Series),
as determined in accordance with Item 1114 of Regulation AB and (ii) none of the
following is true: (A)(1) such Credit Support Provider meets the requirements of
General Instruction I.A. of Form S-3 or General Instructions 1.A.1, 2, 3, 4 and
6 of Form F-3 under the Securities Act and (2) the relevant Credit Support
relating to such Credit Support Provider is not guaranteed by a wholly owned
subsidiary of such Credit Support Provider which does not meet the conditions in
(A)(1); (B) such Credit Support Provider does not meet the conditions of
paragraph (A)(1) but the relevant Credit Support relating to such Credit Support
Provider is fully and unconditionally guaranteed by a direct or indirect parent
of the third party who meets the conditions of paragraph (A)(1) and the
requirements of Rule 3-10 of Regulation S-X under the Exchange Act are satisfied
regarding the information in the reports to be referenced; (C) the relevant
Credit Support relating to such Credit Support Priovider are guaranteed by a
wholly owned subsidiary of such Credit Support Provider and the subsidiary does
not meet the conditions of paragraph (A)(1), but the conditions in paragraph
(A)(1) are met with respect to such issuer and the requirements of Rule 3-10 of
Regulation S-X under the Exchange Act are satisfied regarding the information in
the reports to be referenced.

         "Disqualified Swap Counterparty": A swap counterparty with respect to
which (i) the "significance percentage" as determined in accordance with Item
1115 of Regulation AB is 10% or more and (ii) none of the following is true:
(A)(1) such swap counterparty meets the requirements of General Instruction I.A.
of Form S-3 or General Instructions 1.A.1, 2, 3, 4 and 6 of Form F-3 under the
Securities Act and (2) the relevant swap transaction relating to such swap
counterparty are not guaranteed by a wholly owned subsidiary of such swap
counterparty which does not meet the conditions in (A)(1); (B) such swap
counterparty does not meet the conditions of paragraph (A)(1) but the relevant
swap transaction relating to such swap counterparty are fully and
unconditionally guaranteed by a direct or indirect parent of the third party who
meets the conditions of paragraph (A)(1) and the requirements of Rule 3-10 of
Regulation S-X under the Exchange Act are satisfied regarding the information in
the reports to be referenced; (C) the relevant swap transaction relating to such
swap counterparty are guaranteed by a wholly owned subsidiary of such swap
counterparty and the subsidiary does not meet the conditions of paragraph
(A)(1), but the conditions in paragraph (A)(1) are met with respect to such swap
counterparty and the requirements of Rule 3-10 of Regulation S-X under the
Exchange Act are satisfied regarding the information in the reports to be
referenced.

         "Discount Certificate": Any Certificate that is issued with "original
issue discount" within the meaning of Section 1273(a) of the Code and any other
Certificate designated by the Depositor as issued with original issue discount
for United States Federal income tax purposes.

         "Distribution Date": With respect to any Series (or Class within such
Series), each date specified as a "Distribution Date" for such Series (or Class)
in the related Supplement.

         "Distribution Election": With respect to any Series, as specified in
the related Supplement.

         "Dollar" or "$" or "USD": Such currency of the United States as at the
time of payment is legal tender for the payment of public and private debts.

                                       5

<PAGE>

         "Depository Securities": Securities consisting of Security Entitlements
to Certificated Securities, held by the Depository or a Clearing Corporation or
a nominee of either subject to the control of the Depository and in bearer form
or indorsed in blank by an appropriate Person or registered on the books of the
issuer thereof in the name of the Depository or its Clearing Corporation or a
nominee of either.

         "DCR": Duff & Phelps Credit Rating Co. and any successor thereto.

         "Eligible Account": Either (i) an account or accounts maintained with a
Federal or State chartered depository institution or trust company the long-term
unsecured obligations of which are rated by the Rating Agency the higher of (x)
at least the then current long-term rating of the Certificates or (y) in one of
its two highest long-term rating categories (unless otherwise specified in the
Supplement) at the time any amounts are held in deposit therein or (ii) a trust
account(s) maintained as a segregated account(s) and held by a Federal or State
chartered depository institution or trust company in trust for the benefit of
the Certificateholders; provided, however, that such depository institution or
trust company has a long-term rating in one of the four highest categories by
the Rating Agency.

         "Eligible Investments": With respect to any Series, unless otherwise
specified in the related Supplement, any one or more of the following
obligations or securities; provided, however, that the total stated return
specified by the terms of each such obligation or security is at least equal to
the purchase price thereof; and provided further that no such instrument may
carry the symbol "r" from S&P in its rating:

         (i)  direct obligations of, and obligations fully guaranteed by, the
     United States, the Federal Home Loan Mortgage Corporation, the Federal
     National Mortgage Association, the Federal Farm Credit System or any agency
     or instrumentality of the United States the obligations of which are backed
     by the full faith and credit of the United States; provided, however, that
     obligations of, or guaranteed by, the Federal Home Loan Mortgage
     Corporation, the Federal National Mortgage Association or the Federal Farm
     Credit System shall be Eligible Investments only if, at the time of
     investment, such investment has the rating specified in such Supplement for
     Eligible Investments;

        (ii)  demand and time deposits in, certificates of deposit of, or
     banker's acceptances issued by any depository institution or trust company
     (including the Trustee or any agent of the Trustee acting in their
     respective commercial capacities) incorporated under the laws of the United
     States or any State and subject to supervision and examination by Federal
     and/or State banking authorities so long as the commercial paper and/or the
     short-term debt obligations of such depository institution or trust company
     (or, in the case of a depository institution which is the principal
     subsidiary of a holding company, the commercial paper or other short-term
     debt obligations of such holding company) at the time of such investment or
     contractual commitment providing for such investment have the rating
     specified in such Supplement for Eligible Investments; provided, however,
     that such rating shall be no lower than the lower of the rating on the
     Underlying Securities or the Trust Certificates at the time of purchase of
     the investments;

       (iii)  securities bearing interest or sold at a discount issued by any
     corporation incorporated under the laws of the United States or any State
     that have the rating specified in such Supplement for Eligible Investments
     at the time of such investment or contractual commitment providing for such
     investment; provided, however, that such rating shall be no lower than the
     lower of the rating on the Underlying Securities or the Trust Certificates;
     and provided further that securities issued by any particular corporation
     will not be Eligible Investments to the extent that investment therein will
     cause the then outstanding principal amount of securities issued by such
     corporation and held as part of the Trust for such Series to exceed 10% of
     the aggregate outstanding principal balances and amounts of all the
     Underlying Securities and Eligible Investments held as part of the Trust
     for such Series; and

        (iv)  commercial paper having at the time of such investment the rating
     specified in the Supplement for Eligible Investments.

         "Entitlement Holder": As defined in Section 8-102(a)(7) of the UCC.

                                       6

<PAGE>

         "Event of Default": With respect to any Series (or Class within such
Series), as specified in the related Supplement.

         "Exchange Act": The Securities Exchange Act of 1934, as amended.

         "Exchange Rate Agent": As specified in the Supplement.

         "Executive Officer": With respect to any limited liability company or
corporation, the chief executive officer, the chief operating officer, the chief
financial officer, the president, any vice president, the secretary or the
treasurer of such limited liability company or corporation; with respect to any
partnership, any general partner thereof.

         "Extraordinary Trust Expenses": Any and all costs, expenses or
liabilities arising out of the establishment, existence or administration of the
Trust, other than (i) Ordinary Expenses, and (ii) costs and expenses payable by
a particular Certificateholder, the Trustee or the Depositor pursuant to this
Trust Agreement.

         "Fed": The Federal Reserve Bank of New York.

         "Fed Member Securities Account": In respect of any Person, an account
in the name of such Person at the Fed, to which account Book-Entry Securities
held for such Person are or may be credited.

         "Federal Book-Entry Regulations": (a) the Federal regulations contained
in Subpart B ("Treasury/Reserve Automated Debt Entry System (TRADES)" governing
Book-Entry Securities consisting of U.S. Treasury bonds, notes and bills) and
Subpart D ("Additional Provisions") of 31 C.F.R. Part 357, 31 C.F.R. ss. 357.10
through ss. 357.14 and ss. 357.41 through ss. 357.44 (including related defined
terms in 31 C.F.R. ss. 357.2) and (b) to the extent substantially identical to
the federal regulations referred to in clause (a) above (as in effect from time
to time), the federal regulations governing other Book-Entry Securities.

         "Final Scheduled Distribution Date": With respect to any Certificate,
the date on which all the unpaid principal of (and premium, if any, on) and
interest on such Certificate is scheduled, without giving effect to any
prepayment, exchange or early termination, to become due and payable as provided
therein and in the applicable Supplement.

         "Financial Asset": As defined in Section 8-102(a)(9) of the UCC.

         "Fitch": Fitch Investors Service, L.P., and any successor thereof.

         "Fixed Pass-Through Rate": With respect to any Fixed Rate Certificate,
as defined in the related Supplement.

         "Fixed Rate Certificate": A Certificate that provides for a payment of
interest at a Fixed Pass-Through Rate.

         "Floating Pass-Through Rate": With respect to any Floating Rate
Certificate, as defined in the related Supplement.

         "Floating Rate Certificate": A Certificate that provides for the
payment of interest at a Floating Pass-Through Rate determined periodically by
reference to a formula specified in the related Supplement.

         "Global Security": A registered Certificate evidencing all or part of a
Series (or Class within such Series), issued to the Depository for such Series
or Class in accordance with Section 5.08 and bearing the legend prescribed
therein.

         "Grant": To grant, bargain, sell, warrant, alienate, remise, demise,
release, convey, assign, transfer, deposit, set over and confirm to the Trustee
pursuant to these Standard Terms and the applicable Supplement; and the terms
"Granted" and "Granting" have the meanings correlative to the foregoing.

                                       7

<PAGE>

         "Holder": The Person in whose name a Certificate or Retained Interest
is registered in the Certificate Register on the applicable Record Date. Where
the context requires, "Holder" may refer to the person entitled to exercise the
Voting Rights accompanying a Certificate.

         "Independent": When used with respect to any Person means that such
Person (1) is in fact independent of the Depositor and of any Affiliate, (2)
does not have any direct or indirect material financial interest in the
Depositor or in any Affiliate and (3) is not connected with the Depositor or any
Affiliate as an officer, employee, promoter, underwriter, trustee, partner,
director or person performing similar functions.

         "Investment Property": As defined in Section 9-115 of the UCC.

         "Letter of Credit": With respect to any Series (or Class within such
Series), the letter of credit, if any, providing for the payment of all or a
portion of amounts due in respect of such Series (or Class), issued to the
Trustee for the benefit of the Holders of such Series (or Class), issued by the
related Credit Support Provider, all as specified in the related Supplement.

         "Limited Guarantor": With respect to any Series (or Class within such
Series), a Person specified in the related Supplement as providing a guarantee
or insurance policy or other credit enhancement supporting the distributions in
respect of such Series (or Class within such Series) as and to the extent
specified in such Supplement.

         "Limited Guaranty": With respect to any Series (or Class within such
Series), any guarantee of, or insurance policy or other comparable form of
credit enhancement with respect to, amounts required to be distributed in
respect of such Series (or Class) or payments under all or certain of the
Underlying Securities relating to such Series or Class, executed and delivered
by a Limited Guarantor in favor of the Trustee, for the benefit of the
Certificateholders, as specified in the related Supplement.

         "Liquidation Price": If applicable with respect to any Series, the
price at which the Market Agent sells the Underlying Securities on behalf of the
Trustee, as specified in the applicable Supplement.

         "Liquidation Proceeds": The amounts received by the Trustee in
connection with (i) the liquidation of a defaulted Underlying Security,
collateral, if any, related thereto, or Related Asset or (ii) the repurchase,
substitution or sale of an Underlying Security or Related Asset.

         "Market Agent": The market agent or market agents, if any, appointed
pursuant to Section 8.01, and its or their successors or assigns.

         "Market Agent Agreement": With respect to any Series, the agreement, if
any, dated as of the Closing Date, between the Trustee and the Market Agent, the
form of which will be attached to the related Supplement, and any similar
agreement with a successor Market Agent, in each case as from time to time
amended or supplemented.

         "Merrill Lynch & Co.": Merrill Lynch & Co., a Delaware corporation.

         "Minimum Wire Denomination": $10,000,000 or the equivalent in any
Specified Currency.

         "Moody's": Moody's Investors Service, Inc. and any successors
thereto.

         "Notional Amount": With respect to any Class of Certificates, if
applicable, the initial notional amount specified in the related Supplement on
which distributions of interest may be determined at the applicable Pass-Through
Rate, as the same may be adjusted as specified in such Supplement.

         "Officer's Certificate": A certificate signed by any (or, if specified
in these Standard Terms or any Supplement, more than one) Executive Officer of
the Depositor, and delivered to the Trustee.

         "Opinion of Counsel": A written opinion of counsel, who may, except as
otherwise expressly provided in this Trust Agreement, be counsel for the
Depositor

                                       8

<PAGE>

acceptable to the Trustee, except that any opinion of counsel relating to the
qualification of any account required to be maintained pursuant to this Trust
Agreement as an Eligible Account must be an opinion of counsel who is in fact
Independent of the Depositor.

         "Optional Exchange": shall mean the exchange of Certificates of any
Series (or Class within such Series) for a pro rata portion of the Deposited
Assets of the related Trust.

         "Optional Exchange Date": With respect to any Series (or Class within
such Series), as defined, if applicable, in the related Supplement.

         "Optional Redemption": The right of an Underlying Securities Issuer to
redeem such Underlying Securities in accordance with the terms of the Underlying
Securities Indenture.

         "Ordinary Expenses": The Trustee's customary fee for its services as
Trustee, as set forth in the related Supplement, including but not limited to
(i) the costs and expenses of preparing, sending and receiving all reports,
statements, notices, returns, filings, solicitation of consent or instructions,
or other communications required by this Trust Agreement, (ii) the costs and
expenses of holding and making ordinary collection or payments on the assets of
the Trust and of determining and making distributions, (iii) the costs and
expenses of the Trust's or Trustee's counsel, accountants and other experts for
ordinary or routine consultation or advice in connection with the establishment,
administration and termination of the Trust, and (iv) any other costs and
expenses that are, or reasonably should have been, expected to be incurred in
the ordinary course of administration of the Trust.

         "Outstanding": With respect to Certificates of a specified Series (or
Class within such Series), as of any date of determination, all such
Certificates theretofore executed, authenticated and delivered under these
Standard Terms and the related Supplement except:

         (i)  Certificates theretofore cancelled by the Certificate Registrar;
              and

        (ii ) Certificates, including Predecessor Certificates, in exchange for
              or in lieu of which other Certificates have been executed,
              authenticated and delivered pursuant to this Trust Agreement,
              unless proof satisfactory to the Trustee is presented that any
              such Certificates are held by a bona fide purchaser in whose hands
              such Certificates are valid obligations of the Trust;

provided, however, that in determining whether any request, demand,
authorization, direction, notice, consent or waiver hereunder has been given by
the required percentage of the aggregate Voting Rights, Voting Rights
accompanying Certificates beneficially owned by the Depositor, the Trustee, or
any Affiliate thereof shall be disregarded and deemed not to be Outstanding, and
such Voting Rights shall not be taken into account in determining whether the
requisite percentage of aggregate Voting Rights necessary to effect any such
consent or take any such action has been obtained except that, in determining
whether the Trustee shall be protected in relying upon any such request, demand,
authorization, direction, notice, consent or waiver, only Certificates with
respect to which the Depositor has provided the Trustee an Officer's
Certificate stating that such Certificates are so owned shall be so disregarded.
Certificates so owned that have been pledged in good faith may be regarded as
Outstanding if the pledgee establishes to the satisfaction of the Trustee the
pledgee's right so to act with respect to such Certificates.

         "Participant": A broker, dealer, bank, other financial institution or
other Person for whom from time to time a Depository effects book-entry
transfers and pledges of securities deposited with the Depository.

         "Pass-Through Rate": With respect to any Series (or Class within such
Series) (except certain Discount Certificates and Certificates entitled to
nominal or no interest distributions), the annual rate at which interest accrues
on the Certificates of such Series (or Class), which may be a fixed rate or a
floating rate of interest, determined upon the basis and in the manner specified
in the related Supplement.

         "Paying Agent": As defined in Section 5.13.

                                       9

<PAGE>

         "Person": Any individual, limited liability company, corporation,
partnership, joint venture, association, joint stock company, trust (including
any beneficiary thereof), unincorporated organization or government or any
agency or political subdivision thereof.

         "Predecessor Certificate": As defined in Section 5.05.

         "Prepaid Ordinary Expenses": The amount (if any) paid by the Depositor
to the Trustee on or before the Closing Date to cover Ordinary Expenses, as
specified in the related Supplement.

         "Proceeding": Any suit in equity, action at law or other judicial or
administrative proceeding.

         "Rating Agency": With respect to any Series or Class within such
Series), each nationally recognized statistical rating organization, specified
in the related Supplement, that initially rates the Certificates of such Series
(or Class within such Series).

         "Rating Agency Condition": With respect to any action or occurrence,
unless otherwise specified in the applicable Supplement, that each Rating Agency
shall have been given 10 days (or such shorter period acceptable to each Rating
Agency) prior written notice thereof and that each Rating Agency shall have
notified the Depositor and the Trustee in writing that such action or occurrence
will not result in a reduction or withdrawal of the then current rating of any
Certificate of the applicable Series.

         "Realized Loss": With respect to any defaulted and liquidated
Underlying Security, the excess, if any, of (x) the price paid by the Depositor
for such Underlying Security plus expenses incurred by the Trustee in connection
with the practices and procedures referred to in Section 3.07(b) of these
Standard Terms, to the extent reimbursable under these Standard Terms and the
related Supplement, over (y) Liquidation Proceeds with respect thereto.

         "Record Date": With respect to any Distribution Date for any Series (or
Class within such Series), the date specified in the related Supplement.

         "Regulation AB": Subpart 229.1100 - Asset Backed Securities (Regulation
AB), 17 C.F.R. Sections 229.1100-229.1123, as such may be amended from time to
time, and subject to such clarification and interpretation as have been provided
by the Commission in the adopting release (Asset-Backed Securities, Securities
Act Release No. 33-8518, 70 Fed. Reg. 1,506, 1,531 (Jan. 7, 2005)) or by the
staff of the Commission, or as may be provided by the Commission or its staff
from time to time.

         "Related Assets": Any assets held by a Trust the return of which is
linked to one or more Underlying Securities and which, if applicable, shall be
described in the related Supplement or a schedule thereto.

         "Required Percentage--Amendment": Unless otherwise specified in the
related Supplement, if a Rating Agency Condition is specified in such Supplement
and such Rating Agency Condition is met, or, if a Rating Agency Condition is not
so specified in such Supplement, 66-2/3% of the aggregate Voting Rights of such
Series, and 100% otherwise.

         "Required Percentage--Direction of Trustee": Unless otherwise specified
in the related Supplement, 66-2/3% of the aggregate Voting Rights of such
Series.

         "Required Percentage--Remedies": Unless otherwise specified in the
related Supplement, 66-2/3% of the aggregate Voting Rights of such Series.

         "Required Percentage--Removal of Securities Intermediary": Unless
otherwise specified in the related Supplement, more than 50% of the aggregate
Voting Rights of such Series.

         "Required Percentage--Removal of Trustee": Unless otherwise specified
in the related Supplement, more than 50% of the aggregate Voting Rights of a
Series.

                                       10

<PAGE>

         "Required Percentage--Waiver": Unless otherwise specified in the
related Supplement, 66-2/3% of the aggregate Voting Rights of a Series.

         "Required Principal": As determined for any Distribution Date for a
given Series (or Class within such Series), unless otherwise specified in the
related Supplement, the amounts on deposit in the Certificate Account allocable
to principal payments on the Underlying Securities (including from Credit
Support, if any, and Advances, if any, but excluding amounts in respect of
principal payments to the extent that Advances with respect thereto were
distributed as Required Principal on a prior Distribution Date) and required to
be distributed in respect of the Certificates of such Series (or Class) in
accordance with the terms of such Certificates and such related Supplement.

         "Requisite Reserve Amount": As of any date with respect to any Series
(or Class within such Series), the amount, if any, required to be maintained in
the Reserve Account, if any, for such Series or Class as specified in or
determined pursuant to the related Supplement.

         "Reserve Account": An Eligible Account, if any, created and maintained
pursuant to Section 3.06.

         "Responsible Officer": With respect to the Trustee, any officer within
the Corporate Trust Office, including any Managing Director, Senior Vice
President, Vice President, Assistant Vice President, Assistant Secretary or any
other officer of the Trustee customarily performing functions similar to those
performed by any of the above designated officers and also, with respect to a
particular matter, any other officer to whom such matter is referred because of
such officer's actual knowledge of and familiarity with the particular subject.

         "Retained Interest": If applicable, with respect to any Underlying
Security, an ownership interest in and a right to a portion of the payments
thereon by the obligor thereof, as specified in the related Supplement, held by
the Person so specified in such Supplement.

         "Sale Procedures": Unless otherwise specified in the Supplement, shall
mean that, with respect to any sale of one or more Underlying Securities or
Related Assets, the Market Agent, on behalf of the Trust, shall sell such
Underlying Securities or Related Assets to the highest bidders among not less
than two solicited bidders for such Underlying Securities or Related Assets (one
of which bidders may include Merrill Lynch & Co. or any Affiliate thereof;
provided, however, that neither Merrill Lynch & Co. nor any of its Affiliates
will be under any obligation to bid, and which bidders need not be limited to
recognized broker dealers). In the sole judgment of the Market Agent, bids may
be evaluated on the basis of bids for a single Underlying Security or Related
Asset, a portion of the Underlying Securities or Related Assets, or all of the
Underlying Securities or Related Assets being sold or any other basis selected
in good faith by the Market Agent.

         "S&P": Standard & Poor's Ratings Services, and any successor thereof.

         "Securities Account": As defined in Section 8-501(a) of the UCC.

         "Securities Control": "Control" as defined in Section 8-106 of the UCC
and, for purposes of determining an interest in investment property under UCC
Article 9, Section 9-115(1)(e) of the UCC.

         "securities intermediary": As defined in Section 8-102(a)(14) of the
UCC and, in respect of any Book-Entry Security, a "securities intermediary" (as
defined in 31 C.F.R. ss. 357.2 or, as applicable to such Book-Entry Security,
the corresponding Federal Book-Entry Regulations).

         "Securities Intermediary": With respect to any Series, the Securities
Intermediary shall be the Person so specified in the applicable Supplement until
a successor Person shall have become the Securities Intermediary pursuant to the
applicable provisions of these Standard Terms and the applicable Supplement, and
thereafter "Securities Intermediary" shall mean such successor Person.

         "Security": As defined in Section 8-102(a)(15) of the UCC.

                                       11

<PAGE>

         "Security Certificate": As defined in Section 8-102(a)(9) of the UCC.

         "Security Entitlement": As defined in Section 8-102(a)(17) of the UCC
or, in respect of any Book-Entry Security, as defined in 31 C.F.R. Section 357.2
(or, as applicable to such Book-Entry Security, the corresponding Federal
Book-Entry Regulations).

         "Series": A separate series of Certificates issued pursuant to these
Standard Terms and a related Supplement, which series may be divided into two or
more Classes, as provided in such Supplement.

         "Significant Obligor": As defined in Item 1101(k) of Regulation AB.

         "Specified Currency": As specified in the related Supplement for the
applicable Series or Class, which may be a currency issued by the government of
any country or a composite currency the value of which is determined by
reference to the values of the currencies of any group of countries. If not
specified in the related Supplement, the Specified Currency shall be Dollars.

         "State": Any one of the 50 states of the United States, or the District
of Columbia.

         "Supplement": An agreement incorporating these Standard Terms that
authorizes the issuance of a particular Series (and each Class within such
Series) of Certificates.

         "Surety Bond": If so specified in the Supplement with respect to any
Series (or Class within such Series), the surety bond providing for the
distribution under certain circumstances specified in such Supplement of amounts
to the Certificateholders of such Series (or Class), which surety bond will be
issued to the Trustee for the benefit of such Certificateholders by the related
Credit Support Provider, all as specified in such Supplement.

         "Swap Agreement": If so specified in the Supplement with respect to any
Series, the ISDA Master Agreement dated as of the Closing Date by and between
the Trust and the Swap Counterparty, as the same may be amended or supplemented
from time to time as provided therein.

         "Swap Counterparty": If so specified in the Supplement with respect to
any Series (or Class within such Series), as specified in such Supplement.

         "Swap Distribution Amount": If so specified in the Supplement with
respect to any Series, all amounts then due and owing to the Swap Counterparty
pursuant to the Swap Agreement, other than Swap Termination Payments.

         "Swap Guarantee": If so specified in the Supplement with respect to any
Series, the guarantee issued by the Swap Guarantor in favor of the Trust
substantially in the form attached as an exhibit to the Swap Agreement.

         "Swap Guarantor": If so specified in the Supplement with respect to any
Series, the guarantor specified as such in such Supplement.

         "Swap Receipt Amount": If so specified in the Supplement with respect
to any Series, all amounts due and owing to the Trust pursuant to the Swap
Agreement other than Swap Termination Payments.

         "Swap Termination Payment": If so specified in the Supplement with
respect to any Series, the amount payable by the Swap Counterparty to the Trust,
or by the Trust to the Swap Counterparty, pursuant to the Swap Agreement.

         "Tax Event": The right of an Underlying Securities Issuer to shorten
the maturity of or repurchase such Underlying Securities, in accordance with the
terms of the Underlying Securities Indenture, due to a change in the treatment
of such Underlying Securities under the Code.

         "Trust": With respect to any Series, the segregated asset or pool of
assets subject hereto, constituting the trust created hereby and by the related
Supplement and

                                       12

<PAGE>

to be administered hereunder and thereunder, consisting of those Deposited
Assets, the Credit Support, if applicable, and all sums distributed in respect
thereof that are specified as being part of the Trust for such Series in the
related Supplement, all for the benefit of the Certificateholders of such Series
as of any particular time.

         "Trust Agreement": With respect to each Series, these Standard Terms
and all amendments hereof and, unless the context otherwise requires, the
related Supplement and all amendments thereto.

         "Trustee": With respect to any Series, the Person so specified in the
applicable Supplement until a successor Person shall have become the Trustee
pursuant to the applicable provisions of these Standard Terms and the applicable
Supplement, and thereafter "Trustee" shall mean such successor Person.

         "Trustee's Fed Member": Any Person that is eligible to maintain a Fed
Member Securities Account in such Person's name with the Fed and through which
the Trustee holds Book-Entry Securities.

         "TIA": The Trust Indenture Act of 1939, as amended, as the same is in
force and effect as of the date hereof.

         "UCC": The Uniform Commercial Code as in effect from time to time in
the State of New York and any successor statute.

         "Underlying Securities Indenture": The indenture pursuant to which the
Underlying Securities were issued, as identified in the Underlying Securities
Schedule.

         "Underlying Securities Issuer": With respect to an Underlying Security,
the issuer thereof (including, if applicable, the guarantor of the Underlying
Security), as identified in the Underlying Securities Schedule.

         "Underlying Securities Schedule": Schedule I to the Supplement.

         "Underlying Security" or "Underlying Securities": With respect to any
Series, the asset or assets identified in the Underlying Securities Schedule.
The Underlying Securities for any Series or the related Trust shall not
constitute Underlying Securities for any other Series or any other Trust.

         "Underlying Security Interest Payment Date": With respect to an
Underlying Security, each date specified in the Underlying Securities Schedule
as a date on which interest is scheduled, as of the Closing Date, to be payable
by or on behalf of the Underlying Securities Issuer on such Underlying Security
in accordance with its terms.

         "United States": The United States of America (including the States),
its territories, its possessions and other areas subject to its jurisdiction.

         "Voting Rights": The voting rights with respect to the Underlying
Securities, which voting rights shall be allocated to Certificateholders of each
Class within a given Series (and to the holders of the Retained Interest and
Call Right, if any) in accordance with the Allocation Ratio.

         Section 1.02. Rules of Construction. Unless the context otherwise
requires:

         (i)   a term has the meaning assigned to it;

         (ii)  an accounting term not otherwise defined has the meaning assigned
       to it in accordance with generally accepted accounting principles as in
       effect in the United States from time to time;

         (iii) "or" is not exclusive;

         (iv)  the words "herein", "hereof", "hereunder" and other words of
       similar import refer to this Trust Agreement as a whole and not to any
       particular Article, Section or other subdivision;

                                       13

<PAGE>

         (v)   "including" means including without limitation; and

         (vi)  words in the singular include the plural and words in the plural
       include the singular.

         Section 1.03. Compliance Certificates and Opinions; Record Date. a)
Upon any application or request by the Depositor to the Trustee to take any
action under any provision of this Trust Agreement other than the initial
issuance of the Certificates, the Depositor shall furnish to the Trustee an
Officer's Certificate stating that, in the opinion of the signer thereof, all
conditions precedent, if any, provided for in this Trust Agreement relating to
the proposed action have been complied with and an Opinion of Counsel stating
that in the opinion of such counsel all such conditions precedent, if any, have
been complied with, except that in the case of any such application or request
as to which the furnishing of such documents is specifically required by any
provision of this Trust Agreement relating to such particular application or
request, no additional certificate or opinion need be furnished.

         Every certificate or opinion with respect to compliance with a
condition or covenant provided for in this Trust Agreement (other than a
certificate provided pursuant to Section 3.10(d)) shall include:

         (i)   a statement that the individual signing such certificate or
     opinion has read such covenant or condition and the definitions herein
     relating thereto;

         (ii)  a brief statement as to the nature and scope of the examination
     or investigation upon which the statements or opinions contained in such
     certificate or opinion are based;

         (iii) a statement that, in the opinion of such individual, he or she
     has made such examination or investigation as is necessary to enable him or
     her to express an informed opinion as to whether or not such covenant or
     condition has been complied with; and

         (iv)  a statement as to whether, in the opinion of such individual,
     such condition or covenant has been complied with.

         (b)  The Depositor may at its option by delivery of an Officer's
Certificate to the Trustee set a record date to determine the Holders entitled
to give any consent, request, demand, authorization, direction, notice, waiver
or other act. Notwithstanding TIA Section 316(c), such record date shall be the
record date specified in such Officer's Certificate, which shall be a date not
more than 30 days prior to the first solicitation of Certificateholders in
connection therewith. If such a record date is fixed, such consent, request,
demand, authorization, direction, notice, waiver or other act may be given
before or after such record date, but only the Holders of record at the close of
business on such record date shall be deemed to be Holders for the purposes of
determining whether the requisite aggregate Voting Rights have authorized or
agreed or consented to such consent, request, demand, authorization, direction,
notice, waiver or other act, and for that purpose the aggregate Voting Rights
shall be computed as of such record date; provided, however, that no such
consent, request, demand, authorization, direction, notice, waiver or other act
by the Holders on such record date shall be deemed effective unless it shall
become effective pursuant to the provisions of this Trust Agreement not later
than one year after the record date.

                                   ARTICLE II
                DECLARATION OF TRUSTS; ISSUANCE OF CERTIFICATES;
                      PURPOSE AND CLASSIFICATION OF TRUSTS

         Section 2.01.  Creation and Declaration of Trusts; Assignment of
Deposited Assets. (a) The Depositor, concurrently with the execution and
delivery of the related Supplement, does hereby agree to Grant to the Trustee
for the benefit of the Trustee and the Certificateholders of each given Series
and without recourse, all the right, title and interest of the Depositor,
including any security interest therein for the benefit of the Depositor, in, to
and under the Underlying Securities and other Deposited Assets. Unless otherwise
specified in the Supplement, each such Grant will include all interest, premium
(if any) and principal of, on or with respect to any such Underlying Securities
due after the Cut-off Date and received by the Depositor, and will exclude all
interest, premium (if any) and principal of, on or with respect to any such
Underlying Securities due on or before the Cut-off Date. With respect to any
Concentrated Underlying Security, the Underlying Securities Schedule shall
include information regarding the payment terms

                                       14

<PAGE>

of the Concentrated Underlying Security, the maturity or terms thereof, the
rating, if any, thereof and any other material information with respect thereto.

         (b)  In connection with each Grant referred to in paragraph (a) of this
Section 2.01, the Depositor shall, not later than the applicable Closing Date,
either

          (i) deposit the Underlying Securities for a given Series (except for
     the Underlying Securities attributable to such Series that are to be
     acquired from a Person other than the Depositor, as specified on the
     Underlying Securities Schedule to the applicable Supplement) with the
     Trustee by physical delivery of such Underlying Securities duly endorsed,
     together with any documents necessary to transfer ownership of such
     Underlying Securities, to the Trustee, or

          (ii) have ensured that the Underlying Securities have been delivered
     to a Clearing Agency, in which event (A) the Securities Intermediary or its
     agent, on behalf of the Trustee, has accepted delivery of such Underlying
     Securities through such Clearing Agency, and (B) the Underlying Securities
     have been credited to a Securities Account of the Trustee and maintained by
     the Securities Intermediary on behalf of the Trustee, and the Securities
     Intermediary or its agent shall have the right to hold and maintain such
     Underlying Securities on deposit with such Clearing Agency for all purposes
     of this Trust Agreement.

         (c)  In the case of each delivery of Underlying Securities referred to
in paragraph (b) of this Section 2.01, the Depositor shall be deemed thereby to
represent and warrant to the Trustee and the Securities Intermediary that:

          (i) the Depositor is duly authorized to so deliver the Underlying
     Securities;

          (ii) the Underlying Securities so delivered are genuine;

          (iii) at the time of delivery of the Underlying Securities, Depositor
     owns such Underlying Securities, has the right to transfer its interest in
     such Underlying Securities and such Underlying Securities are free and
     clear of any lien, pledge, encumbrance, right, charge, claim or other
     security interest (other than the lien created by this Trust Agreement);
     and

          (iv) such delivery is irrevocable and free of any continuing claim by
     the Depositor except such as the Depositor may have as a Certificateholder.

         The above representations and warranties shall survive the delivery of
the Underlying Securities and the Certificates in respect thereof. The Depositor
shall further be deemed by such delivery to have made the representations that
to the Depositor's knowledge but without having made any independent inquiry,
as of the Closing Date, no default or event of default with respect to the
Underlying Securities has occurred and is continuing.

         (d)  Unless otherwise specified in the related Supplement, the Grant of
the Deposited Assets accomplished by this Trust Agreement is absolute and shall
constitute a sale. In addition, the Trust created hereunder and thereunder shall
constitute a fixed investment trust for federal income tax purposes under
Treasury Regulation Section 301.7701-4, and all parties hereto and thereto agree
to treat the Trust, any distributions therefrom and the beneficial interest in
the Certificates consistently with such characterization. The provisions of this
Trust Agreement shall be interpreted consistently with such characterization.

         (e) Any Trust created hereunder shall not engage in any business or
activities other than in connection with, or relating to, the holding,
protecting and preserving of the Deposited Assets and the issuance of the
Certificates and, if applicable, Call Rights, and other than those required or
authorized by this Trust Agreement or incidental to and necessary to accomplish
such activities. Any Trust created hereunder shall not issue or sell any
certificates or other obligations other than the Certificates or, if applicable,
Call Rights or otherwise incur, assume or guarantee any indebtedness for money
borrowed.

         (f)  Anything herein to the contrary notwithstanding, none of the
Trustee, the Securities Intermediary or any of the Certificateholders assumes
any of the obligations of the Depositor or any other Person in respect of the
Underlying Securities.

                                       15

<PAGE>

         (g)  The Securities Intermediary expressly agrees with the Trustee and
the Certificateholders that, at all times from and after the date hereof, any
and all of the Deposited Assets held by the Securities Intermediary in the
Certificate Account are to be treated as Financial Assets under, and for all
purposes of, UCC Article 8 and UCC Article 9.

         Section 2.02. Acceptance by Trustee. With respect to each Series, the
Trustee will acknowledge receipt by it, or by a custodian on its behalf, of the
related Underlying Securities now existing or hereafter acquired, and declares
that it will hold such Underlying Securities and all other documents delivered
to it pursuant to this Trust Agreement, and that it will hold all such assets
and such other assets (including Underlying Securities acquired from a Person
other than the Depositor) comprising the Trust for a given Series, in trust for
the exclusive use and benefit of all present and future Certificateholders of
such Series and for the purposes and subject to the terms and conditions set
forth in this Trust Agreement.

         Section 2.03. Representations and Warranties of the Depositor. The
Depositor hereby represents and warrants to the Trustee that as of the Closing
Date or as of such other date specifically provided herein or in the applicable
Supplement:

         (i)   the Depositor is a corporation duly organized, validly existing
     and in good standing under the laws of the State of Delaware;

         (ii)  with respect to each Supplement, to the Depositor's knowledge
     but without having made any independent inquiry, the information set forth
     in the Underlying Securities Schedule with respect to each Underlying
     Security is true and correct in all material respects at the date or dates,
     respecting which, such information is furnished;

         (iii) the execution and delivery of this Trust Agreement by the
     Depositor and its performance of and compliance with the terms of this
     Trust Agreement will not violate the Depositor's certificate of
     incorporation or by-laws or constitute a default (or an event which, with
     notice or lapse of time, or both, would constitute a default) under, or
     result in the breach or acceleration of, any material contract, agreement
     or other instrument to which the Depositor is a party or which may be
     applicable to the Depositor or any of its assets;

         (iv)  the Depositor has the full power and authority to enter into and
     consummate all transactions contemplated by this Trust Agreement, has duly
     authorized the execution, delivery and performance of this Trust Agreement
     and has duly executed and delivered this Trust Agreement. This Trust
     Agreement, upon its execution and delivery by the Depositor and assuming
     due authorization, execution and delivery by the Trustee, will constitute a
     valid, legal and binding obligation of the Depositor, enforceable against
     it in accordance with the terms hereof, except as such enforcement may be
     limited by bankruptcy, insolvency, reorganization, receivership, moratorium
     or other laws relating to or affecting the rights of creditors generally,
     and by general equity principles (regardless of whether such enforcement is
     considered a Proceeding in equity or at law); and

         (v)   any additional representations and warranties, if any, that may
     be specified in the applicable Supplement.

         It is understood and agreed that the representations and warranties of
the Depositor set forth in this Section 2.03 shall survive delivery of the
respective documents and the Underlying Securities to the Trustee and shall
inure to the benefit of the Trustee on behalf of the Certificateholders
notwithstanding any restrictive or qualified endorsement or assignment. Upon
discovery by any of the Depositor or the Trustee of a breach of any of the
foregoing representations and warranties which materially and adversely affects
the interests of the Certificateholders, the party discovering such breach shall
give prompt written notice thereof to the other party.

                                       16

<PAGE>

         Section 2.04. Breach of Representation, Warranty or Covenant. Within 90
days of the earlier of discovery by the Depositor or receipt of notice by the
Depositor of a breach of any representation or warranty of the Depositor set
forth in Section 2.03 that materially and adversely affects the interests of the
Certificateholders of a given Series, the Depositor shall cure such breach in
all material respects.

         Section 2.05. Agreement to Execute, Authenticate and Deliver
Certificates. With respect to each Series and the related Trust, the Trustee
hereby agrees and acknowledges that it will, concurrently with the Grant to and
receipt by it of the related Underlying Securities, cause to be executed,
authenticated and delivered to or upon the written order of the Depositor, in
exchange for the Underlying Securities and such other assets constituting the
Trust for a given Series, Certificates duly authenticated by or on behalf of the
Trustee in an Authorized Denomination evidencing ownership of the entire Trust
for such Series, all in accordance with the terms and subject to the conditions
of Section 5.02.

         Section 2.06. Custody and Holding of Deposited Assets. (a) With respect
to each Series, the Trustee shall hold and maintain the Deposited Assets with
the Securities Intermediary in and through, and hereby directs the Securities
Intermediary to credit any and all such Deposited Assets to, the Certificate
Account (all as further provided in this Article II) in such manner as shall
enable the Trustee to be and have the rights of an Entitlement Holder with
respect to, and have sole dominion and control (including, without limitation,
Securities Control) over, such Deposited Assets.

         (b)   The Securities Intermediary hereby represents, warrants,
covenants and agrees that from and after the Closing Date:

                                       17

<PAGE>

         (i)   Each Certificate Account is a Securities Account, with the
     Trustee (for its benefit and the benefit of the Certificateholders) as the
     Entitlement Holder in, and having sole dominion and control (including,
     without limitation, Securities Control) over, any and all Deposited Assets
     (including, without limitation, any and all assets and properties referred
     to in clause (ii) below) in such Certificate Account.

         (ii)  All assets and properties from time to time transferred or
     credited to the Certificate Account constitute Financial Assets.

         (iii) The Securities Intermediary is (and will remain) a securities
     intermediary and is acting (and will continue to act) as such with respect
     to the Certificate Account, the Deposited Assets therein and the Trustee as
     Entitlement Holder. Unless otherwise instructed by the Trustee in writing,
     the Securities Intermediary will treat the Trustee (for its benefit and the
     benefit of the Certificateholders) as entitled to exercise the rights that
     comprise the Deposited Assets in each Certificate Account. Further, the
     Securities Intermediary is and will remain (A) a bank, banking institution,
     financial firm or similar party, in each case, that regularly accepts in
     its course of its business Book-Entry Securities as a custodial service for
     customers and maintains Securities Accounts in the name of such customers
     reflecting ownership of or interest in such Securities, (B) will maintain
     its books and records reflecting such Book-Entry Securities in the State of
     New York and (C) if the Trustee maintains one or more Certificate Accounts
     with the Securities Intermediary, will have entered into, and will maintain
     in full force and effect, an agreement with the Trustee (which, on the date
     hereof, is comprised of this Trust Agreement) to the effect that their
     respective rights and obligations in respect of each other, said Underlying
     Securities and said Certificate Accounts are governed by the laws of the
     State of New York.

         (iv)  The Securities Intermediary shall hold any and all assets and
     properties from time to time comprising the Deposited Assets (whether
     individually or as part of a fungible bulk) in a manner such that the
     Trustee will have dominion and control (including, without limitation,
     Securities Control) over such Deposited Assets. The Securities Intermediary
     will credit to the appropriate Certificate Account (and will thereby or by
     book entry or otherwise identify as being subject to the Grant to the
     Trustee hereunder) any and all assets and properties from time to time
     comprising the Deposited Assets in accordance with Section 2.06(a) hereof.

         (v)   To effect the intention of clauses (i) through (iv) above, the
     Securities Intermediary or its agent maintains (and will continue to
     maintain)

                  (A) one or more Securities Accounts with the Depository. The
        Securities Intermediary or its agent will instruct the Depository to
        credit such Securities Accounts of the Securities Intermediary or its
        agent with the Depository with the Depository Securities comprising from
        time to time the Deposited Assets; and

                  (B) one or more Fed Member Securities Accounts to which the
        Securities Intermediary through its agent will instruct the Fed to
        credit, in accordance with the Book-Entry Regulations, all Book-Entry
        Securities from time to time comprising the Deposited Assets.

                                       18

<PAGE>

                                  ARTICLE III
                          ADMINISTRATION OF EACH TRUST

         Section 3.01.  Administration of Each Trust. (a) The Trustee shall
administer the Underlying Securities for each given Trust for the benefit of the
Certificateholders of the related Series. In engaging in such activities, the
Trustee shall follow or cause to be followed collection procedures in accordance
with the terms of these Standard Terms and the applicable Supplement, the
respective Underlying Securities and any applicable Credit Support Instruments.
With respect to each Trust, and subject only to the above-described standards
and the terms of these Standard Terms, the related Supplement and the respective
Underlying Securities and applicable Credit Support Instruments, if any, the
Trustee shall have full power and authority, acting alone or through
Administrative Agents as provided in Section 7.02, to do or cause to be done any
and all things in connection with such administration which it deems necessary
to comply with the terms of these Standard Terms and the applicable Supplement.

         (b)  The duties of the Trustee shall be performed in accordance with
applicable local, State and Federal law, and the Trustee shall, at the direction
of the Depositor, make any and all filings, reports, notices or applications
with (as prepared by the Depositor), and seek any comments and authorizations
from, the Commission and any State securities authority on behalf of the Trust
for each Series.

         Section 3.02.  Collection of Certain Underlying Security Payments. With
respect to any Series or Class, the Trustee shall make reasonable efforts to
collect all payments required to be made pursuant to the terms of the Underlying
Securities in a manner consistent with the terms of this Trust Agreement, such
Underlying Securities and any related Credit Support Instruments, if applicable.

         Section 3.03.  Certificate Accounts. (a) For each Series, the Trustee
shall establish and maintain one or more Eligible Accounts (collectively, the
"Certificate Accounts"), which shall be Securities Accounts and shall be held in
trust in the name of the Trustee for its benefit and the benefit of
Certificateholders of such Series. The Trustee on behalf of such
Certificateholders shall possess all right, title and interest in all funds on
deposit from time to time in each Certificate Account and in all proceeds
thereof. With respect to each Series and in accordance with Section 2.06, the
Certificate Accounts shall be under the sole dominion and control (including,
without limitation, Securities Control) of the Trustee for the benefit of the
related Certificateholders. With respect to each Series, not later than the
close of business on the Business Day on which the Trustee receives such amounts
in the form of immediately available funds (so long as such funds are received
by the Trustee by 3:00 p.m., New York City time, and on the next Business Day
otherwise), the Trustee shall deposit or cause to be deposited in the
Certificate Accounts all amounts received by it with respect to the Deposited
Assets, any Credit Support and all Liquidation Proceeds related to such Series
including:

         (i)   all payments on account of principal of such Underlying
     Securities;

         (ii)  all payments on account of interest on such Underlying
     Securities;

         (iii) all payments on account of premium (if any) on such Underlying
     Securities;

         (iv)  any payments in respect of any such Credit Support;

         (v)  any Advances made as required pursuant to Section 4.04; and

         (vi) any interest or investment income earned on funds deposited in the
     related Accounts.

         Unless otherwise specified in the applicable Supplement, it is
understood and agreed that payments in the nature of prepayment or redemption
penalties, late payment charges, default interest or reinvestment income which
may be received by the Trustee shall be deposited by the Trustee in the
Certificate Account and shall not be retained by the Trustee for its own
account.

         If, at any time, the Certificate Account for any Series ceases to be an
Eligible Account, the Trustee shall within five Business Days (or such longer
period, not to exceed 30 calendar days, as to which the Rating Agency Condition
is met) establish a new

                                       19

<PAGE>

Certificate Account meeting the conditions specified above and the Trustee shall
within five Business Days transfer any cash and any investments on deposit in
the Certificate Account to such new Certificate Account, and from the date such
new Certificate Account is established, it shall be the Certificate Account for
such Series.

         (b)  The Trustee shall give notice to the Depositor of the location of
each Eligible Account constituting the Certificate Account and prior to any
change thereof, if such Eligible Account is or will be located at an institution
other than United States Trust Company of New York.

         Section 3.04. Distribution or Sale of the Underlying Securities. If (a)
there occurs a payment default on the Underlying Securities, (b) there occurs an
acceleration of the date of maturity of the Underlying Securities or (c) the
Underlying Securities Issuer of any Concentrated Underlying Securities ceases to
be a reporting company under the Exchange Act, (d) any Swap Counterparty becomes
a Disqualified Swap Counterparty or (e) any Credit Support becomes a
Disqualified Credit Support, then the Trustee, upon receiving notice of the
events set forth in (a), (b), (c), (d) or (e) shall exercise one of the
following remedies, in accordance with the Distribution Election:

         (i)  immediately direct the Market Agent to sell the Underlying
     Securities and a pro rata portion of the Related Assets held by such Trust,
     in accordance with the Sale Procedures, and the Liquidation Proceeds, if
     any, shall be deposited into the Certificate Account for distribution in
     accordance with the Allocation Ratio on the first Business Day (or such
     other date specified in the applicable Supplement) following such deposit
     into the Certificate Account;

         (ii)  distribute the Underlying Securities and a pro rata portion of
     the Related Assets in accordance with the Allocation Ratio to each Holder'
     s last address as it appears in the Certificate Register within three
     Business Days (or such other date specified in the applicable Supplement)
     of receiving the notice referred to in the first sentence of this Section
     3.04; or

         (iii) provide that the Holders of a given Series or Class may vote in
     favor of either (i) or (ii), in accordance with the procedures set forth in
     the applicable Supplement.

         In the case of a sale by the Market Agent of Underlying Securities and
Related Assets pursuant to clause (i) of this Section 3.04, the Trustee shall
deliver such Underlying Securities and Related Assets to the purchaser of such
Underlying Securities and Related Assets only against payment in same day funds
and the Trustee shall deposit the same into the Certificate Account.

                                       20

<PAGE>

         Section 3.05. Investment of Funds in the Accounts. The Trustee may
direct any depository institution maintaining the Certificate Account or the
Reserve Account, if any, for the Series and any other segregated Eligible
Account, which Eligible Account shall be a Securities Account the contents of
which are held for the benefit of Certificateholders of such applicable Series
(each, an "Account"), to invest the funds therein at the specific written
direction of the Depositor in one or more Eligible Investments bearing interest
or sold at a discount, which shall be held to maturity unless payable on demand
and which funds shall not be reinvested upon the maturity or demand for payment
of such Eligible Investment. If the Depositor does not provide any investment
directions by 10:00 a.m. on any Business Day, funds held in any Account will be
invested in the Eligible Investments specified in clause (iv) of the definition
thereof until receipt of investment directions to the contrary. Investments of
such funds shall be invested in Eligible Investments that will mature so that
such funds will be available for distribution on the next Distribution Date.
Except as otherwise provided in the applicable Supplement, any earnings with
respect to such Eligible Investments shall be paid to, and any losses with
respect to such Eligible Investments shall be solely for the account of, the
Certificateholders in proportion to their interest in the invested funds. In the
event amounts on deposit in an Account are at any time invested in an Eligible
Investment payable on demand, the Securities Intermediary, on behalf of the
Trustee and the Trust, shall:

         (i)   consistent with any notice required to be given thereunder,
     demand that payment thereon be made on the last day such Eligible
     Investment may otherwise mature hereunder in an amount equal to the lesser
     of (1) all amounts then payable thereunder and (2) the amount required to
     be withdrawn on such date; and

         (ii)  demand same day payment of all amounts due thereunder upon a
     determination by the Trustee that such Eligible Investment would not
     constitute an Eligible Investment in respect of funds thereafter on deposit
     in any Account.

None of the Trustee, the Depositor or the Securities Intermediary shall in any
way be held liable by reason of any insufficiency in any Account resulting from
any loss on any Eligible Investment made in accordance with this Trust
Agreement.

         Section 3.06.  Maintenance of Credit Support. (a) On the applicable
Closing Date, the Trustee at the written direction of the Depositor or, if so
specified in the applicable Supplement, the Depositor shall, to the extent
specified in the applicable Supplement, establish and maintain, or enter into,
as applicable, in the name of the Trustee, either as part of the related Trust
or outside it, for the benefit of the Certificateholders of the related Series,
the Credit Support specified in the applicable Supplement. To the extent
specified in the applicable Supplement, the Depositor will make or cause to be
made any initial deposit to the Certificate Account or any Reserve Account
(which shall be an Eligible Account) for the related Series as of the Closing
Date. Unless the Supplement for a given Series provides otherwise, if a Reserve
Account exists for such Series, collections with respect to the Underlying
Securities for such Series not distributed to the Certificateholders of such
Series shall be deposited in the Reserve Account. The Reserve Account, if any,
shall be an asset of the Depositor (and the income earned on any amounts held in
the Reserve Account shall be allocable to the Depositor, who agrees to include
any such income in its gross income for all federal, state and local income and
franchise tax purposes) and will not be a part of or otherwise be included in
the Trust but will be held for the benefit of the Certificateholders.

         (b)   Amounts on deposit in the Reserve Account and amounts available
pursuant to any other Credit Support for such Series shall be applied by the
Trustee to make distributions of principal of and premium (if any) and interest
on the Certificates of such Series as required pursuant to Section 4.01 and the
applicable Supplement to the extent that funds are not otherwise available for
such purpose. If specified in such Supplement, immediately after each
Distribution Date, amounts on deposit in the Reserve Account for such Series in
excess of a specified amount shall be paid to the Person so specified in such
Supplement.

         Section 3.07. Realization upon Defaulted Underlying Securities. (a) The
Trustee on behalf of the Certificateholders, shall assert claims under each
applicable Credit Support Instrument, and shall take such reasonable steps as
are necessary to receive payment or to permit recovery thereunder with respect
to any defaulted Underlying Securities, subject in all cases to the provisions
of Article VII hereof.

         (b)   Unless otherwise provided in the related Supplement, if the
Trustee is unable to obtain full recovery in respect of a defaulted Underlying
Security and any

                                       21

<PAGE>

related Credit Support Instrument pursuant to Section 3.07(a), the Trustee shall
follow or cause to be followed such normal practices and procedures as it deems
necessary or advisable to realize upon such defaulted Underlying Security and
such Credit Support Instrument, subject in all cases to the provisions of
Article VII hereof.

         (c)   If the Liquidation Proceeds of a defaulted Underlying Security
are less than the sum of (i) the outstanding principal balance of the defaulted
Underlying Security and (ii) the aggregate amount of expenses incurred by the
Trustee in connection with the practices and procedures referred to in paragraph
(b) of this Section 3.07 to the extent reimbursable under these Standard Terms
and the related Supplement, the Trust for the applicable Series shall recognize
a Realized Loss equal to the amount of such difference. Any such Realized Loss
shall be allocated in accordance with Section 4.05.

          Section 3.08.  Retained Interest. The Retained Interest, if any, in
any Underlying Security shall initially be held by the Person so specified in
the related Supplement as and to the extent specified therein.

         Section 3.09. Access to Certain Documentation. The Trustee shall
provide to any Federal, State or local regulatory authority that may exercise
authority over any Certificateholder access to the documentation in the
Trustee's possession regarding the Underlying Securities required by applicable
laws and regulations. Such access shall be afforded without charge, but only
upon reasonable written request and during normal business hours at the offices
of the Trustee designated by it. In addition, access to the documentation in the
Trustee's possession regarding the Underlying Securities related to a given
Series (or Class within such Series) will be provided to any Certificateholder
of such Series (or Class) upon reasonable written request during normal business
hours at the offices of the Trustee designated by it at the expense of the
Certificateholder requesting such access.

         Section 3.10.  Reports by the Depositor. The Depositor shall:

         (i)   file with the Trustee, within 30 days after the Depositor is
     required to file the same with the Commission, copies of the annual reports
     and of the information, documents and other reports (or copies of such
     portions of any of the foregoing as the Commission may from time to time by
     rules and regulations prescribe) which the Depositor is required to file
     with the Commission pursuant to Section 13 or Section 15(d) of the Exchange
     Act; or, if the Depositor is not required to file information, documents or
     reports pursuant to either of such Sections, then to file with the Trustee
     and the Commission, in accordance with rules and regulations prescribed by
     the Commission, such of the supplementary and periodic information,
     documents and reports which may be required pursuant to Section 13 of the
     Exchange Act in respect of a security listed and registered on a national
     securities exchange as may be prescribed in such rules and regulations;

        (ii)   file with the Trustee and the Commission, in accordance with the
     rules and regulations prescribed by the Commission, such additional
     information, documents and reports with respect to compliance by the
     Depositor with the conditions and covenants provided for in this Trust
     Agreement, as may be required by such rules and regulations, certificates
     or opinions of independent accountants, conforming to the requirements of
     TIA Section 314(e);

        (iii)  supply to the Trustee (and the Trustee shall transmit to all
     Certificateholders, in the manner and to the extent provided in TIA Section
     313(c)), such summaries of any information, documents and reports required
     to be filed by the Depositor pursuant to clauses (i) and (ii) of this
     Section 3.10 as may be required by rules and regulations prescribed by the
     Commission; and

        (iv)   furnish to the Trustee, not less often than annually, a
     certificate from the principal executive, financial or accounting officer
     of the Depositor as to his or her knowledge of the Depositor's compliance
     with all conditions and covenants under this Trust Agreement. For purposes
     of this clause (iv), such compliance shall be determined without regard to
     any period of grace or requirement of notice provided under this Trust
     Agreement.

Any reports, statements, documents or other information required to be furnished
by the Depositor to the Trustee pursuant to these Standard Terms or any
Supplement shall be deemed to have been delivered to the Trustee if the Trustee
is in possession of such reports, statements, documents or other information at
the time they are to be furnished pursuant to these Standard Terms or any
Supplement.

                                       22

<PAGE>

Each annual report on Form 10-K will be signed by the Depositor and will include
a certification required by Section 302 of the Sarbanes-Oxley Act of 2002, in
the form prescribed by Item 601 of Regulation S-K under the Securities Act.

         Section 3.11. Charges and Expenses. Except as otherwise provided in
these Standard Terms or the related Supplement, no amounts in the nature of fees
or charges shall be payable by or withheld from the Trust, the Depositor or any
other person and there shall be no recourse or claim against the Trust or the
property of the Trust for all or any part of any fees or charges payable to any
person.

                                   ARTICLE IV
                 DISTRIBUTIONS AND REPORTS TO CERTIFICATEHOLDERS

         Section 4.01.  Distributions. (a) On each Distribution Date for a given
Series, the Trustee shall apply Available Funds in the Certificate Account for
such Series in the manner and priority set forth in the Supplement for such
Series. In any event, however, any amounts collected during any period shall be
distributed to the Holders no later than the Distribution Date immediately
following the receipt thereof.

         (b)   All distributions to Holders shall be payable only from Available
Funds, and no provision of this Trust Agreement shall be deemed to create any
obligation on the part of the Trustee or the Depositor to make any distribution
from any other source.

         Section 4.02.  Distributions on Certificates. (a) Distributions on any
Certificate that are payable and are punctually paid or duly provided for on any
Distribution Date shall be distributed to the Person in whose name such
Certificate (or one or more Predecessor Certificates) is registered at the close
of business on the related Record Date notwithstanding the cancellation of such
Certificate upon any transfer or exchange subsequent to such related Record
Date.

         The distribution of interest and principal on Certificates shall be
made:

         (i)   if the Certificateholder is a Depository, to the Depository,
     which shall credit the relevant Participant's account at such Depository
     in accordance with the policies and procedure of the Depository; or

         (ii)  if the Holder is not a Depository, at the Corporate Trust Office
     (except as otherwise specified pursuant to the applicable Supplement) or,
     at the option of the Trustee, by check mailed to the address of the Person
     entitled thereto as such address shall appear in the Certificate Register
     or, if provided pursuant to the applicable Supplement and in accordance
     with arrangements satisfactory to the Trustee, at the option of the
     registered Holder by wire transfer to an account designated by the
     registered Holder. Notwithstanding clause (i) of this paragraph (a), with
     respect to a Holder of Certificates not held in a Depository and having at
     least the Minimum Wire Denomination, such payment shall be made by wire
     transfer of immediately available funds to the account designated by such
     Holder in a written request received by the Trustee not later than 10 days
     prior to such Distribution Date; provided, however, that if a wire transfer
     cannot be made for any reason, payment shall be made by check. The Trustee
     shall not be required to send federal funds wires until any corresponding
     payments which were not same day funds when received by it have become same
     day funds.

         (b) Each Certificate delivered under this Trust Agreement upon transfer
of or in exchange for or in lieu of any other Certificate shall carry the rights
to interest accrued and undistributed, and to accrue, that were carried by such
other Certificate.

         (c) All computations of interest due with respect to any Certificate of
any Series or Class within such Series shall be made as specified in the
Supplement applicable to that particular Series or Class.

         (d) With respect to any computations or calculations to be made under
these Standard Terms, the applicable Supplement and the Certificates, except as
otherwise provided, all percentages resulting from any calculation of accrued
interest will be rounded, if necessary, to the nearest 1/100,000 of 1%
(.0000001), with five one-millionths of a percentage point rounded upward.

                                       23

<PAGE>

         (e) The final distribution of principal and/or premium shall be made
upon presentation and surrender of such Certificates at the Corporate Trust
Office.

         Section 4.03. Reports to Certificateholders. Unless otherwise specified
in the applicable Supplement, on the fifth Business Day following each such
Distribution Date the Trustee shall forward or cause to be forwarded to the
Depositor, each Holder of such Series, each Swap Counterparty, if any, each
Rating Agency rating such Series and such other Persons as may be specified in
such Supplement, a statement setting forth:

         (i)   the amounts received by the Trustee as of the last such statement
     in respect of principal, interest and premium on the Underlying Securities,
     the Swap Receipt Amount, if any, and any other derivatives transaction that
     may be entered into by the Trust pursuant to the terms of these Standard
     Terms and the related Supplement;

         (ii)  the Swap Distribution Amount, if any, received by the Trustee as
     of such Distribution Date and any other amounts payable pursuant to any
     other derivatives transaction that may be entered into by the Trust
     pursuant to the terms of these Standard Terms and the related Supplement;

         (iii) the amount of compensation received by the Trustee, and any
     Administrative Agent, for the period relating to such Distribution Date,
     and the amount of any other fees or expenses accrued and paid by the trust
     for the period relating to such Distribution Date with an identification of
     the general purpose of such fees and the party receiving such fees or
     expenses;

         (iv)  the amount of the distribution on such Distribution Date to
     Holders allocable to principal of and premium, if any, and interest on the
     Certificates of each such Class and to the Retained Interest, and the
     amount of aggregate unpaid interest accrued as of such Distribution Date;

         (v)   the applicable Record Date and interest accrual date for
     calculating the distributions on such Distribution Date;

         (vi)  in the case of each Class of Floating Rate Certificates of such
     Series, the respective Floating Pass-Through Rate applicable to each such
     Class on such Distribution Date, as calculated in accordance with the
     method specified in such Certificates and the related Supplement;

         (vii) if the Supplement provides for a Reserve Account, the balance of
     such Reserve Account at beginning and end of the period relating to such
     Distribution Date and any material Reserve Account activity during such
     period.

        (viii) if the Supplement provides for Advances, the aggregate amount of
     Advances, if any, included in such distribution, and the aggregate amount
     of unreimbursed Advances, if any, at the close of business on such
     Distribution Date;

         (ix)  the aggregate stated principal amount and, if applicable,
     notional amount of the Underlying Securities related to such Series, any
     delinquency or loss information with respect to the Underlying Securities,
     any material breaches of representations, warranties or covenants related
     to the Underlying Securities, the current interest rate or rates thereon at
     the close of business on such Distribution Date, and the current rating
     assigned to the Certificates, as provided to the Trustee in writing in an
     instrument specifically referring to this Trust Agreement by the applicable
     rating agency;

         (x)   the aggregate Certificate Principal Balance (or Notional Amount,
     if applicable) of each Class of such Series at the close of business on
     such Distribution Date, separately identifying any reduction in such
     aggregate Certificate Principal Balance (or Notional Amount) due to the
     allocation of any Realized Losses on such Distribution Date or otherwise as
     may be specified by the Depositor;

         (xi)  as to any Series (or any Class within such Series) for which
     Credit Support has been obtained, the amount or notional amount of coverage
     of each element of Credit Support (and rating, if any, thereof) included
     therein as of the close of business on such Distribution Date, any payments
     made with respect to each element of Credit Support for the period relating
     to such Distribution Date with an

                                       24

<PAGE>

     identification of the general purpose of such payments and the party
     receiving such payments and any amounts drawn on each element of Credit
     Support; and

         (xii) any other information appropriate for a Series, as specified in
     the applicable Supplement.

         Within a reasonable period of time after the end of each calendar year,
the Trustee shall furnish to each Person who at any time during each such
calendar year was a Holder a statement containing the information set forth in
clause (iii) above, aggregated for such calendar year during which such person
was a Holder. Such obligation of the Trustee shall be deemed to have been
satisfied to the extent that substantially comparable information shall be
provided by the Trustee pursuant to any requirements of the Code as are from
time to time in effect. The Trustee shall supply to Holders in writing at such
Holder's expense who so request all materials received by the Trustee from the
Underlying Securities Issuer.

         Section 4.04.  Advances. (a) Unless otherwise specified in the
applicable Supplement, the Trustee shall have no obligation to make Advances (as
defined below) with respect to the Underlying Securities or in favor of the
Holders of any Series (or Class within such Series) of Certificates.

         (b)   However, as and to the extent provided in the Supplement for a
given Series, and subject to the terms of paragraphs (c) and (d) of this Section
4.04, on or prior to each Distribution Date, the Trustee shall advance or cause
to be advanced in immediately available funds for deposit in the Certificate
Account for such Series an advance (each, an "Advance") in an amount equal,
unless otherwise specified in the related Supplement, to the aggregate of
distributions of principal, premium (if any) and interest due on the Underlying
Securities for such Series (or Class) during the related Collection Period, to
the extent remaining unpaid at the time of such Advance. In satisfaction of its
obligation to make such Advances, the Trustee shall make such Advances from its
own funds and may recover Advances from late collections received by the Trustee
on the applicable Underlying Securities, proceeds from any applicable Credit
Support, if any, and Liquidation Proceeds with respect to the Underlying
Securities for such Series or Class, as specified in the related Supplement, as
to which any such Advance was made.

         (c)   Notwithstanding any provision herein to the contrary, no Advance
shall be required to be made hereunder if the Trustee reasonably believes that
it will be unable to recover such Advance from related late collections, Credit
Support proceeds, if any, or Liquidation Proceeds with respect to the applicable
Underlying Securities. It is further understood and agreed that the Trustee
shall not be obligated to make any Advances in respect of reductions in the
amount of collections on the Underlying Securities due to bankruptcy proceedings
with respect to the Underlying Securities or the obligors thereof.

         (d)   Notwithstanding any provision herein to the contrary, unless
otherwise provided in the related Supplement for a given Series, any Advances
made in respect of any Underlying Securities related to such Series (or Class
within such Series) that subsequently are deemed by the Trustee to be
nonrecoverable from related late collections, Credit Support proceeds, if any,
or Liquidation Proceeds may be reimbursed to the Trustee through the application
of amounts on deposit in the Certificate Account for such Series allocable to
any of such Underlying Securities prior to the distributions of interest,
premium (if any) and principal with respect to the Certificates of such Series
or Class.

         Section 4.05.  Allocation of Realized Losses and Trust Expenses. With
respect to any Series, Realized Losses and Extraordinary Trust Expenses, if any,
shall be allocated on any Distribution Date in accordance with the Allocation
Ratio, provided, however, that distributions pursuant to Section 3.04 shall be
completed as the earliest practicable date.

         Section 4.06.  Compliance with Withholding Requirements. (a)
Notwithstanding any other provision of this Trust Agreement to the contrary, the
Trustee shall comply with all Federal withholding requirements respecting
distributions to Holders of interest or original issue discount that the Trustee
believes are applicable under the Code. The consent of Holders shall not be
required for such withholding.

         (b)   Each Holder will provide the Trustee (and, so long as the
Certificates are held at a Depository in the form of Global Certificates, each
Beneficial Owner of

                                       25

<PAGE>

the Certificates will provide such Depository and the Trustee) with evidence
that there should not be any withholding tax assessed for Federal income tax
purposes in respect of distributions to such Holder, such evidence to take the
form of a statement, on a duly executed and up-to-date Internal Revenue Service
Form W-8 (or successor form), Form W-9 (or successor form), or Form 4224 (or
successor form), as applicable, that identifies the Beneficial Owner of the
Certificate; provided, however, that for so long as the Certificates are held at
a Depository in the form of Global Certificates, the Holder shall have no
obligation to provide the Trustee with any such evidence except to the extent it
has received such evidence from Beneficial Owners of the Certificates. The
Trustee shall not be required to accept any such Internal Revenue Service forms
if it believes that they are not accurate (but the Trustee shall not be required
to make any independent investigation to determine their accuracy).

         (c)   If any tax or other governmental charge shall become payable by
or on behalf of the Trustee, including any tax or governmental charge required
to be withheld from any payment by the Trustee under the provisions of any
applicable law or regulation with respect to any Underlying Securities or the
Certificates, such tax or governmental charge shall be payable by the Holder and
may be withheld by the Trustee. The consent of the Holder shall not be required
for such withholding. In the event the Trustee does withhold any amount from
interest or original issue discount distributions or Advances thereof to any
Holder pursuant to Federal withholding requirements, the Trustee shall indicate
in the statement required pursuant to Section 4.03 the amount so withheld.

         (d)   The Depositor and the Trustee shall have the right to refuse the
surrender, registration of transfer or exchange of any Certificate with respect
to which such tax or other governmental charge shall be payable until such
payment shall have been made by the Holder thereof.

         Section 4.07.  Optional Exchange. (a) The terms and conditions, if any,
of an Optional Exchange will be specified in the related Supplement; provided,
however, that any right of Optional Exchange shall be exercisable only to the
extent that the Depositor provides upon the Trustee's request an Opinion of
Counsel that (i) such exchange would not be inconsistent with continued
satisfaction of the applicable requirements for exemption under Rule 3a-7 (or
other applicable rule or exemption) under the Investment Company Act of 1940, as
amended, and all applicable rules, regulations and interpretations thereunder
and (ii) such exchange would not affect the characterization of the Trust as a
"grantor trust" under the Code. The terms of an Optional Exchange may include,
but are not limited to, the following:

         (i)   a requirement that the exchanging Holder tender to the Trustee
     Certificates of each Class within such Series;

         (ii)  a minimum Certificate Principal Balance or Notional Amount, as
     applicable, with respect to Certificates being tendered for exchange by a
     single Holder;

         (iii) a requirement that the Certificate Principal Balance or Notional
     Amount, as applicable, of each Certificate tendered for exchange be an
     Authorized Denomination;

         (iv)  specified dates on which a Holder may effect such an Optional
     Exchange (each, an "Optional Exchange Date"), as specified in the
     applicable Supplement;

         (v)   limitations on the right of an exchanging Holder to receive any
     benefit upon Optional Exchange from any Credit Support; and

         (vi)  adjustments to the value of the proceeds of any Optional Exchange
     based upon required prepayment of future expense allocations and the
     establishment of a reserve for any unanticipated Extraordinary Trust
     Expenses.

         (b) Unless otherwise provided in the applicable Supplement, no
Certificate may be exchanged pursuant to this Section 4.07 unless the Trustee
has received at least 30 days (or such shorter period acceptable to the Trustee
or specified in the applicable Supplement) but not more than 45 days prior to an
Optional Exchange Date a telegram, telex, facsimile transmission or letter from
a member of a national securities exchange or the National Association of
Securities Dealers, Inc., the Depository (in accordance with its normal
procedures) or a commercial bank or trust company in the United States setting
forth the name of the Holder, the Certificate Principal Balance or Notional
Amount of such Registered Certificate to be exchanged and the number or a
description of

                                       26

<PAGE>

the tenor and the terms of such Certificate, a statement that the Optional
Exchange is being exercised thereby and an assurance that the Registered
Certificate to be exchanged with the form entitled "Option to Elect Exchange" on
the reverse of the Registered Certificate duly completed will be received by
such Trustee not later than five Business Days after the date of such telegram,
telex, facsimile transmission or letter, and such Certificate and form duly
completed must be received by such Trustee by such fifth Business Day. Any
tender by the Holder thereof for Optional Exchange shall be irrevocable. Unless
otherwise provided in the applicable Supplement, the Optional Exchange option
may be exercised pursuant to this Section 4.07 by the Holder of a Certificate
for less than the aggregate Certificate Principal Balance or Notional Amount of
such Certificate as long as the Certificate Principal Balance or Notional Amount
remaining Outstanding after such Optional Exchange is an Authorized Denomination
and all other requirements set forth in the related Supplement are satisfied.
Upon such partial exchange, such Certificate shall be cancelled and a new
Certificate or Certificates for the remaining Certificate Principal Balance or
Notional Amount thereof shall be issued (which shall be in the name of the
Holder of such exchanged Certificate).

         (c)  Upon the completion of any such Optional Exchange, the Trustee
shall give prompt written notice thereof to each Rating Agency.

         Section 4.08.  Call Right. (a) The holder of a Call Right may purchase
Certificates of a given Series or Class from the Holders thereof prior to
maturity if the applicable Supplement designates such Series or Class as a
Callable Series, or upon the occurrence of a Tax Event or an Optional
Redemption. The Call Terms shall be set forth in the applicable Supplement and
shall include, without limitation, the following:

         (i)  the initial holder of the Call Right;

         (ii) whether the Certificate Principal Balance or Notional Amount of
     each Certificate being purchased pursuant to the Call Right must be an
     Authorized Denomination;

         (iii) the Call Date or Dates; and

         (iv)  the Call Price.

         (b)  A Call Right may be exercised at the option of the holder thereof,
in accordance with the Call Terms, upon not less than 35 days' (or such shorter
period acceptable to the Trustee or specified in the applicable Supplement) nor
more than 60 days' prior notice sent via facsimile with transmission confirmed
to the Trustee at the Corporate Trust Office. Such notice to the Trustee shall
include the Certificate Principal Balance (or Notional Amount) of the
Certificates to be purchased and shall reference the Call Price and the Call
Date. On or prior to the second Business Day following receipt of such notice
from the holder of the Call Right, the Trustee shall notify the Holders of the
Certificates by first class mail; such notices shall state:

                                       27

<PAGE>

         (i)   the Certificate Principal Balance (or Notional Amount) of
     Certificates to be purchased;

         (ii)  the Call Price;

         (iii) the name and address of the Paying Agent;

         (iv)  that Certificates called for purchase must be surrendered to the
     Paying Agent in order to collect the Call Price;

         (v)  that interest on Certificates called for purchase pursuant to the
     Call Right ceases to accrue on and after the Call Date, and the only
     remaining right of Holders of such Certificates is to receive payment of
     the Call Price upon surrender of the Certificates to the Paying Agent; and

         (vi)  that, if any Certificate contains a CUSIP, CINS or ISIN number,
     no representation is being made as to the correctness of the CUSIP, CINS or
     ISIN number either as printed on the Certificates or as contained in such
     notice and that reliance may be placed only on the other identification
     numbers printed on the Certificates.

         (c) If less than all of the Certificates are to be purchased pursuant
to the exercise of the Call Right, the Trustee shall select the Certificates to
be purchased in accordance with the requirements of the principal national
securities exchange on which the Certificates are listed or, if the Certificates
are not listed on a national securities exchange, on a pro rata basis, by lot or
by such other method as such Trustee in its sole discretion shall deem to be
fair and appropriate. The Trustee shall notify the Depositor and the Certificate
Registrar promptly in writing of the Certificates or portions of the
Certificates to be purchased by the holder of the Call Right, provided, however,
that this Section 4.08(c) shall not apply to Certificates subject to a Call
Right due to a Tax Event or an Optional Redemption.

         (d) Once such notice is mailed to a Holder, such Holder shall not be
entitled to any right as a Holder other than the right to receive payment of the
Call Price on the Call Date and the Certificates subject to the Call Right shall
be deemed to have been automatically surrendered to the Trust for further
transfer to the holder exercising its Call Right. Upon surrender of any
Certificates to the Paying Agent, the Holders of such Certificates shall be paid
the Call Price. Notice of purchase shall be deemed to be given when mailed,
whether or not the Holder receives the notice. In any event, failure to give
such notice, or any defect therein, shall not affect the validity of the
proceedings for the purchase of Certificates held by Holders to whom such notice
was properly given.

         (e) At or prior to 12:00 noon on the Call Date, the holder of the Call
Right to be exercised shall deposit with the Paying Agent by wire transfer in
same-day funds money sufficient to pay the Call Price of the Certificates to be
redeemed on that date.

         (f) If a notice has been given in the manner provided above, the
Certificates or portion of Certificates specified in such notice to be purchased
shall become due and payable on the Call Date at the Call Price stated therein,
together with accrued interest (if applicable) on and after such dates. Upon
surrender of any Certificate in connection with the Call Right, such Certificate
shall be paid and redeemed by the holder of the Call Right at the Call Price.

         (g) Upon surrender of any Certificate that is purchased in part, the
Depositor shall execute and the Trustee shall authenticate and deliver to the
Holder a new Certificate equal in principal amount to the portion of such
surrendered Certificate not purchased.

         (h) Notwithstanding anything to the contrary in these Standard Terms or
any Supplement, a Series or Class will be subject to a Call Right of the
Underlying Securities Issuer if the Underlying Securities Issuer gives notice of
a Tax Event or an Optional Redemption, regardless of whether such Series or
Class is also designated a Callable Series in the applicable Supplement, and in
the case of a Tax Event or an Optional Redemption the required notice of the
Call Right shall be the lesser of the time set forth in Section 4.08(b) and the
time set forth in the notice provisions relating to

                                       28

<PAGE>

such Tax Event or Optional Redemption, respectively, in the Underlying
Securities Indenture, as specified in the related Supplement.

                                   ARTICLE V
                                THE CERTIFICATES

         Section 5.01. The Certificates. (a) The Certificates of any Series (or
Class within such Series) shall be issued in fully registered form without
coupons and shall be substantially in the form of the exhibit attached to the
applicable Supplement.

         (b)   Each Series (and all Classes within such Series) shall be created
by a Supplement authorized by the Depositor and establishing the terms and
provisions of such Series. Each Trust must be a fixed investment trust under the
Code. Each such Series may be issued in one or more Classes, with such further
particular designation added or incorporated in such title for the Certificates
of any particular Series or Class within such Series as the Depositor may
determine. Each Certificate shall bear upon its face the designation so selected
for the Series and Class to which it belongs. All Certificates of the same
Series and Class shall be identical in all respects except for the denominations
thereof. All Certificates of all Classes within any one Series at any time
Outstanding shall be identical except for differences among the Certificates of
the different Classes within such Series specified in the applicable Supplement.
Except as otherwise provided in the related Supplement, all Certificates of a
particular Series (and all Classes within such Series) issued under this Trust
Agreement shall be in all respects equally and ratably entitled to the benefits
hereof without preference, priority or distinction on account of the actual time
or times of authentication and delivery, all in accordance with the terms and
provisions of this Trust Agreement.

         Section 5.02.  Execution, Authentication and Delivery. (a) The
Certificates shall be executed by the Trustee by one of its Responsible
Officers, which may be in facsimile form and imprinted or otherwise reproduced
thereon. The signature of any of the Responsible Officers may be manual or
facsimile. Certificates bearing the manual or facsimile signature of individuals
who were at any time the Responsible Officers of the Trustee shall be binding,
notwithstanding that such individuals or any of them have ceased to hold such
offices prior to the authentication and delivery of such Certificates.

         (b)  Each Certificate shall be dated as of the later of the date
specified in the related Supplement and the date of its authentication.

         (c)  No Certificate shall be entitled to any benefit under this Trust
Agreement or be valid or obligatory for any purpose, unless there appears on
such Certificate a certificate of authentication substantially in one of the
forms provided for herein executed by the Trustee by the manual signature of one
of its Responsible Officers, and such signature upon any Certificate shall be
conclusive evidence, and the only evidence, that such Certificate has been duly
authenticated and delivered hereunder and is entitled to the benefits of this
Trust Agreement.

         Section 5.03.  Temporary Certificates. Pending the preparation of
Definitive Certificates or permanent Global Securities of any Series (or Class
within each such Series), and upon receipt of a Depositor Order, the Trustee
shall execute, authenticate and deliver temporary Certificates which are
printed, lithographed, typewritten, mimeographed or otherwise produced, in any
Authorized Denomination, substantially of the tenor of the Definitive
Certificates or permanent Global Securities in lieu of which they are issued, in
registered form and with such appropriate insertions, omissions, substitutions
and other variations as may be authorized by such Depositor Order. Any such
temporary Certificate may be in global form, representing all or a portion of
the Outstanding Certificates of such Series or Class. Every such temporary
Certificate shall be executed, authenticated and delivered by the Trustee upon
the same conditions and in substantially the same manner, and with the same
effect, as the Definitive Certificates or permanent Global Securities in lieu of
which is issued.

         If temporary Certificates of any Series (or Class within such Series)
are issued, the Trustee will cause Definitive Certificates or Global Securities
of such Series or Class to be prepared without unreasonable delay. After the
preparation of Definitive Certificates of such Series or Class, the temporary
Certificates of such Series or Class shall be exchangeable for Definitive
Certificates or permanent Global Securities of such Series or Class upon
surrender of the temporary Certificates of such Series or Class at the Corporate
Trust Office, without charge to the Holder. Upon

                                       29

<PAGE>

surrender for cancellation of any one or more temporary Certificates of any
Series or Class within such Series, the Trustee, upon receipt of a Depositor
Order, shall execute, authenticate and deliver in exchange therefor Definitive
Certificates or permanent Global Securities with a like Certificate Principal
Balance or Notional Amount, as applicable, of the same Series (or Class within
such Series) of Authorized Denomination and of like tenor. Until so exchanged,
temporary Certificates of any Series (or Class within such Series) shall in all
respects be entitled to the same benefits under this Trust Agreement as
Definitive Certificates or permanent Global Securities of such Series or Class,
except as otherwise specified in the applicable Supplement.

         Upon any exchange of a portion of a temporary Global Security for a
permanent definitive Global Security or for the individual Definitive
Certificates represented thereby, the temporary Global Security shall be
endorsed by the Trustee to reflect the reduction of the aggregate Certificate
Principal Balance or Notional Amount, as applicable, evidenced thereby,
whereupon the aggregate Certificate Principal Balance or Notional Amount, as
applicable, of such temporary Global Security shall be reduced for all purposes
by the amount so exchanged and endorsed.

         Section 5.04.  Registration; Registration of Transfer and Exchange. (a)
The Trustee shall cause to be kept a register for each Series (the registers
maintained in such office and in any other office or agency of the Trustee being
herein sometimes collectively referred to as the "Certificate Register") in
which a transfer agent and registrar (which may be the Trustee) (the
"Certificate Registrar") shall provide for the registration of Certificates and
the registration of transfers and exchanges of Certificates. The Trustee is
hereby initially appointed Certificate Registrar for the purpose of registering
Certificates and transfers and exchanges of Certificates as herein provided;
provided, however, that the Trustee may appoint one or more co-Certificate
Registrars. Upon any resignation of any Certificate Registrar, the Depositor
shall promptly appoint a successor or, in the absence of such appointment,
assume the duties of Certificate Registrar.

         If a Person other than the Trustee is appointed by the Depositor as
Certificate Registrar, the Depositor will give the Trustee prompt written notice
of the appointment of a Certificate Registrar and of the location, and any
change in the location, of the Certificate Register, and the Trustee shall have
the right to rely upon a certificate executed on behalf of the Certificate
Registrar by an Executive Officer thereof as to the names and addresses of the
Holders and the principal amounts and numbers of the Certificates held by each
Holder.

         (b)  Upon surrender for registration of transfer any Certificate of any
Series (or Class within such Series) at the office or agency of the Trustee, if
the requirements of Section 8-401(a) of the UCC are met to the Depositor's
satisfaction, the Depositor shall execute, and the Trustee, upon receipt of a
Depositor Order, shall authenticate and deliver, in the name of the designated
transferee or transferees, one or more new Certificates of any Authorized
Denominations, of a like Series, Class and aggregate Certificate Principal
Balance or Notional Amount, as applicable.

         (c)   Notwithstanding any other provisions of this Section 5.04, unless
and until it is exchanged in whole or in part for the individual Certificates
represented thereby, a Global Security representing all or a portion of the
Certificates of a Series (or Class within such Series) may not be transferred
except as a whole by the Depository for such Series or Class to a nominee of
such Depository or by a nominee of such Depository to such Depository or another
nominee of such Depository or by such Depository or any such nominee to a
successor Depository for such Series or Class or a nominee of such successor
Depository.

         (d)   At the option of the Holder, Certificates of any Series (or Class
within such Series) (other than a Global Security, except as set forth below)
may be exchanged for other Certificates of the same Series or Class of any
Authorized Denomination of like tenor and aggregate Certificate Principal
Balance or Notional Amount, as applicable, upon surrender of the Certificates to
be exchanged at the office or agency of the Trustee maintained for such purpose.

         (e)   All Certificates issued upon any registration of transfer or
exchange of Certificates shall constitute complete and indefeasible evidence of
ownership in the Trust related to such Certificates and be entitled to the same
benefits under this Trust Agreement as the Certificates surrendered upon such
registration of transfer or exchange.

                                       30

<PAGE>

         (f)   Every Certificate presented or surrendered for registration of
transfer or exchange shall (if so required by the Depositor, the Trustee or the
Certificate Registrar) be duly endorsed, or be accompanied by a written
instrument of transfer in form satisfactory to the Depositor, the Trustee or the
Certificate Registrar, duly executed, by the Holder thereof or his attorney duly
authorized in writing, with such signature guaranteed by a brokerage firm or
financial institution that is a member of a Securities Approved Medallion
Program such as Securities Transfer Agents Medallion Program (STAMP), Stock
Exchange Medallion Program (SEMP) or New York Stock Exchange Inc. Medallion
Signature Program (MSP).

         (g)   No service charge shall be made to a Holder for any registration
of transfer or exchange of Certificates, but the Trustee may require payment of
a sum sufficient to cover any tax or other governmental charge that may be
imposed in connection with any registration of transfer or exchange of
Certificates, other than exchanges pursuant to Section 5.03 not involving any
transfer.

         Section 5.05.  Mutilated, Destroyed, Lost and Stolen Certificates. If
(i) any mutilated Certificate is surrendered to the Trustee at its Corporate
Trust Office or (ii) the Depositor and the Trustee receive evidence to their
satisfaction of the destruction, loss or theft of any Certificate, and there is
delivered to the Depositor and the Trustee such security or indemnity as they
may require to hold each of them and any Paying Agent harmless, and neither the
Depositor nor the Trustee receives notice that such Certificate has been
acquired by a bona fide purchaser, then the Depositor shall execute and the
Trustee, upon receipt of a Depositor Order, shall authenticate and deliver, in
exchange for or in lieu of any such mutilated, destroyed, lost or stolen
Certificate, a new Certificate of the same Series or Class of like tenor, form,
terms and principal amount, bearing a number not contemporaneously Outstanding.
Any Certificate executed, authenticated and delivered under this Section 5.05 in
lieu of a lost, destroyed or stolen Certificate (a "Predecessor Certificate")
shall be deemed to evidence the same interest as the Predecessor Certificate.

         Upon the issuance of any new Certificate under this Section 5.05, the
Trustee may require the payment of a sum sufficient to cover any tax or other
governmental charge that may be imposed in respect thereto and any other
expenses (including the fees and expenses of the Trustee) connected therewith.

         Every new Certificate of any Series or Class issued pursuant to this
Section 5.05 shall constitute complete and indefeasible evidence of ownership in
the Trust related to such Series, whether or not the Predecessor Certificate
shall be at any time enforceable by anyone, and shall be entitled to all the
benefits of this Trust Agreement equally and proportionately with any and all
other Certificates of that Series or Class duly issued hereunder.

         The provisions of this Section 5.05 are exclusive and shall preclude
(to the extent lawful) all other rights and remedies with respect to the
replacement or payment of Predecessor Certificates.

         Section 5.06.  Persons Deemed Owners. (a) The Depositor, the Trustee,
the Securities Intermediary and any agent of the Depositor, the Trustee or the
Securities Intermediary may treat the Person in whose name any Certificate is
registered as the owner of such Certificate for the purpose of receiving
distributions of principal of (and premium, if any) and (subject to Section
4.02) interest, if any, on such Certificate and for all other purposes
whatsoever, whether or not such Certificate be overdue, and neither the
Depositor, the Trustee or the Securities Intermediary, nor any agent of the
Depositor, the Trustee or the Securities Intermediary shall be affected by
notice to the contrary.

         (b)   None of the Depositor, the Trustee, the Securities Intermediary
or any of their agents will have any responsibility or liability for any aspect
of the records relating to or distributions made by the Depository to Beneficial
Owners of interests in a Global Security or for maintaining, supervising or
reviewing any records relating to such Beneficial Owners.

         Section 5.07.  Cancellation. Unless otherwise specified pursuant to
Section 5.01 for Certificates of any Series, all Certificates surrendered for
payment, redemption, transfer or exchange shall, if surrendered to any Person
other than the Trustee, be delivered to the Trustee and shall be promptly
cancelled by the Trustee. No Certificates shall be authenticated in lieu of or
in exchange for any Certificates

                                       31

<PAGE>

cancelled as provided in this Section 5.07, except as expressly permitted by
this Trust Agreement.

         Section 5.08.  Global Securities. (a) If the Supplement provides that
a Series (or Class within such Series) of Certificates shall be held by the
Depository in book-entry form, then the Depositor shall execute and, upon
receipt of a Depositor Order, the Trustee shall authenticate and deliver one or
more Global Securities that (i) shall represent an aggregate initial Certificate
Principal Balance or Notional Amount, as applicable, equal to the aggregate
initial Certificate Principal Balance or Notional Amount, as applicable, of the
Certificates of such Series or Class to be represented by such one or more
Global Securities, (ii) shall be registered in the name of the Depository for
such Global Security or Securities or the nominee of such Depository, (iii)
shall be delivered by the Trustee to such Depository or pursuant to such
Depository's instruction and (iv) shall bear a legend substantially to the
following effect:

"UNLESS THIS GLOBAL SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE
DEPOSITORY FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY
CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF A NOMINEE OF THE DEPOSITORY (AND
ANY PAYMENT IS MADE TO A NOMINEE OF THE DEPOSITORY), ANY TRANSFER, PLEDGE OR
OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH
AS THE REGISTERED OWNER HEREOF HAS AN INTEREST HEREIN.

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR THE INDIVIDUAL
CERTIFICATES REPRESENTED HEREBY, THIS GLOBAL SECURITY MAY NOT BE TRANSFERRED
EXCEPT AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY OR BY A
NOMINEE OF THE DEPOSITORY TO THE DEPOSITORY OR TO ANOTHER NOMINEE OF THE
DEPOSITORY OR BY THE DEPOSITORY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITORY OR
A NOMINEE OF SUCH SUCCESSOR DEPOSITORY."

         (b)   No Holder of a Certificate of such Series or Class will receive a
Definitive Certificate representing such Holder's interest in such Certificate
or Certificates, except as provided in Section 5.10. Unless and until Definitive
Certificates have been issued to Holders of such Series or Class pursuant to
Section 5.10:

        (i)    the provisions of this Section 5.08 shall be in full force and
     effect;

        (ii)   the Certificate Registrar and the Trustee shall be entitled to
     deal with the Depository for all purposes of this Trust Agreement
     (including the distribution of principal of, and premium, if any, and
     interest on the Certificates and the giving of instructions or directions
     hereunder) as the sole Holder of the Certificates of such Series or Class,
     and shall have no obligation to the Beneficial Owners of interests in such
     Series or Class;

       (iii)   to the extent that the provisions of this Section 5.08 conflict
     with any other provisions of this Trust Agreement, the provisions of this
     Section 5.08 shall control;

       (iv)    the rights of Beneficial Owners of such Series or Class shall be
     exercised only through the Depository and shall be limited to those
     established by law and agreements between such Beneficial Owners and the
     Depository or its Participants; and

        (v)    whenever this Trust Agreement requires or permits actions to be
     taken based upon instructions or directions of Holders of a specified
     percentage of the aggregate Voting Rights of a Series or Class, the
     Depository shall be deemed to represent such percentage only to the extent
     that it has received instructions to such effect from Beneficial Owners of
     such Series or Class or Participants in such Depository's system owning or
     representing, respectively, such required percentage of the beneficial
     interest in the Certificates of such Series or Class and has delivered such
     instructions to the Trustee.

         (c)   Each Depository for a Global Security must, at the time of its
designation and at all times while it serves as such Depository, be a Clearing
Agency registered under the Exchange Act and any other applicable statute or
regulation.

                                       32

<PAGE>

         Section 5.09.  Notices to Depository. Whenever a notice or other
communication to the Holders of a Series or Class within such Series represented
by one or more Global Securities is required under this Trust Agreement, unless
and until Definitive Certificates for such Series or Class shall have been
issued to such Beneficial Owners pursuant to Section 5.10, the Trustee shall
give all such notices and communications specified herein to be given to Holders
of the Certificates of such Series to the Depository, and shall have no
obligation to the Beneficial Owners.

         Section 5.10. Definitive Certificates. (a) If in respect of a Series
(or Class within such Series) represented by one or more Global Securities (i)
the Depositor advises the Trustee and the Securities Intermediary in writing
that the Depository is no longer willing or able to properly discharge its
responsibilities with respect to the Certificates of such Series or Class and
the Depositor does not appoint a successor within 90 days or (ii) the Depositor
at its option advises the Trustee and the Securities Intermediary in writing
that it elects to terminate the book-entry system of such Series or Class
through the Depository, then the Depository shall notify all Beneficial Owners
or Participants in the Depository's system with respect to such Series or Class
and the Trustee of the occurrence of any such event and of the availability of
definitive, fully registered Certificates ("Definitive Certificates") for such
Series or Class to Beneficial Owners of such Series or Class requesting the
same.

         Upon surrender to the Trustee of the Global Securities of such Series
or Class by the Depository, accompanied by registration instructions, the
Trustee upon receipt of a Depositor Order for the execution, authentication and
delivery of Definitive Certificates of such Series or Class, will execute,
authenticate and deliver Definitive Certificates of such Series or Class in an
aggregate Certificate Principal Balance or Notional Amount, as applicable, equal
to the aggregate Certificate Principal Balance or Notional Amount, as
applicable, of the Global Security or Securities representing Certificates of
such Series or Class in exchange for such Global Security or Securities. None of
the Depositor, the Certificate Registrar, the Trustee or the Securities
Intermediary shall be liable for any delay in delivery of such instructions and
may conclusively rely on, and shall be protected in relying on, such
instructions. Upon the exchange of a Global Security for Definitive
Certificates, such Global Security shall be cancelled by the Trustee. Definitive
Certificates issued in exchange for a Global Security shall be registered in
such names and in such Authorized Denominations as the Depository for such
Global Security, pursuant to instructions from its Participants, any indirect
participants or otherwise, shall instruct the Trustee. The Trustee shall deliver
such Certificates to the Person in whose names such Certificates are so
registered. Upon the issuance of Definitive Certificates of Series or Class, the
Trustee shall recognize the holders of the Definitive Certificates of such
Series or Class as Holders.

         (b)   In addition, if the Depositor so specifies with respect to the
Certificates of a given Series, a Beneficial Owner may, on terms acceptable to
the Depositor and the Depository for such Global Security, receive individual
Definitive Certificates in exchange for such beneficial interest. Upon the
request of such Beneficial Owner, the Trustee upon receipt of a Depositor Order
shall execute, authenticate and deliver, without service charge,

         (i)   to each such Person specified, a new individual Certificate or
     Certificates of the same Series or Class, of any Authorized Denomination as
     requested by such Person in an aggregate Certificate Principal Balance or
     Notional Amount, as applicable, equal to and in exchange for such Person's
     beneficial interest in the Global Security; and

         (ii)  to such Depository a new Global Security in an Authorized
     Denomination equal to the difference, if any, between the aggregate
     Certificate Principal Balance or Notional Amount, as applicable, of the
     surrendered Global Security and the aggregate Certificate Principal Balance
     or Notional Amount, as applicable, of individual Certificates delivered to
     Holders thereof.

         In any exchange provided for above, the Trustee, upon receipt of a
Depositor Order, will execute, authenticate and deliver individual Certificates
in registered form in Authorized Denominations.

                                       33

<PAGE>

         Section 5.11.  Currency of Distributions. (a) Except as otherwise
specified pursuant to the applicable Supplement, distributions of the principal
of (and premium, if any) and interest in respect of Certificates of any Series
or Class will be made in Dollars.

         (b)   In the case of a Series denominated in a Specified Currency other
than the Dollar, all exchange rate calculations shall be based upon the noon
buying rate in New York City for cable transfers as certified for customs
purposes by the Fed for such Specified Currency. If the Fed does not publish a
noon buying rate for the applicable Specified Currency, the applicable
Supplement will designate the source for calculating the Dollar value of such
Specified Currency.

         (c)   With respect to any Series, any decision or determination to be
made regarding exchange rates shall be made by an Exchange Rate Agent, provided,
however, that such Exchange Rate Agent shall accept such appointment in writing
and the terms of such appointment shall be acceptable to the Trustee and shall
require such Exchange Rate Agent to make such determination by the method
provided in Section 5.11(b) for the making of such decisions or determination.
All decisions and determinations of such Exchange Rate Agent regarding exchange
rates shall be in its sole discretion and shall, in the absence of manifest
error, be conclusive for all purposes and irrevocably binding upon the
Depositor, the Trustee and all Holders of such Series.

         (d)   If distributions in respect of a Series must be made in a
Specified Currency other than Dollars and such currency is unavailable due to
the imposition of exchange controls or other circumstances beyond the control of
the Trustee and the Depositor or is no longer used by the government of the
country issuing such Specified Currency or is no longer commonly used for the
settlement of transactions by public institutions of or within the international
banking community, then all distributions in respect of such Series shall be
made in Dollars until such Specified Currency is available.

         Section 5.12.  Conditions of Execution, Authentication and Delivery of
New Series. (a) Certificates of a new Series may be issued at any time and from
time to time after the execution and delivery of these Standard Terms and the
related Supplement. The Trustee shall execute, authenticate and deliver such
Certificates upon a Depositor Order and upon delivery by the Depositor to the
Trustee of the following:

         (i)   The delivery of the Underlying Securities in accordance with
     Section 2.01(b);

         (ii)  An Opinion of Counsel to the Depositor, addressed to the Trustee,
     stating:

               1. The Certificates are in the form contemplated by the Trust
          Agreement and assuming that the Certificates have been duly executed,
          authenticated and delivered by the Trustee in the manner described in
          its certificate delivered today, the Certificates are entitled to the
          benefits provided in the Trust Agreement and constitute valid and
          binding obligations of the Trust, enforceable against the Trust in
          accordance with their terms, except as the enforcement thereof may be
          limited by bankruptcy, insolvency (including, without limitation, all
          laws relating to fraudulent transfers), reorganization, moratorium or
          similar laws affecting enforcement of creditors' rights generally and
          except as enforcement thereof is subject to general principles of
          equity (regardless of whether enforcement is considered in a
          proceeding in equity or at law), and will be entitled to the benefits
          of the Trust Agreement.

               2. Execution, authentication and delivery of such Certificates by
          the Trustee will not violate the terms of the Trust Agreement.

               3. The execution and delivery of the Trust Agreement will not
          contravene the certificate of incorporation or by-laws of the Company
          or result in any violation of any of the terms or provisions of any
          law or regulation or, to our knowledge of any indenture, mortgage or
          other agreement by which the Company is bound.

               4. The Trust Agreement has been duly authorized, executed and
          delivered by the Company and (assuming the due authorization,
          execution and delivery thereof by the Trustee and the Securities
          Intermediary) constitutes a legal, valid and binding obligation of the
          Company enforceable against the Company in accordance with its terms,
          except as enforcement thereof may be limited by bankruptcy, insolvency
          (including, without limitation, all laws relating to fraudulent

                                       34

<PAGE>

          transfers), reorganization, moratorium or other similar laws affecting
          enforcement of creditors' rights generally and except as enforcement
          thereof is subject to general principles of equity (regardless of
          whether enforcement is considered in a proceeding in equity or at
          law).

         (iii) An Officer's Certificate of the Depositor, dated as of the
     Closing Date, to the effect that all of the requirements of this Section
     5.12 have been satisfied, and that the Depositor is not in breach of this
     Trust Agreement and that the execution and delivery of this Trust Agreement
     and the Certificates will not result in any breach of any of the terms,
     conditions, or provisions of, or constitute a default under, the
     Depositor's certificate of incorporation and by-laws, or any indenture,
     mortgage, deed of transfer or other agreement or instrument to which the
     Depositor is a party or by which it or its property is bound or any order
     of any court or administrative agency entered in any Proceeding to which
     the Depositor is a party or by which it or its property may be bound or to
     which it or its property may be subject;

         (iv)  A Supplement consistent with the applicable provisions of
     these Standard Terms; (v) All agreements, instruments or other documents
     called for by the applicable Supplement as a condition to the issuance of
     the Certificates of such Series; (vi) If applicable, a fully executed copy
     of any Swap Agreement or other Credit Support Instrument, together with all
     documents and opinions required to be delivered to the Trust upon execution
     thereof pursuant to the terms thereof; and (vii) Written instructions by
     the Depositor to the Trustee directing the Trustee to enter into and
     perform any obligations under any Swap Agreement or other Credit Support
     Instrument, if applicable, and/or the Market Agent Agreement, if
     applicable.

         (b)   If all the Certificates of a Series are not to be originally
issued at the same time, then the documents required to be delivered pursuant to
this Section 5.12 must be delivered only once, prior to the authentication and
delivery of the first Certificate of such Series; provided, however, that any
subsequent Depositor Order to the Trustee to authenticate Certificates of such
Series upon original issuance shall constitute a representation and warranty by
the Depositor that, as of the date of such request, the statements made in this
Section 5.12 shall be true and correct as if made on such date.

                                       35

<PAGE>

         Section 5.13.  Appointment of Paying Agent. The Trustee may appoint one
or more paying agents (each, a "Paying Agent") with respect to the Certificates
of any Series. Any such Paying Agent shall be authorized to make distributions
to Certificateholders of such Series from the Certificate Account for such
Series pursuant to the provisions of the Supplement and shall report the amounts
of such distributions to the Trustee. Any Paying Agent shall have the revocable
power to withdraw funds from such Certificate Account for the purpose of making
the distributions referred to above. The Trustee may revoke such power and
remove the Paying Agent if the Trustee determines in its sole discretion that
the Paying Agent shall have failed to perform its obligations under this Trust
Agreement in any material respect; provided, however, no Paying Agent may be
removed or replaced until a successor (which successor may be the Trustee) has
been appointed as provided for herein and has accepted the appointment. The
Paying Agent shall initially be the Trustee and any co-paying agent chosen by
the Trustee and acceptable to the Depositor, including, if and so long as any
Series or Class within such Series is listed on the Luxembourg Stock Exchange
and such exchange so requires, a co-paying agent in Luxembourg or another
European city, as specified in the related Supplement. Any Paying Agent shall be
permitted to resign as Paying Agent upon 30 days' notice to the Trustee. In the
event that the Trustee shall no longer be the Paying Agent, the Trustee shall
appoint a successor or additional Paying Agent. The Trustee shall cause each
successor to act as Paying Agent to execute and deliver to Trustee an instrument
in which such successor or additional Paying Agent shall agree with the Trustee
that it will hold all sums, if any, held by it for distribution to the
Certificateholders in trust for the benefit of the Certificateholders entitled
thereto until such sums shall be distributed to such Certificateholders and will
agree to such other matters as are required by TIA Section 317(b). The Paying
Agent shall return all unclaimed funds to the Trustee and upon removal shall
also return all funds in its possession to the Trustee. The provisions of
Sections 7.01, 7.03, 7.04 and 7.06 shall apply to the Trustee also in its role
as Paying Agent, for so long as the Trustee shall act as Paying Agent. Any
reference in this Trust Agreement to the Paying Agent shall include any
co-paying agent unless the context requires otherwise. Notwithstanding anything
contained herein to the contrary, the appointment of a Paying Agent pursuant to
this Section 5.13 shall not release the Trustee from the duties, obligations,
responsibilities or liabilities arising under this Trust Agreement other than
with respect to funds paid to such Paying Agent.

         Section 5.14.  Authenticating Agent. (a) The Trustee may appoint one or
more Authenticating Agents (each, an "Authenticating Agent") with respect to the
Certificates of any Series which shall be authorized to act on behalf of the
Trustee in authenticating such Certificates in connection with the issuance,
delivery and registration of transfer or exchange of such Certificates. Whenever
reference is made in this Trust Agreement to the authentication of Certificates
by the Trustee or the Trustee's certificate of authentication, such reference
shall be deemed to include authentication on behalf of the Trustee by an
Authenticating Agent and a certificate of authentication executed on behalf of
the Trustee by an Authenticating Agent. Each Authenticating Agent must be
acceptable to the Depositor. Notwithstanding anything contained herein to the
contrary, the appointment of an Authenticating Agent pursuant to this Section
5.14 shall not release the Trustee from the duties, obligations,
responsibilities or liabilities arising under this Trust Agreement.

         (b)   Any institution succeeding to the corporate agency business of
any Authenticating Agent shall continue to be an Authenticating Agent without
the execution or filing of any power or any further act on the part of the
Trustee or such Authenticating Agent. An Authenticating Agent may at any time
resign by giving notice of resignation to the Trustee and to the Depositor. The
Trustee may at any time terminate the agency of an Authenticating Agent by
giving notice of termination to such Authenticating Agent and to the Depositor.
Upon receiving such a notice of resignation or upon such a termination, or in
case at any time an Authenticating Agent shall cease to be acceptable to the
Trustee or the Depositor, the Trustee promptly may appoint a successor
Authenticating Agent which may be the Trustee. Any successor Authenticating
Agent upon acceptance of its appointment hereunder shall become vested with all
the rights, powers and duties of its predecessor hereunder, with like effect as
if originally named as an Authenticating Agent. No successor Authenticating
Agent shall be appointed unless acceptable to the Depositor. The Trustee agrees
to pay to each Authenticating Agent from time to time reasonable compensation
for its services under this Section. The provisions of Sections 7.01, 7.03 and
7.04 shall be applicable to any Authenticating Agent.

         (c)   Pursuant to an appointment made under this Section, the
Certificates may have endorsed thereon, in lieu of the Trustee's certificate of
authentication, an alternate certificate of authentication in substantially the
following form:

                                       36

<PAGE>

            "This is one of the Certificates described in the Standard Terms and
the related Supplement.

         Dated:            [NAME OF AUTHENTICATING AGENT]
                           as Authenticating Agent
                              for the Trustee,

                                  By:
                                     ---------------------
                                      Authorized Officer"

         Section 5.15.  Voting Rights with Respect to Underlying Securities. (a)
Within five Business Days after receipt of notice of any meeting of, or other
occasion for the exercise of voting rights or the giving of consents by owners
of any of the Underlying Securities, the Trustee shall give notice to the
Holders, setting forth (i) such information as is contained in such notice to
owners of Underlying Securities, (ii) a statement that Holders will be entitled,
subject to any applicable provision of law and any applicable provisions of such
Underlying Securities to instruct the Trustee as to the exercise of Voting
Rights, if any, pertaining to such Underlying Securities and (iii) a statement
as to the manner in which instructions may be given to the Trustee to give a
discretionary proxy to a person designated in the notice received by the
Trustee. Such notice shall be given by the Trustee to the Holders of record on
such Record Date.

         Upon the written request of the applicable Holder, received on or
before the date established by the Trustee for such purpose, the Trustee shall
endeavor, insofar as practicable and permitted under any applicable provision of
law and any applicable provision of or governing the Underlying Securities, to
vote in accordance with any nondiscretionary instruction set forth in such
written request. The Trustee shall not vote except as specifically authorized
and directed in written instructions from the applicable Holder entitled to give
such instructions. Notwithstanding the foregoing, if the Trustee determines
(based solely upon advice furnished by nationally recognized independent tax
counsel, whether at the request of any Holder or otherwise) that the exercise of
voting rights with respect to any Underlying Securities could result in a "sale
or other disposition" of such Underlying Securities within the meaning of
Section 1001(a) of the Code, as amended, the Trustee shall exercise such voting
rights in a manner that would not result in any such sale or other disposition.
The Trustee will have no responsibility to undertake on its own initiative to
determine that any exercise of voting rights will result in any such sale or
other disposition.

         (b)   By accepting delivery of a Certificate, whether upon original
issuance or subsequent transfer, exchange or replacement thereof, and without
regard to whether ownership is beneficial or otherwise, the Holder agrees so
long as it is an owner thereof that it shall not grant any consent (i) to any
conversion of the timing of payment of, or the method or rate of accruing,
interest on the Underlying Securities underlying the Certificates held by such
Holder or (ii) to any redemption or prepayment of the Underlying Securities
underlying the Certificates held by such Holder. The Trustee shall not grant any
consent solicited from the owners of the Underlying Securities underlying the
Certificates with respect to the matters set forth in this Section nor shall it
accept or take any action in respect of any consent, proxy or instructions
received from any Holder in contravention of the provisions of this Section.

         Section 5.16.  Actions by Certificateholders. (a) Wherever in this
Trust Agreement a provision is made that an action may be taken or a notice,
demand or instruction given by Certificateholders or Beneficial Owners, such
action, notice or instruction may be taken or given by any Certificateholder or
Beneficial Owner.

         (b)   Each Certificateholder or Beneficial Owner shall have the right
to assert any rights and privileges of a Certificateholder or Beneficial Owner,
and shall have the right to proceed directly and individually against any Person
to enforce any remedies hereunder and shall not be required to act in concert
with any other Certificateholder or Beneficial Owner or any other Person.

         (c)   Any request, demand, authorization, direction, notice, consent,
waiver or other act by a Certificateholder or Beneficial Owner of a Certificate
shall bind such Certificateholder or Beneficial Owner and every subsequent
Certificateholder or Beneficial Owner of such Certificate or any Certificate
issued upon the registration of transfer thereof or in exchange therefor or in
lieu thereof in respect of anything done, suffered or omitted to be done by the
Certificateholder or Beneficial Owner or the

                                       37

<PAGE>

Trustee in reliance thereon, whether or not notation of such action is made upon
such Certificate.

         (d)   Holders are beneficial owners of the right to receive principal
payments and interest payments to which such Certificates relate and, as such,
will have the right following an event of default with respect to any Underlying
Security to proceed directly against the Underlying Securities Issuer(s). Such
Certificateholders are not required to join other Holders of Certificates, the
Depositor, the Trustee or the Securities Intermediary in order to proceed
against the Underlying Securities Issuer(s).

         Section 5.17.  Events of Default. If any Event of Default shall occur
and be continuing with respect to any Class of Certificates, then, and in each
and every case, the Trustee shall exercise any rights in respect of the related
Underlying Securities as provided in the applicable Supplement.

         Section 5.18.  Judicial Proceedings Instituted by Trustee; Trustee May
Bring Suit. If there shall be a failure to make payment of the principal of or
premium, if any, or interest on any Underlying Security, then the Trustee, in
its own name, and as trustee of an express trust, as holder of such Underlying
Security, shall be, to the extent permitted by and in accordance with the terms
of the Underlying Security, subject to the limitations on acceleration and the
exercise of remedies set forth therein, and further subject to the provisions of
Sections 7.01(c) and 7.06(f) herein, entitled and empowered to institute
Proceedings at law, in equity or otherwise, including the power to make a demand
on the trustee in respect of such Underlying Security, if provided for, to take
action to enforce the Underlying Security for the collection of the sums so due
and unpaid on such Underlying Security and may prosecute any such Proceeding to
judgment or final decree with respect to the whole amount of any such sums so
due and unpaid.

         Section 5.19.  Control by Certificateholders. The Holders of
Certificates of any Class holding Certificates representing not less than the
Required Percentage--Direction of Trustee of the aggregate Voting Rights of the
Outstanding Certificates of such Class shall have the right to direct the time,
method and place of conducting any Proceeding for any remedy available to the
Trustee or exercising any trust or power conferred on the Trustee under this
Trust Agreement, including any right of the Trustee as holder of the Underlying
Securities; provided that:

         (i)   such direction shall not be in conflict with any rule of law or
     with this Trust Agreement and would not involve the Trustee in personal
     liability or expense;

         (ii)  the Trustee shall determine, based upon an Opinion of Counsel,
     that the action so directed would not be unjustly prejudicial to the
     Holders of Certificates of such Class not taking part in such direction;
     and

         (iii) the Trustee may take any other action deemed proper by the
     Trustee which is not inconsistent with such direction.

         Section 5.20.  Waiver of Past Defaults. The Holders of the Required
Percentage--Waiver of Certificates of any Series may (a) waive any past default
under this Trust Agreement and its consequences or (b) direct the Trustee to
vote such percentage of the Underlying Securities held by the Trustee as
corresponds to the percentage of the aggregate Principal Amount of the
Certificates of such Series held by such Holders to waive any past default
thereunder and its consequences with respect to such Series; provided that such
Holders may not waive or direct the Trustee to waive a default

         (i)   in the payment of the principal of or premium, if any, or
     interest on the Underlying Securities; or

         (ii)  in respect of a covenant or provision hereof that under Section
     11.01 hereof cannot be modified or amended without the consent of the
     Holder of each Outstanding Certificate affected.

Upon any waiver of a default under this Trust Agreement or direction that is
effective to waive a default in respect of the Underlying Securities, such
default shall cease to exist with respect to this Trust Agreement, any Event of
Default arising therefrom shall be deemed to have been cured for every purpose
of this Trust Agreement and any direction given by the Trustee on behalf of such
Holders in respect of any Underlying Securities

                                       38

<PAGE>

shall be annulled with respect thereto; but no such waiver shall extend to any
subsequent or other default or Event of Default or impair any right consequent
thereon.

         Section 5.21.  Right of Certificateholders to Receive Payments Not to
Be Impaired. Anything in this Trust Agreement to the contrary notwithstanding,
the right of any Certificateholder to receive distributions of payments required
pursuant to Section 4.01 hereof on the Certificates when due, or to institute
suit for enforcement of any such payment on or after the applicable Distribution
Date or other date specified herein for the making of such payment, shall not be
impaired or affected without the consent of such Certificateholder.

         Section 5.22. Remedies Cumulative. Every remedy given hereunder to the
Trustee or to any of the Certificateholders shall not be exclusive of any other
remedy or remedies, and every such remedy shall be cumulative and in addition to
every other remedy given hereunder or now or hereafter given by statute, law,
equity or otherwise.

                                   ARTICLE VI
                                 THE DEPOSITOR

         Section 6.01.  Liability of the Depositor. The Depositor shall be
liable in accordance herewith only to the extent of the obligations specifically
imposed by these Standard Terms and the related Supplement.

         Section 6.02.  Limitation on Liability of the Depositor. (a) The
Depositor shall not be under any obligation to expend or risk its own funds or
otherwise incur financial liability in the performance of its duties hereunder
or under a Supplement or in the exercise of any of its rights or powers if
reasonable grounds exist for believing that the repayment or such funds or
adequate indemnity against such risk or liability is not reasonably assured to
it.

         (b)   Neither the Depositor nor any of its directors, officers,
employees or agents shall be under any liability to any Trust or the
Certificateholders of any Series for any action taken, or for refraining from
the taking of any action, in good faith pursuant to this Trust Agreement, or for
errors in judgment; provided, however, that this provision shall not protect the
Depositor against any breach of representations, warranties or covenants made
herein, or against any liability which would otherwise be imposed by reason of
willful misfeasance, bad faith or negligence in the performance of duties or by
reason of reckless disregard of obligations and duties hereunder.

         (c)   The Depositor shall not be under any obligation to appear in,
prosecute or defend any legal action unless such action is related to its
respective duties under this Trust Agreement and, in its opinion, does not
involve it in any expense or liability; provided, however, that the Depositor
may in its discretion undertake any such action which it may deem necessary or
desirable with respect to this Trust Agreement and the rights and duties of the
parties hereto and the interests of the Certificateholders hereunder. The
Depositor shall be under no obligation whatsoever to appear in, prosecute or
defend any action, suit or other Proceeding in respect of any Underlying
Securities.

         (d)   The Depositor shall not be liable to any Certificateholder for
any action or non-action by it in reliance upon the advice of or information
from legal counsel, accountants, and a Certificateholder of a Certificate or any
other person believed by it in good faith to be competent to give such advice or
information, including, without limitation, the Market Agent or the other
parties to this Trust Agreement. The Depositor may rely and shall be protected
in acting upon any written notice, request, direction or other document believed
by it to be genuine and to have been signed or presented by the proper party or
parties.

         (e)   The Depositor shall not incur any liability to any
Certificateholder if, by reason of any provision of any present or future law,
or regulation thereunder, or any governmental authority, or by any reason of any
act of God or war or other circumstance beyond the control of the relevant
party, the Depositor shall be prevented or forbidden from doing or performing
any act or thing which the terms of this Trust Agreement provide shall be done
or performed; and the Depositor shall not incur any liability to any
Certificateholder by reason of any non-performance or delay, caused as
aforesaid, in the performance of any act or thing which the terms of this Trust
Agreement provide shall or may be done or performed, or by reason of any
exercise of, or failure to exercise, any discretion provided for in this Trust
Agreement.

         Section 6.03.  Depositor May Purchase Certificates. The Depositor may
at any time purchase Certificates in the open market or otherwise. Certificates
so purchased by

                                       39

<PAGE>

the Depositor may, at the discretion of the Depositor, be held or resold.
Certificates beneficially owned by the Depositor will be disregarded for
purposes of determining whether the required percentage of the aggregate Voting
Rights has given any request, demand, authorization, direction, notice, consent
or waiver hereunder.

         Section 6.04.  Merger or Consolidation of the Depositor.Nothing in this
Trust Agreement shall prevent any consolidation or merger of the Depositor with
or into any other corporation, or any consolidation or merger of any other
corporation with or into the Depositor or any sale or transfer of all or
substantially all of the property and assets of the Depositor to any other
Person lawfully entitled to acquire the same; provided, however, that, so long
as Certificates are outstanding hereunder, the Depositor covenants and agrees
that any such consolidation, merger, sale or transfer shall be upon the
condition that the due and punctual performance and observance of all the terms,
covenants and conditions of this Trust Agreement to be kept or performed by the
Depositor shall be assumed by the Person (if other than the Depositor) formed by
or resulting from any such consolidation or merger, or which shall have received
the transfer of all or substantially all of the property and assets of the
Depositor, just as fully and effectually as if successor Person had been the
original party of the first part hereto; and in the event of any such sale or
transfer the predecessor Depositor may be dissolved, wound up and liquidated at
any time thereafter.

         Section 6.05.  No Liability of the Depositor with Respect to the
Underlying Securities; Certificateholders to Proceed Directly Against the
Underlying Securities Issuer(s). (a) The sole obligor with respect to any
Underlying Security is the Underlying Securities Issuer(s). The Depositor shall
not have any obligation on or with respect to the Underlying Securities; and its
obligations with respect to Certificates shall be solely as set forth in this
Trust Agreement.

         (b)   The Depositor is not authorized to proceed against the Underlying
Securities Issuer in the event of a default or to assert the rights and
privileges of Certificateholders and has no duty in respect thereof.

                                   ARTICLE VII
                                   THE TRUSTEE

         Section 7.01.  Duties of Trustee. (a) The Trustee undertakes to perform
such duties and only such duties as are specifically set forth in these Standard
Terms and the related Supplement. The Trustee shall exercise in case of receipt
of notice of Default (as such term is defined in paragraph (d) below) such of
the rights and powers vested in it by this Trust Agreement, and shall use the
same degree of care and skill in their exercise, as a prudent person would
exercise or use under the circumstances in the conduct of such person's own
affairs. In the event that the Underlying Securities Issuer ceases to file
periodic reports under the Exchange Act, the Depositor shall notify the Trustee
of that fact and the Trustee shall take such actions as specifically set forth
in the Supplement. The Trustee shall exercise those rights in a manner
consistent with the status of any Trust created hereunder as a fixed investment
trust for federal income tax purposes as directed by the Depositor. The Trustee
shall not have any power to vary the investment of any Certificateholders of any
Series or to accept any assets (other than proceeds of the Underlying
Securities) other than the Underlying Securities transferred to it on the
Closing Date of any Series. Any permissive right of the Trustee enumerated in
this Trust Agreement shall not be construed as a duty and shall be interpreted
consistently with the status of the Trust as a fixed investment trust.

         (b)   The Trustee, upon receipt of all resolutions, certificates,
statements, opinions, reports, documents, orders or other instruments furnished
to the Trustee which are specifically required to be furnished pursuant to any
provision of this Trust Agreement, shall examine them to determine, in its best
judgment, whether they conform to the requirements of this Trust Agreement. If
any such instrument is found not to conform to the requirements of this Trust
Agreement, the Trustee shall take action as it deems appropriate to have the
instrument corrected, and if the instrument is not corrected to the Trustee's
satisfaction, the Trustee will provide notice thereof to the Depositor and
Certificateholders.

         (c)   No provision of this Trust Agreement shall be construed to
relieve the Trustee from liability for its own negligent action, its own
negligent failure to act or its own misconduct; provided, however, that:

         (i)   the duties and obligations of the Trustee shall be determined
     solely by the express provisions of this Trust Agreement, the Trustee shall
     not be liable except

                                       40

<PAGE>

     for the performance of such duties and obligations as are specifically set
     forth in this Trust Agreement, no implied covenants or obligations shall be
     read into this Trust Agreement against the Trustee and, in the absence of
     bad faith on the part of the Trustee, the Trustee may conclusively rely, as
     to the truth of the statements and the correctness of the opinions
     expressed therein, upon any certificates or opinions furnished to the
     Trustee that conform to the requirements of this Trust Agreement;

         (ii)  the Trustee shall not be personally liable for an error of
     judgment made in good faith by a Responsible Officer or Responsible
     Officers of the Trustee, unless it shall be proved that the Trustee was
     negligent in ascertaining the pertinent facts;

         (iii) the Trustee shall not be personally liable with respect to any
     action taken, suffered or omitted to be taken by it in good faith in
     accordance with the direction of Holders of the Required
     Percentage--Direction of Trustee of the aggregate Voting Rights of a given
     Series (or Class or group of Classes within such Series), as specified in
     the applicable Supplement relating to the time, method and place of
     conducting any Proceeding for any remedy available to the Trustee, or
     exercising any trust or power conferred upon the Trustee, under this Trust
     Agreement;

         (iv)  the Trustee shall not be required to expend or risk its own funds
     or otherwise incur financial liability in the performance of any of its
     duties hereunder or in the exercise of any of its rights or powers if there
     is reasonable ground for believing that the repayment of such funds or
     adequate indemnity against such risk or liability is not reasonably assured
     to it;

         (v)   except for actions expressly authorized by this Trust Agreement,
     the Trustee shall take no actions reasonably likely to impair the interests
     of the Trust in any Underlying Security now existing or hereafter acquired
     or to impair the value of any Underlying Security now existing or hereafter
     acquired;

         (vi)  except as expressly provided in this Trust Agreement, the Trustee
     shall have no power to vary the corpus of the Trust including by (A)
     accepting any substitute obligation or asset for an Underlying Security
     initially assigned to the Trustee under Section 2.01, (B) adding any other
     investment, obligation or security to the Trust or (C) withdrawing from the
     Trust any Underlying Securities;

         (vii) in the event that the Paying Agent or the Certificate Registrar
     shall fail to perform any obligation, duty or agreement in the manner or on
     the day required to be performed by the Paying Agent or Certificate
     Registrar, as the case may be, under this Trust Agreement, the Trustee
     shall be obligated promptly upon its knowledge thereof to perform such
     obligation, duty or agreement in the manner so required;

        (viii) the Trustee shall not be liable to any Certificateholder for
     any action or non-action by it in reliance upon the advice of or
     information from legal counsel, accountants, any Certificateholder or any
     other person believed by it in good faith to be competent to give such
     advice or information, including, without limitation, the Market Agent or
     the other parties to this Trust Agreement. The Trustee may rely and shall
     be protected in acting upon any written notice, facsimile transmission,
     request, direction or other document believed by it to be genuine and to
     have been signed or presented by the proper party or parties;

         (ix)  the Trustee shall not incur any liability to any
     Certificateholder if, by reason of any provision of any present or future
     law, or regulation thereunder, or any governmental authority, or by any
     reason of any act of God or war or other circumstance beyond the control of
     the relevant party, the Trustee shall be prevented or forbidden from doing
     or performing any act or thing which the terms of this Trust Agreement
     provide shall be done or performed; and the Trustee shall not incur any
     liability to any Certificateholder by reason of any non-performance or
     delay, caused as aforesaid, in the performance of any act or thing which
     the terms of this Trust Agreement provide shall or may be done or
     performed, or by reason of any exercise of, or failure to exercise, any
     discretion provided for in this Trust Agreement;

         (x)   the Trustee shall be under no obligation whatsoever to appear in,
     prosecute or defend any Proceeding in respect of any Underlying Securities;

                                       41

<PAGE>

         (xi)  whenever in the administration of this Trust Agreement the
     Trustee shall deem it desirable that a matter be proved or established
     prior to taking, suffering or omitting any action hereunder, the Trustee
     (unless other evidence be herein specifically prescribed) may, in the
     absence of bad faith on its part, conclusively rely upon an Officers'
     Certificate; and (xii) the Trustee may consult with counsel of its
     selection and, the advice of such counsel or any Opinion of Counsel
     selected by the Trustee with due care shall be full and complete
     authorization and protection in respect of any action taken, suffered or
     omitted by it hereunder in reliance thereon.

         (d)   As promptly as practicable after, and in any event within 10 days
after, the occurrence of any Default (as such term is defined below) hereunder
with respect to any Class of Certificates, the Trustee shall transmit by mail to
the Depositor and the Holders of Certificates of such Class in accordance with
TIA Section 313(c), notice of such Default hereunder actually known to the
Trustee, unless such Default shall have been cured or waived; provided, however,
that, except in the case of a Default in the payment of the principal of or
premium, if any, or interest on any Underlying Security, the Trustee shall be
protected in withholding such notice if and so long as a trust committee of
Responsible Officers of the Trustee in good faith determines that the
withholding of such notice is in the interests of the Holders of the
Certificates of such Class. For the purpose of this Section 7.01(d), the term
"Default" means, with respect to any Class of Certificates, any event that is,
or after notice or lapse of time or both would become, an Event of Default with
respect to such Class of Certificates.

         (e)   Within five (5) Business Days after the receipt by the Trustee of
a written application by any three or more Certificateholders stating that such
Certificateholders desire to communicate with other Certificateholders with
respect to their rights under this Trust Agreement or under the Certificates,
and accompanied by a copy of the form of proxy or other communication which such
Certificateholders propose to transmit, and by reasonable proof that each such
Certificateholder has owned its Certificates for a period of at least six (6)
months preceding the date of such application, the Trustee shall, at its
election, either:

         (i)   afford to such Certificateholders access to all information so
     furnished to or received by the Trustee; or

         (ii)  inform such Certificateholders as to the approximate number of
     Certificateholders according to the most recent information so furnished to
     or received by the Trustee, and as to the approximate cost of mailing to
     such Certificateholders the form of proxy or other communication, if any,
     specified in such application.

If the Trustee shall elect not to afford to such Certificateholders access to
such information, the Trustee shall, upon the written request of such
Certificateholders, mail to all such Certificateholders copies of the form of
proxy or other communication which is specified in such request, with reasonable
promptness after a tender to the Trustee of the material to be mailed and of
payment, or provision for the payment, of the reasonable expenses of such
mailing.

         (f)   The Trustee shall prepare for filing, at the direction of and
with information provided by the Depositor, periodic reports for the Trust
pursuant to the Exchange Act, and the rules and regulations promulgated
thereunder on behalf of the Depositor. The Depositor shall respond reasonably
promptly to any inquiry of the Trustee concerning such reports and shall provide
the information required for such reports within three days of the filing due
date.

                                       42

<PAGE>

         Section 7.02.  Agreements Between Trustee and Administrative Agents.
(a) The Trustee may enter into Administration Agreements with one or more
Administrative Agents in order to delegate to such Administrative Agents certain
of its administrative obligations with respect to a Series hereunder; provided,
however, that:

         (i)   such delegation shall not release the Trustee from the duties,
     obligations, responsibilities or liabilities arising hereunder;

         (ii)  such delegation shall not cause the Administrative Agent to be
     considered a servicer under Regulation AB;

         (iii) the Rating Agency Condition shall have been satisfied with
     respect to the entering into of any such agreement;

         (iv)  such agreement must be consistent with these Standard Terms and,
     with respect to Certificates of any Series, the related Supplement;

         (v)   the Trustee will remain solely liable for all fees and expenses
     it may owe to such Administrative Agent;

         (vi)  the Administrative Agent shall give representations and
     warranties in such Administration Agreement that are the same in substance
     as those set forth in Section 7.10 herein (references therein to the Trust
     Agreement, the Trustee and the Depositor shall be to the applicable
     Administration Agreement, Administrative Agent and Trustee, respectively,
     for purposes of this Section 7.02(a)); and

         (vii) such Administrative Agent shall meet the eligibility
     requirements of a Trustee pursuant to Section 7.07 herein.

An Administration Agreement must provide that an entity serving as
Administrative Agent may resign from its obligations and duties under this Trust
Agreement with respect to any Series only if such resignation, and the
appointment of a successor, would satisfy the Rating Agency Condition or upon a
determination that the duties of the Administrative Agent with respect to such
Series are no longer permissible under applicable law. No such resignation shall
become effective until the Trustee or a successor Administrative Agent has
assumed the obligations of such Administrative Agent with respect to such
Series. In addition, with respect to any Series (or Class within such Series),
each Administration Agreement shall impose on the Administrative Agent
requirements conforming to the provisions set forth in Section 3.01 and provide
for administration of the related Trust and all or certain specified Underlying
Securities for such Series consistent with the terms of this Trust Agreement.
Additional requirements relating to the scope and contents of any Administration
Agreement may be provided in the applicable Supplement. The Trustee shall
deliver to the Depositor copies of all Administration Agreements into which it
enters, and any amendments or modifications thereof, promptly upon the Trustee'
s execution and delivery of any such instruments.

         (b)   Upon the occurrence of an Administrative Agent Termination Event,
the Trustee shall be entitled to terminate the relevant Administration Agreement
and the rights and obligations of any such Administrative Agent under any
Administration Agreement in accordance with the terms and conditions of any such
Administration Agreement. If such Administration Agreement is terminated, the
Trustee shall simultaneously reassume direct responsibility for all obligations
delegated in such Administration Agreement without any act or deed on the part
of the applicable Administrative Agent, and the Trustee shall administer
directly the related Underlying Securities or shall enter into an Administration
Agreement with a successor Administrative Agent which so qualifies under Section
7.02(a). If the Trustee is unwilling or unable to act, it may appoint, or
petition a court of competent jurisdiction for the appointment of, an
Administrative Agent which so qualifies under Section 7.02(a). Pending such
appointment, the Trustee must act in such capacity (except that if the Trustee
is prohibited by law from doing so, then the Trustee will not be so obligated).

         (c)   If an Administrative Agent is administering one or more
Underlying Securities pursuant to an Administration Agreement, the
Administrative Agent shall deposit into an Eligible Account established by such
Administrative Agent (an "Administration Account") any amounts collected with
respect thereto, and all such amounts shall be distributed to the Trustee for
deposit into the related Certificate Account not later than the Business Day
after receipt thereof.

                                       43

<PAGE>

         Section 7.03.  Certain Matters Affecting the Trustee. (a) Except as
otherwise provided in this Article VII:

         (i)   the Trustee may request and rely upon and shall be protected in
     acting or refraining from acting upon any resolution, Officer's
     Certificate, certificate of auditors or any other certificate, statement,
     instrument, opinion, report, notice, facsimile transmission, request,
     consent, order, appraisal, bond or other paper or document reasonably
     believed by it to be genuine and to have been signed or presented by the
     proper party or parties;

         (ii)  the Trustee may consult with counsel and any Opinion of Counsel
     shall be full and complete authorization and protection in respect of any
     action taken or suffered or omitted by it hereunder in good faith and in
     accordance with such Opinion of Counsel;

         (iii) the Trustee shall be under no obligation to exercise any of the
     trusts or powers vested in it by this Trust Agreement or to institute,
     conduct or defend any litigation hereunder or in relation hereto, at the
     request, order or direction of any of the Certificateholders, pursuant to
     the provisions of this Trust Agreement, unless such Certificateholders
     shall have offered to the Trustee reasonable security or indemnity against
     the costs, expenses and liabilities which may be incurred therein or
     thereby;

         (iv ) the Trustee shall not be personally liable for any action taken,
     suffered or omitted by it in good faith and believed by it to be authorized
     or within the discretion or rights or powers conferred upon it by this
     Trust Agreement;

         (v)   the Trustee shall not be bound to make any investigation into the
     facts of matters stated in any resolution, certificate, statement,
     instrument, opinion, report, notice, facsimile transmission, request,
     consent, order, appraisal, approval, bond or other paper or document
     believed by it to be genuine, unless requested in writing to do so by
     Holders of the Required Percentage--Direction of Trustee of the aggregate
     Voting Rights of the affected Series (or Class or Classes within any such
     Series), as specified by the applicable Supplement; provided, however, that
     if the payment within a reasonable time to the Trustee of the costs,
     expenses or liabilities likely to be incurred by it in the making of such
     investigation is, in the opinion of the Trustee, not reasonably assured to
     the Trustee by the security afforded to it by the terms of this Trust
     Agreement, the Trustee may require reasonable indemnity against such
     expense or liability as a condition to taking any such action;

         (vi)  the Trustee may execute any of the trusts or powers hereunder or
     perform any duties hereunder either directly or by or through agents or
     attorneys or a custodian and shall not be liable for any misconduct or
     negligence of any such agents or attorneys selected with due care by it;
     and

         (vii) the Trustee shall not be personally liable for any loss
     resulting from the investment of funds held in any Certificate Account or
     Reserve Account in accordance with Section 3.05.

         (b)   All rights of action under this Trust Agreement or under any of
the Certificates, enforceable by the Trustee, may be enforced by it without the
possession of any of the Certificates of any Series (or Class within such
Series), or the production thereof at the trial or other Proceeding relating
thereto, and any such Proceeding instituted by the Trustee shall be brought in
its name for the benefit of all the Holders of such Certificates, subject to the
provisions of this Trust Agreement.

                                       44

<PAGE>

         Section 7.04.  Trustee Not Liable for Recitals in Certificates or
Underlying Securities. The Trustee assumes no responsibility for the correctness
of the recitals contained herein and in the Certificates or in any document
issued in connection with the sale of the Certificates (other than the signature
and authentication on the Certificates). Except as set forth in Section 7.10,
the Trustee makes no representations or warranties as to the validity or
sufficiency of this Trust Agreement or of the Certificates of any Series (other
than the signature and authentication on the Certificates) or of any Underlying
Security or related document. The Trustee shall not be accountable for the use
or application by the Depositor, of any of the Certificates or of the proceeds
of such Certificates.

         Section 7.05.  Trustee May Own Certificates. The Trustee in its
individual capacity or any other capacity may become the owner or pledgee of
Certificates with the same rights it would have if it were not Trustee;
provided, however, that in determining whether the required percentage of
aggregate Voting Rights shall have consented to any action hereunder requiring
the consent of the Certificateholders, any interest beneficially held by the
Trustee in its individual capacity shall be excluded.

         Section 7.06.  Trustee's Fees and Expenses. (a) The applicable
Supplement shall specify the amount and circumstances of the Trustee's
compensation and the source thereof.

         (b)   If the Prepaid Ordinary Expenses set forth in the Supplement is
greater than zero, the Trustee acknowledges that the Depositor has paid to the
Trustee an amount equal to the Prepaid Ordinary Expenses specified therein, and
the Trustee agrees that the payment of such amount shall constitute full and
final satisfaction of and payment for all such expenses.

         (c)   If the Prepaid Ordinary Expenses set forth in the Supplement is
zero, the Supplement may indicate that Ordinary Expenses will be paid for by the
Trust, in which case the Trustee shall be paid on a periodic basis by the Trust
at the rate or amount and on the terms provided for in the Supplement. In such
cases, the Trustee agrees that its right to receive such payments from the Trust
shall constitute full and final satisfaction of and payment for all Ordinary
Expenses and that the Trustee shall have no claim on payment of Ordinary
Expenses from any other source, including the Depositor.

         (d)   If the Prepaid Ordinary Expenses set forth in the Supplement is
zero, the Supplement may provide that the Depositor shall pay to the Trustee
from time to time a fee for its services and expenses as Trustee as set forth in
the Supplement payable at the times set forth therein. In such cases, the
Trustee agrees that its right to receive such payments from the Depositor shall
constitute full and final satisfaction of and payment for all Ordinary Expenses
and that the Trustee shall have no claim for payment of Ordinary Expenses from
the Trust. The Trustee further agrees that, notwithstanding any failure by the
Depositor to make such periodic payments of the Ordinary Expenses, the Trustee
shall continue to perform its obligations under this Trust Agreement. The
Depositor's obligations to pay Ordinary Expenses under this Trust Agreement
shall be extinguished and of no further effect upon the payment of Ordinary
Expenses due and owing on the termination of the Trust pursuant to Section 10.01
hereof.

         (e)   Subject to paragraph (f) of this Section 7.06, all Extraordinary
Trust Expenses, to the extent not paid by a third party are, and shall be,
obligations of the Trust and when due and payable shall be satisfied solely by
the Trust.

         (f)   The Trustee shall not take any action, including appearing in,
instituting or conducting any action or suit hereunder or in relation hereto
which is not indemnifiable under Section 7.11 hereof which, in the Trustee's
opinion, would or might cause it to incur costs, expenses or liabilities that
are Extraordinary Trust Expenses unless (i) the Trustee is satisfied that it
will have adequate security or indemnity in respect of such costs, expenses and
liabilities, (ii) the Trustee has been instructed to do so by Certificateholders
representing not less than 100% of the aggregate principal amount of
Certificates then outstanding and (iii) such Certificateholders have agreed that
such costs, expenses or liabilities shall be paid by the Trustee from the Trust.

         Section 7.07.  Eligibility Requirements for Trustee. (a) The Trustee
hereunder shall at all times be a corporation or an association which is not an
Affiliate of the Depositor (but may have normal banking relationships with the
Depositor and its Affiliates) organized and doing business under the laws of any
State or the United States, authorized under such laws to exercise corporate
trust powers which shall be

                                       45

<PAGE>

eligible to act as a trustee under TIA Section 310(a), having a combined capital
and surplus of at least $50,000,000, subject to supervision or examination by
Federal or State authority and have a rating from S&P of BBB- or higher. If such
corporation or association publishes reports of conditions at least annually,
pursuant to law or to the requirements of the aforesaid supervising or examining
authority, then for the purposes of this Section 7.07 the combined capital and
surplus of such corporation or association shall be deemed to be its combined
capital and surplus as set forth in its most recent report of conditions so
published. In the event that at any time such Trustee shall cease to be eligible
in accordance with the provisions of this Section 7.07, such Trustee shall
resign immediately in the manner and with the effect specified in Section 7.08.

         (b)   In determining whether the Trustee has a conflicting interest
under TIA Section 310(b) with respect to any Class of Certificates and this
Section 7.07, each other Class of Certificate will be treated as having been
issued under an indenture other than this Trust Agreement.

         Section 7.08.  Resignation or Removal of the Trustee; Appointment of
Successor Trustee. (a) The Trustee may at any time resign as Trustee hereunder
by written notice of its election so to do, delivered to the Depositor, and such
resignation shall take effect upon the appointment of a successor Trustee and
its acceptance of such appointment as hereinafter provided; provided, however,
that in the event of such resignation, the Trustee shall (i) assist the
Depositor in finding a successor Trustee acceptable to the Depositor and (ii)
negotiate in good faith concerning any prepaid but unaccrued fees.

         (b)   The Depositor or Holders of the Required Percentage--Removal of
Trustee of Certificates may at any time remove the Trustee as Trustee hereunder
by written notice delivered to the Trustee in the manner provided in Section
11.04 hereof, and such removal shall take effect upon the appointment of the
successor Trustee and its acceptance of such appointment as provided in
paragraph (e) of this Section 7.08; provided, however, that in the event of such
removal, the Depositor shall negotiate in good faith with the Trustee in order
to agree regarding payment of the termination costs of the Trustee resulting
from such removal.

         (c)   Upon the designation and acceptance thereof of a successor
Trustee, following either resignation or removal of the Trustee, the Trustee
shall deliver to the successor Trustee all records relating to the Certificates
in the form and manner then maintained by the Trustee, which shall include a
hard copy thereof upon written request of the successor Trustee.

         (d)   If at any time the Trustee shall become incapable of acting or
shall be adjudged a bankrupt or insolvent, or a receiver of the Trustee or of
its property shall be appointed, or any public officer shall take charge or
control of the Trustee or of its property of affairs for the purpose of
rehabilitation, conservation or liquidation, the Depositor shall petition any
court of competent jurisdiction for the removal of the Trustee and the
appointment of a successor Trustee. In the event the Trustee resigns or is
removed, the Trustee shall reimburse the Depositor for any fees or charges
previously paid to the Trustee in respect of duties not yet performed under this
Trust Agreement which remain to be performed by a successor Trustee.

         (e)   In case at any time the Trustee acting hereunder notifies the
Depositor that it elects to resign or the Depositor or Holders of the Required
Percentage--Removal of Trustee of Certificates notifies or notify the Trustee
that it or they elects or elect to remove the Trustee as Trustee, the Depositor
shall, within sixty (60) days after the delivery of the notice of resignation or
removal, appoint a successor Trustee, which shall satisfy the requirements for a
trustee under Section 7.07. If no successor Trustee has been appointed within
sixty (60) days after the Trustee has given written notice of its election to
resign or the Depositor or Holders of the Required Percentage--Removal of
Trustee of Certificates have given written notice to the Trustee of its or their
election to remove the Trustee, as the case may be, the Trustee may petition any
court of competent jurisdiction for the appointment of a successor Trustee.
Every successor Trustee shall execute and deliver to its predecessor and to the
Depositor an instrument in writing accepting its appointment hereunder, and
thereupon such successor Trustee, without any further act or deed, shall become
fully vested with all the rights, powers, duties and obligations of its
predecessor and for all purposes shall be the Trustee under this Trust
Agreement, and such predecessor, upon payment of all sums due it and on the
written request of the Depositor, shall execute and deliver an instrument
transferring to such successor all rights, obligations and powers of such
predecessor hereunder, and shall duly assign, transfer and deliver all right,
title and interest in the Deposited Assets and parts thereof to such successor.
Any successor Trustee shall promptly give

                                       46

<PAGE>

notice of its appointment to the Certificateholders of Certificates for which it
is successor Trustee in the manner provided in Section 11.04 hereof.

         (f)   Any Person into or with which the Trustee may be merged,
consolidated or converted shall be the successor of such Trustee without the
execution or filing of any document or any further act other than as required by
Section 7.18 (d)hereof.

                                       47

<PAGE>

         Section 7.09.  Appointment of Office or Agency. As specified in a
Supplement, the Trustee shall appoint an office or agency in The City of New
York where the Certificates may be surrendered for registration of transfer or
exchange, and presented for the final distribution with respect thereto, and
where notices and demands to or upon the Trustee in respect of the Certificates
of the related Series and this Trust Agreement may be served.

         Section 7.10.  Representations and Warranties of Trustee. The Trustee
represents and warrants that:

         (i)   the Trustee is duly organized, validly existing and in good
     standing under the laws of its jurisdiction of incorporation or
     association;

         (ii)  neither the execution nor the delivery by the Trustee of this
     Trust Agreement, nor the consummation by it of the transactions
     contemplated hereby nor compliance by it with any of the terms or
     provisions hereof will contravene any Federal or New York law, governmental
     rule or regulation governing the banking or trust powers of the Trustee or
     any judgment or order binding on it, or violate its charter documents or
     by-laws or constitute a default under (or an event which, without notice or
     lapse of time or both, would constitute a default) under, or result in the
     breach or acceleration of any material contract, indenture, mortgage,
     agreement or instrument to which it is a party or by which any of its
     properties may be bound;

         (iii) the Trustee has full power, authority and right to execute,
     deliver and perform its duties and obligations as set forth herein and in
     each Supplement to which it is a party and has taken all necessary action
     to authorize the execution, delivery and performance by it of this Trust
     Agreement;

         (iv)  this Trust Agreement has been duly executed and delivered by the
     Trustee and constitutes, subject to due execution by the Depositor, the
     legal, valid and binding obligation of the Trustee, enforceable in
     accordance with its terms, except as enforcement may be limited by the
     applicable bankruptcy, insolvency, reorganization, moratorium or similar
     laws affecting the rights of creditors generally and general principles of
     equity (regardless of whether such enforceability is considered in a
     proceeding in equity or at law);

         (v)   the Trustee is not in violation, and the execution and delivery
     of the Trust Agreement by the Trustee and its performance and compliance
     with the terms thereof will not constitute a violation, of any order or
     decree of any court or any order or regulation of any federal, state,
     municipal or governmental agency having jurisdiction over the Trustee or
     its properties, which violation would reasonably be expected to have a
     material adverse effect on the condition (financial or otherwise) or
     operations of the Trustee or its properties or on the performance of its
     duties hereunder;

         (vi)  there are no actions or proceedings against, or investigations
     of, the Trustee pending, or, to the knowledge of the Trustee, threatened,
     before any court, administrative agency or other tribunal (A) that could
     reasonably be expected to prohibit its entering into the Trust Agreement,
     (B) seeking to prevent the issuance of the Certificates contemplated by the
     Trust Agreement or (C) that could reasonably affect the performance by the
     Trustee of its obligations under, or the validity or enforceability against
     the Trustee of, the Trust Agreement; and

         (vii) no consent, approval, authorization or order of any court,
     governmental agency or body is required for the execution, delivery and
     performance by the Trustee of, or compliance by the Trustee with, the Trust
     Agreement, or for the consummation of the transactions contemplated by the
     Trust Agreement, except for such consents, approvals, authorizations and
     orders, if any, that have been obtained prior to the Closing Date.

The representations and warranties of the Trustee set forth in this Section 7.10
shall survive the receipt of Underlying Securities by the Trustee and shall
survive the delivery of the Trust Agreement by the Trustee to the Depositor.

         Section 7.11.  Indemnification of Trustee by the Depositor;
Contribution. (a) The Depositor agrees, to the extent the Trustee is not
reimbursed pursuant to Section 7.06 hereof, to indemnify the Trustee against,
and hold it harmless from, any loss, expense or liability incurred in connection
with any Proceeding relating to this Trust

                                       48

<PAGE>

Agreement or the Certificates or the performance of any of the Trustee's duties
hereunder, other than any loss, liability or expense incurred by reason of
wilful misfeasance, bad faith or negligence in the performance of the Trustee's
duties hereunder or by reason of reckless disregard of the Trustee's
obligations and duties hereunder.

         (b)   If the indemnification provided for in paragraph (a) of this
Section 7.11 is invalid or unenforceable in accordance with its terms, then the
Depositor shall contribute to the amount paid or payable by the Trustee as a
result of such liability in such proportion as is appropriate to reflect the
relative benefits received by the Depositor on one hand and the Trustee as
Trustee on the other hand. For this purpose (i) the benefits received by the
Depositor shall be the aggregate amount received by it upon the sale of such
Certificates, less the costs and expenses of such sale, including the cost of
acquisition of the Underlying Securities or parts thereof evidenced thereby, and
(ii) the benefits received by the Trustee, as Trustee shall be the aggregate
amount of fees received by it as Trustee, less costs and expenses incurred by it
as Trustee in relation to such Certificates. If, however, the allocation
provided by the immediately preceding two sentences is not permitted by
applicable law, then the Depositor shall contribute to such amount paid or
payable by the Trustee in such proportion as is appropriate to reflect not only
such relative benefits but also the relative fault of the Depositor on the one
hand and the Trustee on the other in connection with the actions or omissions
which resulted in such liability, as well as any other relevant equitable
considerations.

         (c)   In case any claim shall be made or action brought against the
Trustee for any reason for which indemnity may be sought against the Depositor
as provided above, the Trustee may promptly notify the Depositor in writing
setting forth the particulars of such claim or action and the Depositor may
assume the defense thereof. In the event that the Depositor assumes the defense,
the Trustee shall have the right to retain separate counsel in any such action
but shall bear the fees and expenses of such counsel unless (i) the Depositor
shall have specifically authorized the retaining of such counsel or (ii) the
parties to such suit include the Trustee and the Depositor, and the Trustee has
been advised in writing by such counsel that one or more legal defenses may be
available to it which may not be available to the Depositor, in which case the
Depositor shall not be entitled to assume the defense of such suit
notwithstanding its obligation to bear the reasonable fees and expenses of such
counsel.

         (d)   The term "Liability", as used in this Section 7.11, shall include
any losses, claims, damages, expenses (including without limitation the Trustee'
s reasonable costs, expenses and attorneys' fees and expenses) in defending
itself against any losses, claims or investigations of any nature whatsoever.

         (e)   The obligations of the Depositor under this Section 7.11 shall be
in addition to any liability which the Depositor may otherwise have and shall
extend, upon the same terms and conditions, to each officer and director of the
Trustee, and to each person, if any, who controls the Trustee within the meaning
of the Exchange Act.

         (f)   Notwithstanding anything to the contrary contained in this
Section 7.11, the Depositor shall not be liable for settlement of any such claim
by the Trustee entered into without the prior written consent of the Depositor,
which consent shall not be unreasonably withheld.

         (g)   The indemnity provided in this Section 7.11 shall survive the
termination or discharge of this Trust Agreement.

         Section 7.12.  No Liability of the Trustee with Respect to the
Underlying Securities; Certificateholders to Proceed Directly Against the
Underlying Securities Issuer(s). (a) The sole obligor with respect to any
Underlying Security is the Underlying Securities Issuer(s). The Trustee shall
not have any obligation on or with respect to the Underlying Securities; and its
obligations with respect to Certificates shall be solely as set forth in this
Trust Agreement.

         (b)   The Trustee is not authorized to proceed against the Underlying
Securities Issuer in the event of a default or to assert the rights and
privileges of Certificateholders of Certificates and has no right or duty in
respect thereof except as expressly provided herein.

         Section 7.13.  The Depositor to Furnish Trustee with Names and
Addresses of Certificateholders. The Depositor will furnish to the Trustee
within 15 days after each

                                       49

<PAGE>

Record Date with respect to any Distribution Date, and at such other times as
the Trustee may request in writing, within 30 days after receipt by the
Depositor of any such request, a list, in such form as the Trustee may
reasonably require, of all information in the possession or control of the
Depositor as to the names and addresses of the Certificateholders, in each case
as of a date not more than 15 days prior to the time such list is furnished;
provided, however, that so long as the Trustee is the sole Registrar, no such
list need be furnished.

         Section 7.14.  Preservation of Information. The Trustee shall preserve,
in as current a form as is reasonably practicable, the names and addresses of
Certificateholders contained in the most recent list furnished to the Trustee as
provided in Section 7.14, and the names and addresses of Certificateholders
received by the Trustee in its capacity as Registrar, if so acting. The Trustee
may destroy any list furnished to it as provided in Section 7.14, upon receipt
of a new list so furnished.

         Section 7.15.  Reports by Trustee. If required, within 60 days after
May 15 of each year, commencing with the year 2007, the Trustee shall transmit
to the Certificateholders, as provided in TIA Section 313(c), a brief report
dated as of such May 15, if required by TIA Section 313(a).

         Section 7.16.  Trustee's Application for Instructions from the
Depositor. Any application by the Trustee for written instructions from the
Depositor may, at the option of the Trustee, set forth in writing any action
proposed to be taken or omitted by the Trustee under this Trust Agreement and
the date on and/or after which such action shall be taken or such omission shall
be effective, if, but only if, the obligations of the Trustee with respect to
such proposed action or omission, in the view of the Trustee, are not set forth
reasonably clearly in these Standard Terms and the related Supplement. The
Trustee shall not be liable for any action taken by, or omission of, the Trustee
in accordance with a proposal included in such application on or after the date
specified in such application (which date shall not be less than ten (10)
Business Days after the date a Responsible Officer of the Depositor actually
receives such application, unless any such Responsible Officer shall have
consented in writing to any earlier date) unless, prior to taking any such
action (or the effective date in the case of an omission), the Trustee shall
have received written instructions in response to such application specifying
the action to be taken or omitted; provided, however, that this provision shall
not protect the Trustee from liability for any action or omission constituting
willful misconduct, bad faith or negligence.

         Section 7.17.  Assessment of Compliance by Trustee; Annual Independent
Certified Public Accountant's Report, Etc.

         (a)   On or prior to March 15 of each year, with respect to any Series,
commencing with the year following the year of issuance of certificates of such
Series, the Trustee shall deliver to the Depositor an assessment of compliance
(or other such form that may be reasonably requested by the Depositor from the
Trustee to conform to the requirements of Regulation AB) that contains the
following: (i) statement of the Trustee's responsibility for assessing
compliance with the servicing criteria applicable to it under the Trust
Agreement;

         (ii)  a statement that the Trustee used the criteria in Item 1122(d) of
Regulation AB (17 CFR 229.1122) to assess compliance with the applicable
servicing criteria under the Trust Agreement;

         (iii) the Trustee's assessment of compliance with the applicable
servicing criteria during and as of the end of the prior calendar year, setting
forth any material instance of noncompliance identified by the Trustee; and

         (iv)  a statement that a registered public accounting firm has issued
an attestation report on the Trustee's assessment of compliance with the
applicable servicing criteria under the trust agreement during and as of the end
of the prior calendar year.

         (b)   The Trustee shall cause a firm of independent certified public
accountants to deliver to the Depositor on or before March 15 a report with
respect to each Series, that attests to, and reports on, the Trustee's
assessment delivered pursuant to Section 7.17(a), which attestation report shall
be made in accordance with the requirements of Rule 15d-18 under the Exchange
Act.

                                       50

         (c)   On or before March 15 of each calendar year, with respect to each
Series, commencing the year following the year of issuance of certificates of
such Series, the Trustee shall deliver to the Depositor a statement of
compliance addressed to the Depositor and signed by an authorized officer of the
Trustee, to the effect that (i) a review of the Trustee's activities during the
immediately preceding calendar year (or applicable portion thereof) and of its
performance under the Trust Agreement during such period has been made under
such officer's supervision, and (ii) to the best of such officers' knowledge,
based on such review, the Trustee has fulfilled all of its obligations under the
Trust Agreement in all material respects throughout such calendar year (or
applicable portion thereof) or, if there has been a failure to fulfill any such
obligation in any material respect, specifically identifying each such failure
known to such officer and the nature and the status thereof.

         Section 7.18.  Information to be Provided by the Trustee

         In connection with any transaction pursuant to a Trust Agreement, the
Trustee shall (i) within five Business Days following request by the Depositor
provide to the Depositor, in form and substance reasonably satisfactory to the
Depositor, the information and materials specified in paragraphs (a) and(b) of
this Section and (ii) as promptly as practicable following notice to or
discovery by the Trustee, provide the Depositor (in writing and in form and
substance reasonably satisfactory to the Depositor) the information specified in
paragraph (c) of this Section.

         (a)   If so requested by the Depositor the Trustee shall provide
information regarding the Trustee as is requested for compliance with Items
1103(a)(1), 1108, 1109, 1117 and 1119 of Regulation AB. Such information shall
include, at a minimum:

         (i)   the Trustee's form of organization;

         (ii)  a description of how long the Trustee has been acting as Trustee
for transactions similar to the contemplated transaction;

         (iii) the number of transactions similar to the contemplated
transaction for which the Trustee has acted as Trustee;

         (iii) the number of asset-backed securities transactions for which the
Trustee, as of the most recent year end, acts as trustee and the aggregate
outstanding dollar amount of securities issued in connection with such
asset-backed securities transactions;

         (iv)  a discussion of the Trustee's experience in, and procedures for,
the function it will perform under these Standard Terms and the related
Supplement;

         (v)   a description of any material changes during the three-year
period immediately preceding the contemplated transaction to the Trustee's
policies or procedures with respect to the function it will perform under these
Standard Terms and the related Supplement;

         (vi)  information regarding the Trustee's financial condition, to the
extent that there is a material risk that an adverse financial event or
circumstance involving the Trustee could have a material adverse effect on the
performance by the Trustee of its obligations under these Standard Terms and the
related Supplement;

         (vii) information regarding advances made by the Trustee, with respect
to transactions similar to the contemplated transaction, for the three-year
period immediately preceding the contemplated transaction, which may be limited
to a statement by an authorized officer of the Trustee to the effect that the
Trustee has made all advances required to be made with respect to such
transactions for such period, or, if such statement would not be accurate,
information regarding the percentage and types of advances not made as require
and the reasons for such failure to advance;

        (viii) a description of any material legal or governmental proceedings
pending (or known to be contemplated) against the Trustee;

         (ix)  a description of any affiliations or relationships between the
Trustee and the Depositor, any underwriter, any Significant Obligor, any Credit
Support Provider, Swap Counterparty or other material party related contemplated
transaction as contemplated by Item 1100(d)(1) of Regulation AB

                                       51

<PAGE>

         (b) In addition to such information as the Trustee is obligated to
provide pursuant to other provisions of these Standard Terms, if so requested by
the Depositor, the Trustee shall provide such information as is reasonably
required to facilitate preparation of distribution reports in accordance with
Item 1121 of Regulation AB. Such information shall be provided concurrently with
the reports delivered pursuant to Section 4.03 hereof.

         (c) The Trustee shall (i) notify the Depositor in writing of (A) any
material litigation or government proceedings pending against the Trustee and
(B) any affiliations between the Trustee and any of the parties identified in
clause (ix) of paragraph (a) of this Section, and (ii) provide the Depositor
with a description of such proceedings, affiliations or relationships.

         As a condition to the succession of the Trustee as trustee under these
Standard Terms and any Supplement by any Person (i) into which the Trustee may
be merged or consolidated or (ii) which may be appointed as a successor to the
Trustee, the Trustee shall provide to the Depositor at least 15 calendar days
prior to the effective date of such succession or appointment, (i) written
notice to the Depositor of such succession or appointment and (ii) in writing
and in form and substance reasonably satisfactory to the Depositor, all
information reasonably requested by the Depositor in order to comply with its
reporting obligation under Item 6.02 of Form 8-K with respect to any Series (or
any Class of such Series).

                                  ARTICLE VIII
                                  MARKET AGENT

         Section 8.01.  Market Agent. (a) If specified for a given Series, on
the Closing Date the Trustee shall enter into a Market Agent Agreement with
Merrill Lynch & Co. as the initial Market Agent, in the form attached to the
related Supplement. The Market Agent shall serve as such under the terms and
provisions hereof and of the Market Agent Agreement. The Market Agent, including
any successor appointed pursuant hereto, shall be a member of the National
Association of Securities Dealers, Inc., have capitalization of at least
$25,000,000, and be authorized by law to perform all the duties imposed upon it
by this Trust Agreement and the Market Agent Agreement. The Market Agent may be
removed at any time by the Trustee, acting at the written direction of the
Depositor; provided, however, that such removal shall not take effect until the
appointment of a successor Market Agent. The Market Agent may resign upon 30
days' written notice delivered to the Trustee. The Depositor shall use its best
efforts to appoint a successor Market Agent that is a qualified institution,
effective as of the effectiveness of any such resignation or removal.

                                   ARTICLE IX
                             SECURITIES INTERMEDIARY

         Section 9.01.  Resignation or Removal of the Securities Intermediary;
Appointment of Successor Securities Intermediary. (a) The Securities
Intermediary may at any time resign as Securities Intermediary hereunder by
written notice of its election so to do, delivered to the Trustee and the
Depositor, and such resignation shall take effect upon the appointment of a
successor Securities Intermediary and its acceptance of such appointment as
hereinafter provided; provided, however, that in the event of such resignation,
the Securities Intermediary shall (i) assist the Trustee and the Depositor in
finding a successor Securities Intermediary acceptable to the Trustee and the
Depositor and (ii) negotiate in good faith concerning any prepaid but unaccrued
fees.

         (b)   The Trustee, the Depositor or the Holders of the Required
Percentage--Removal of Securities Intermediary of Certificates may at any time
remove the Securities Intermediary as Securities Intermediary hereunder by
written notice delivered to the Securities Intermediary in the manner provided
in Section 11.04 hereof, and such removal shall take effect upon the appointment
of the successor Securities Intermediary and its acceptance of such appointment
as provided in paragraph (e) of this Section 9.01; provided, however, that in
the event of such removal, the Depositor shall negotiate in good faith with the
Securities Intermediary in order to agree regarding payment of the termination
costs of the Securities Intermediary resulting from such removal.

         (c)   Upon the designation and acceptance thereof of a successor
Securities Intermediary, following either resignation or removal of the
Securities Intermediary, the Securities Intermediary shall deliver to the
successor Securities Intermediary all records relating to the Certificates in
the form and manner then maintained by the

                                       52

<PAGE>

Securities Intermediary, which shall include a hard copy thereof upon written
request of the successor Securities Intermediary.

         (d)   If at any time the Securities Intermediary shall become incapable
of acting or shall be adjudged a bankrupt or insolvent, or a receiver of the
Securities Intermediary or of its property shall be appointed, or any public
officer shall take charge or control of the Securities Intermediary or of its
property of affairs for the purpose of rehabilitation, conservation or
liquidation, the Depositor shall petition any court of competent jurisdiction
for the removal of the Securities Intermediary and the appointment of a
successor Securities Intermediary. In the event the Securities Intermediary
resigns or is removed, the Securities Intermediary shall reimburse the Depositor
for any fees or charges previously paid to the Securities Intermediary in
respect of duties not yet performed under this Trust Agreement which remain to
be performed by a successor Securities Intermediary.

         (e)   In case at any time the Securities Intermediary acting hereunder
notifies the Trustee or the Depositor that it elects to resign or the Trustee,
the Depositor or Holders of the Required Percentage--Removal of Securities
Intermediary of Certificates notifies or notify the Securities Intermediary that
it or they elects or elect to remove the Securities Intermediary as Securities
Intermediary, the Depositor shall, within sixty (60) days after the delivery of
the notice of resignation or removal, appoint a successor Securities
Intermediary, which shall satisfy the requirements set forth in Section 2.06. If
no successor Securities Intermediary has been appointed within sixty (60) days
after the Securities Intermediary has given written notice of its election to
resign or the Trustee, the Depositor or Holders of the Required
Percentage--Removal of Securities Intermediary of Certificates have given
written notice to the Securities Intermediary of its or their election to remove
the Securities Intermediary, as the case may be, the Securities Intermediary may
petition any court of competent jurisdiction for the appointment of a successor
Securities Intermediary. Every successor Securities Intermediary shall execute
and deliver to its predecessor, to the Trustee and to the Depositor an
instrument in writing accepting its appointment hereunder, and thereupon such
successor Securities Intermediary, without any further act or deed, shall become
fully vested with all the rights, powers, duties and obligations of its
predecessor and for all purposes shall be the Securities Intermediary under this
Trust Agreement, and such predecessor, upon payment of all sums due it and on
the written request of the Trustee and the Depositor, shall execute and deliver
an instrument transferring to such successor all rights, obligations and powers
of such predecessor hereunder, and shall duly assign, transfer and deliver all
right, title and interest in the Deposited Assets and parts thereof to such
successor. Any successor Securities Intermediary shall promptly give notice of
its appointment to the Certificateholders of Certificates for which it is
successor Securities Intermediary in the manner provided in Section 11.04
hereof.

         (f)   Any Person into or with which the Securities Intermediary may be
merged, consolidated or converted shall be the successor of such Securities
Intermediary without the execution or filing of any document or any further act.

                                       53

<PAGE>

                                   ARTICLE X
                                   TERMINATION

         Section 10.01.  Termination upon Liquidation of All Underlying
Securities. (a) The respective obligations and responsibilities under this Trust
Agreement of the Depositor and the Trustee (other than the obligations of the
Trustee to make distributions to Holders of the Certificates of any given Series
as hereafter set forth and to provide information reports and information tax
reporting) shall terminate upon the distribution to such Holders of all amounts
held in all the Accounts for such Series and required to be paid to such Holders
pursuant to this Trust Agreement on the Distribution Date coinciding with the
final payment on or other liquidation (which may include redemption or other
purchase thereof by the applicable Underlying Securities Issuer) (or any Advance
with respect thereto) of the last Deposited Asset remaining in the Trust for
such Series or the disposition of all property acquired upon liquidation of any
such Underlying Security; provided, however, that in no event shall any trust
created hereby continue beyond the earlier of (1) any date set forth in Section
13 of the applicable Supplement as the termination date for such trust or (2)
the expiration of 21 years from the death of the last survivor of the
descendants of Joseph P. Kennedy, the late ambassador of the United States to
the Court of St. James, living on the date hereof.

         (b)   The Depositor shall provide the Trustee with written notice of
any of the events set forth in paragraph (a) of this Section 10.01.

         (c)   Upon presentation and surrender of the Certificates by the
Certificateholders on the Final Scheduled Distribution Date, or the Distribution
Date coinciding with or next following the earlier to occur of the occurrences
specified in paragraph (a) of this Section 10.01, with respect to the applicable
Series of Certificates, the Trustee shall distribute to each Holder presenting
and surrendering its Certificates (i) the amount otherwise distributable on such
Distribution Date in accordance with Section 4.01 in respect of the Certificates
so presented and surrendered, or (ii) as specified in the applicable Supplement,
if in connection with the Trustee's sale of all the remaining Underlying
Securities. Any funds not distributed on such Distribution Date shall be set
aside and held in trust for the benefit of Certificateholders not presenting and
surrendering their Certificates in the aforesaid manner, and shall be disposed
of in accordance with this Section 10.01 and Section 4.01 hereof. Immediately
following the deposit of funds in trust hereunder, the Trust for such Series
shall terminate. Subject to applicable escheat laws, the Trustee shall pay to
the Depositor any cash that remains unclaimed, together with interest, if any,
thereon, held by the Trustee on the date two years after such termination.

                                   ARTICLE XI
                            MISCELLANEOUS PROVISIONS

         Section 11.01.  Amendment. (a) Unless otherwise specified in the
applicable Supplement, this Trust Agreement may be amended from time to time by
the Depositor, the Trustee and the Securities Intermediary without notice to or
consent of any of the Certificateholders, for any of the following purposes:

         (i)   to cure any ambiguity;

         (ii)  to correct or supplement any provision herein that may be
     inconsistent with any other provision herein or in the Supplement;

         (iii) to change the Trustee or the Securities Intermediary for a
     Series subsequent to the Closing Date for such Series;

         (iv)  to provide for administration of separate Trusts by more than one
     trustee;

         (v)   to provide for a successor Trustee or successor Securities
     Intermediary with respect to Certificates of one or more Series;

         (vi)  to provide for the issuance of a new Series pursuant to a
     Supplement issued hereunder pursuant to Sections 5.01 and 5.12 hereof;

         (vii) to add or supplement any Credit Support for the benefit of any
     Certificateholders (provided, however, that if any such addition affects
     any Series

                                       54

<PAGE>

     or Class of Certificateholders differently than any other Series or Class
     of Certificateholders, then such addition will not, as evidenced by an
     Opinion of Counsel, have a material adverse effect on the interests of any
     affected Series or Class of Certificateholders);

        (viii) to add to the covenants, restrictions or obligations of the
     Depositor, the Trustee, the Securities Intermediary or the Administrative
     Agent, if any, for the benefit of the Certificateholders;

         (ix)  to comply with any requirements imposed by the Code; or

         (x)   to add, change or eliminate any other provisions with respect to
     matters or questions arising under this Trust Agreement.

         Any amendment made pursuant to this paragraph (a) is subject to the
condition that such amendment shall satisfy the Rating Agency Condition with
respect to such amendment and shall not cause any Trust created hereunder to
fail to qualify as a fixed investment trust (or "grantor trust") for federal
income tax purposes.

         (b)    Without limiting the generality of the foregoing, unless
otherwise specified in the applicable Supplement, with respect to any Series,
this Trust Agreement may also be modified or amended from time to time by the
Depositor, the Trustee and the Securities Intermediary with the consent of the
Holders of Certificates representing the Required Percentage--Amendment of the
aggregate Voting Rights of those Certificates that are adversely affected by
such modification or amendment for the purpose of adding any provision to or
changing in any manner or eliminating any of the provisions of this Trust
Agreement or of modifying in any manner the rights of the Holders of
Certificates; provided, however, that no such amendment shall (i) reduce in any
manner the amount of, or delay the timing of, payments received on Underlying
Securities which are required to be distributed on any Certificate without the
consent of the Holders of such Certificates, (ii) reduce the percentage of
aggregate Voting Rights required to take any action specified in this Trust
Agreement, without the consent of the Holders of all Certificates of such Series
or Class then Outstanding, or (iii) cause any Trust created hereunder to fail to
qualify as a fixed investment trust (or "grantor trust") for federal income tax
purposes.

         Notwithstanding any other provision of this Trust Agreement, for
purposes of the giving or withholding of consents pursuant to this Section
11.01, Certificates registered in the name of the Depositor, the Trustee, the
Securities Intermediary or any Affiliate of the Depositor, the Trustee or the
Securities Intermediary shall be entitled to Voting Rights with respect to
matters affecting such Certificates. Notwithstanding any other provision of this
Trust Agreement, this paragraph (b) shall not be amended without the unanimous
consent of the Holders of all such Certificates.

         (c)    Promptly after the execution of any such amendment or
modification, the Trustee shall furnish a copy of such amendment or modification
to each Certificateholder of the affected Series or Class and to the Rating
Agency. It shall not be necessary for the consent of Certificateholders under
this Section 11.01 to approve the particular form of any proposed amendment, but
it shall be sufficient if such consent shall approve the substance thereof. The
manner of obtaining such consents and of evidencing the authorization of the
execution thereof by Certificateholders shall be subject to such reasonable
regulations as the Trustee may prescribe.

         Section 11.02. Limitation on Rights of Certificateholders. (a) The
death or incapacity of any Certificateholder shall not operate to terminate this
Trust Agreement or the Trust, nor entitle such Certificateholder's legal
representatives or heirs to claim an accounting or to take any action or
Proceeding in any court for a partition or winding up of the applicable Trust,
nor otherwise affect the rights, obligations and liabilities of the parties
hereto or any of them.

         (b)    No Certificateholder of a given Series shall have any right to
vote (except as expressly provided for herein) or in any manner otherwise
control the operation and management of any Trust, or the obligations of the
parties hereto, nor shall anything herein set forth, or contained in the terms
of the Certificates, be construed so as to constitute the Certificateholders
from time to time as partners or members of an association; nor shall any
Certificateholder be under any liability to any third person by reason of any
action taken by the parties to this Trust Agreement other than pursuant to the
provisions hereof.

                                       55

<PAGE>

         (c)    No Certificateholder of a given Series shall have any right by
virtue of any provision of this Trust Agreement to institute any Proceeding in
equity or at law upon or under or with respect to this Trust Agreement, unless:

         (i) such Holder previously shall have given to the Trustee a written
     notice of breach of this Trust Agreement and of the continuance thereof;

         (ii) the Holders of Certificates of such Series evidencing not less
     than the Required Percentage--Remedies of the aggregate Voting Rights of
     such Series shall have made written request upon the Trustee to institute
     such Proceeding in its own name as Trustee hereunder;

         (iii) such Certificateholder or Certificateholders shall have offered
     to the Trustee such reasonable indemnity as it may require against the
     costs, expenses and liabilities to be incurred therein or thereby;

         (iv) the Trustee, for 15 days after its receipt of such notice,
     request and offer of indemnity, shall have neglected or refused to
     institute any such Proceeding; and

         (v) no direction inconsistent with such written request has been given
     to the Trustee during such 15-day period by Certificateholders evidencing
     not less than the Required Percentage--Remedies of the aggregate Voting
     Rights of such Series.

It is understood and agreed that the Trustee shall not be obligated to make any
investigation of matters arising under this Trust Agreement or to institute,
conduct or defend any Proceeding hereunder or in relation hereto at the request,
order or direction of any Certificateholders unless such Certificateholders have
offered to the Trustee the reasonable indemnity referred to above. It is further
understood and agreed, and expressly covenanted by each Certificateholder of
each Series with every other Certificateholder of such Series and the Trustee,
that no one or more Holders of Certificates of such Series shall have any right
in any manner whatever by virtue of any provision of this Trust Agreement to
affect, disturb or prejudice the rights of the Holders of any other of the
Certificates of such Series, or to obtain or seek to obtain priority over or
preference to any other such Holder, or to enforce any right under this Trust
Agreement, except in the manner herein provided and for the equal, ratable and
common benefit of all Certificateholders of such Series. For the protection and
enforcement of the provisions of this Section 11.02, each and every
Certificateholder and the Trustee shall be entitled to such relief as can be
given either at law or in equity.

         Section 11.03. Governing Law. This Trust Agreement (including, without
limitation, the establishment and maintenance of Certificate Accounts and all
interests, duties and obligations of the parties hereunder or thereunder or with
respect hereto or thereto) and each Certificate shall be construed in accordance
with and governed by the law of the State of New York.

         Section 11.04. Notices. (a) All directions, demands and notices
hereunder shall be in writing and shall be delivered as set forth in the
applicable Supplement.

         (b)    Any notice required to be provided to a Holder shall be given by
first class mail, postage prepaid, at the last address of such Holder as shown
in the Certificate Register. Any notice so mailed within the time prescribed in
this Trust Agreement shall be conclusively presumed to have been duly given when
mailed, whether or not the Certificateholder receives such notice.

        (c)     Any and all notices to be given to the Depositor shall be deemed
to have been duly given if sent by facsimile transmission to the Depositor at
Merrill Lynch & Co., World Financial Center, New York, New York 10080,
Attention: Michael F. Connor, facsimile transmission number (212) 449-9054,
telephone confirmation number (212) 449-2401. The Depositor may change this
information by written notice to the Trustee and to the Securities Intermediary.

         (d)    Any and all notices to be given to the Trustee shall be deemed
to have been duly given if sent by facsimile transmission to the Trustee at he
Bank of New York, 101 Barclay Street, Floor 8E, New York, NY 10286, Attn:
Corporate Trust Dealing & Trading Group, referencing the designation of the
applicable Series, facsimile transmission

                                       56

<PAGE>

number (212) 815-2850, telephone confirmation number (212) 815-2849. The Trustee
may change this information by notice to the Depositor and to the Securities
Intermediary.

         (e)    Any and all notices to be given to the Securities Intermediary
shall be deemed to have been duly given if sent by facsimile transmission to the
Securities Intermediary at The Bank of New York, 101 Barclay Street, Floor 8E,
New York, NY 10286, Attn: Corporate Trust Dealing & Trading Group, referencing
the designation of the applicable Series, facsimile transmission number (212)
815-2380, telephone confirmation number (212) 815-2915. The Securities
Intermediary may change this information by notice to the Depositor and to the
Trustee.

         (f)    Any and all notices to be given to the Swap Counterparty, if
any, will be specified in the Supplement.

         Section 11.05. Notice to Rating Agencies. (a) The Trustee shall use its
best efforts promptly to provide notice to each Rating Agency with respect to
each of the following of which it has actual knowledge:

         (i) any change or amendment to this Trust Agreement;

         (ii) the resignation or termination of the Trustee;

         (iii) the final payment to Holders of the Certificates of any Class;

         (iv) any change in the location of the Certificate Account; and

         (v) any event that would result in the inability of the Trustee to
     make Advances.

         (b) In addition, the Trustee shall promptly furnish to each Rating
Agency copies of each report to Certificateholders described in Section 4.03.

         (c) Any such notice pursuant to this Section 11.05 shall be in writing
and shall be deemed to have been duly given if personally delivered or mailed by
first class mail, postage prepaid, or by express delivery service to each Rating
Agency at the address specified below or in the applicable Supplement.

         (d) (i) Any and all notices to be given to Moody's shall be deemed to
     have been duly given if sent by facsimile transmission to Moody's at
     Moody's Investors Service, Inc., 99 Church Street, New York, NY 10007,
     Attention: CBO/CLO Monitoring Department, facsimile transmission number
     (212) 553-0355, telephone confirmation number (212) 553-1494. Moody's may
     change this information by notice to the Depositor and the Trustee.

         (ii) Any and all notices to be given to S&P shall be deemed to have
     been duly given if sent by facsimile transmission to Standard & Poor's
     Ratings Services, 55 Water Street, 40th Floor, New York, NY 10041,
     Attention: Structured Finance Surveillance Group, facsimile transmission
     number (212) 438-2664, telephone confirmation number (212) 438-2482. S&P
     may change this information by notice to the Depositor and the Trustee.

         (iii) Any and all notices to be given to DCR shall be deemed to have
     been duly given in sent by facsimile transmission to DCR at Duff & Phelps
     Credit Rating Co., 55 E. Monroe Street, Suite 3500, Chicago, IL 60603-5701,
     Attention: Karen O'Donnell, facsimile transmission number (312) 368-3155,
     telephone confirmation number (312) 368- 3100. DCR may change this
     information by notice to the Depositor and the Trustee.

         (iv) Any and all notices to be given to Fitch shall be deemed to have
     been duly given in sent by facsimile transmission to Fitch at Fitch
     Investors Service, L.P., One State Street Plaza, New York, NY 10004,
     telephone confirmation number (212) 908-0243. Fitch may change this
     information by notice to the Depositor and the Trustee.

         Section 11.06. Severability of Provisions. If any one or more of the
covenants, agreements, provisions or terms of this Trust Agreement shall be for
any reason whatsoever held invalid, then such covenants, agreements, provisions
or terms shall be deemed severable from the remaining covenants, agreements,
provisions or terms

                                       57

<PAGE>

of this Trust Agreement and shall in no way affect the validity or
enforceability of the other provisions of this Trust Agreement or of the
Certificates or the rights of the Holders thereof.

         Section 11.07. Nonpetition Covenant. Notwithstanding any prior
termination of this Trust Agreement, each of the Trustee (including any
Administrative Agent, Authenticating Agent and Paying Agent) and the Depositor
agrees that it shall not, until the date which is one year and one day after the
termination of a Series, acquiesce, petition or otherwise invoke or cause a
Trust to invoke the process of the United States, any State or other political
subdivision thereof or any entity exercising executive, legislative, judicial,
regulatory or administrative functions of or pertaining to government for the
purpose of commencing or sustaining a case by or against the Trust under a
Federal or state bankruptcy, insolvency or similar law or appointing a receiver,
liquidator, assignee, trustee, custodian, sequestrator or other similar official
of such Trust or all or any part of the property or assets of such Trust or
ordering the winding up or liquidation of the affairs of such Trust.

         Section 11.08. No Recourse. None of the Trustee (including any
Administrative Agent, Authenticating Agent or Paying Agent), the Securities
Intermediary or the Depositor shall have any recourse to the Underlying
Securities, except as specifically provided in the related Supplement.

         Section 11.09. Article and Section References. All Article and Section
references used in these Standard Terms, unless otherwise provided, are to
Articles and Sections in these Standard Terms.

         Section 11.10. Counterparts. These Standard Terms may be executed
simultaneously in any number of counterparts, each of which counterparts shall
be deemed to be an original, and such counterparts shall constitute one and the
same instrument.

         Section 11.11. Trust Indenture Act. This Trust Agreement is subject to
the provisions of the TIA and shall, to the extent applicable, be governed by
such provisions. The Trustee agrees to take all actions within its control to
prevent these Standard Terms, as supplemented by any Supplements, from failing
to qualify under the TIA.

                                       58

<PAGE>

         IN WITNESS WHEREOF, the Depositor, the Trustee and the Securities
Intermediary have caused these Standard Terms to be duly executed by their
respective officers thereunto duly authorized, in each case as of the day and
year first above written.

                               MERRILL LYNCH DEPOSITOR, INC.,
                                  as Depositor

                               By:

                               ______________________________
                               Name:  Stephan Kuppenheimer
                               Title:  President

                               THE BANK OF NEW YORK,
                                    as Trustee

                               By:

                               ______________________________
                               Name:  Kevin Pennant
                               Title:  Assistant Vice President

                               THE BANK OF NEW YORK,
                                    as Securities Intermediary

                               By:

                               ______________________________
                               Name:  Kevin Pennant
                               Title:  Assistant Vice President

                                       59

<PAGE>

EXHIBIT A

                               Form of Certificate

                              (begins on next page)

<PAGE>

EXHIBIT B

                             Market Agent Agreement

                              (begins on next page)

<PAGE>

EXHIBIT C

                            Form of Escrow Agreement

                              (begins on next page)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]